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The Consensus Workshop on Formaldehyde consisted of bringing together scientists from academia,
government, industry and public interest groups to address some important toxicological questions
concerning the health effects of formaldehyde. The participants in the workshop, the Executive Panel
which coordinated the meeting, and the questions posed, all were chosen through a broadly based
nomination process in order to achieve as comprehensive a consensus as possible. The subcommittees
considered thetoxicological problems associatedwith formaldehyde in the areas ofexposure, epidemiology,
carcinogenicity/histology/genotoxicity, immunology/sensitization/irritation, structure activity/biochemis-
try/metabolism, reproduction/teratology, behavior/neurotoxicity/psychology and risk estimation. Some
questions considered included the possible human carcinogenicity offormaldehyde, as well as other human
health effects, and the interpretation of pathology induced by formaldehyde. These reports, plus
introductory material on the procedures used in setting up the Consensus Workshop are presented here.
Additionally, there is included a listing ofthe data base that was made available to the panel chairmen
prior to the meeting and was readily accessible to the participants during their deliberations in the
meeting. This data base, since it was computerized, was also capable of being searched for important
terms. These materials were supplemented by information brought by the panelists.
The workshop has defined the consensus concerning a number of major points in formaldehyde
toxicology and has identified a number of major deficits in understanding which are important guides to
future research.
Introduction
Background
At the request ofthe White House Office on Science
and Technology Policy (OSTP), the Environmental
Protection Agency (EPA) has worked with the National
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Center for Toxicological Research (NCTR) to conduct a
Consensus Workshop on Formaldehyde. This workshop
is part ofthe NCTR Consensus Workshop Series, which
continues the commitment ofaddressing today's impor-
tant and often controversial toxicological issues. This
series is an evolving process where scientists from
academia, government, industry, and public interest
groups can meet and resolve scientific questions on the
basis ofthe best science currently available. Since this
is a relatively new approach to toxicological questions,
the "workings" of the workshop will be explained in
some detail in an effort to give a clear understanding of
the process and, hopefully, provide some insight into
howfuture workshops canutilize the experiences ofthis
one to optimize their chances for success.
History of this Consensus Workshop
Upon the determination of OSTP that it would be
useful for a Consensus Workshop to convene and
attempt to resolve some important controversies con-
cerning the scientific status of formaldehyde,the EPA
and NCTR entered into an Interagency Agreement,
which determined that an Executive Panel, drawn from
academia, government, industry and public interest
groups, would be appointed and provide direction to the
workshop. This direction consisted of: (1) defining the
format of the workshop, which eventually consisted of
eight separate panels; (2) determining the topics, in theCONSENSUS WORKSHOP ON FORMALDEHYDE
form of questions, which focused the discussion; (3)
selecting the experts in the various fields to comprise
the section panels; and (4) choosing the section chair-
man and alternate chairman of each panel.
Three months before the meeting, the chairman of
the Executive Panel notified the chairmen ofthe various
sections that a compilation ofall current information on
formaldehyde, both published and unpublished litera-
ture, was available. The compilation was able to be
searched by keywords, permitting the massive amount
of material to be amenable to analysis. This data base
(Appendix I) was also available at the Consensus
Workshop, as were copies of whatever reprints were
required by the panel members.
Workshop Ground Rules
Before the meeting, the chairman of the Executive
Panel and the section chairmen discussed the role ofthe
section chairmen and what was expected in terms ofthe
report from each section. Ground rules established by
the Executive Panel for conducting the workshop were
as follows.
(1) Each panel's report was to focus on those areas
where consensus was reached on an issue by the panel,
including the major considerations and factors in reach-
ing agreement. Other general ideas, as well as special
issues where consensus was not reached, were to be
listed and the scientific basis preventing consensus
stated.
(2) Reaching consensus does not mean formal voting.
Instead, the chairman was to guide the discussion in an
effort to get agreement of all members of the panel on
each topic of discussion-asking at the end whether
there is a consensus.
(3) The alternate chairman/secretary was to take
notes during the panel meetings. The chairman was to
have the responsibility for submission ofthe panel draft
reports in time for typing and prior to the Wednesday
morning session.
(4) The draft report from each working group was to
be reviewed by each member ofthat panel. Ideally, each
panel's report was to be drafted and reviewed by every
member before leaving the workshop. If this was not
accomplished, a draft was to be sent to each panel
member for comment. If a second draft were to be
necessary, the same procedures would be followed.
(5) Written comments or requests to present in-
formation/data from the floor were to be received by the
panel chairman for consideration and inclusion in the
panel deliberation. No other comments were to be
accepted.
(6) Executive Panel members were not to revise or
editthe working group reports. Theirduties were: (a) to
read each panel's report and to identify either areas
requiring clarification or inconsistencies between vari-
ous panels' findings so that the chairmen ofthe relevant
panels could attempt to correct these problems and (b)
to write a short introduction explaining the purpose of
the workshop and the process followed in selecting
topics and participants as well as in discussing topics.
The conclusions ofeach workinggroup were to speak for
themselves and not require interpretation, summary or
introduction.
(7) In the final document, a disclaimer was to be cited
that the statements contained therein should in no way
be construed as representing the official opinion or
position of any agency, organization or institution to
which participants in the workshop belong.
(8) The findings ofthe Risk Estimation Panel were to
be circulated to all panelists for evaluation and comment,
with a turnaround time not to exceed three weeks. The
Risk Estimation Panel was then to have the responsibil-
ity for final drafting of their report based on their
deliberation and the commentsfromthe otherpanelists.
(9) During the deliberation of the Risk Assessment
Panel, the chairperson or designate was to report only
the findings ofthe panel as a whole. Ifa panel chairman
or designate were to have a personal comment, he/she
could notify the chairman ofthe Risk Assessment Panel
in writing as was the case for any other member of the
panel and the audience.
(10) The Risk Assessment Panel report was to be
bound by the consensus findings of the panels. Valid
scientific disagreements within the panel were to be
treated as stated in item (1) above.
Workshop Foci
Recent scientific studies have heightened concern
about the possible human health effects of formalde-
hyde. The data relating to some of these health effects
have been reviewed by governmental, independent and
international panels of scientists. These reviews of the
formaldehyde data have resulted in regulatory actions
or proposals by several federal agencies; however, con-
troversy remains over a number of scientific issues. At
the request of the Regulatory Work Group on Science
and Technology, White House Office of Science and
Technology Policy, the National Center forToxicological
Research (NCTR) convened a scientific consensus work-
shop on formaldehyde to discuss and seek general
agreement on the existing scientific data and identify
future research needs.
The Consensus Workshop on Formaldehyde met and
discussed in an objective and nonadversarial fashion the
relevant scientific evidence on formaldehyde in the
general areas ofepidemiology, exposure, toxicology and
risk estimation. The endpoints discussed for each ofthe
above general areas could include, but were not re-
stricted to: carcinogenicity, genotoxicity, irritation, re-
productive effects/teratology, behavioral effects, im-
munotoxicology/sensitization, neurotoxicity, biochemi-
caleffects/metabolism andhistopathological effects. The
emphasis ofthe workshop was to develop consensus on
the scientific issues concerning formaldehyde; however,
the results may also be used to assist in future regula-
tory decision making.
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Because of the wide variety of information available
within a topic, the nature of the area addressed and
difference in the scope and depth of the questions, the
different panels chosetopresentthe answersdifferently.
Some panels gave answers directly, others decided to
present the response in a narrative form. To preserve
the nuances and subtleties of the different panels of
experts, there has been no editing ofthe panel reports,
other than that required for journal publication. This
led to some significant differences in the style, pacing
and flow of the narrative.*
Workshop Orientation
Each panel specifically concentrated on the "science"
and the scientific questions ofnumerous issues concern-
ingformaldehydeand deliberately avoidedphilosophical,
policy and/or regulatory aspects. Despite the organiza-
tional difficulties in obtaining a "balanced input" from
divergent scientific viewpoints, the workshop demon-
stratedthat, inconsideringscienceissueswithgive-and-
take discussion, many of the differences have been
significantly narrowed and consensus reached on many
important toxicological issues. It is hoped that this
workshophasbeeninstrumentalinupdatingandsynthe-
sizing the scientific data on formaldehyde and strength-
ening the factual basis for environmental health risk
assessment of this substance.
Each panel prepared and reviewed a report from its
deliberations, and the chairmen ofeach panel presented
the reports to the workshop in plenary session. The
panel reports follow in their entirety. Because of the
density of information, complexities, and variances of
the panel reports, the Executive Panel decided not to
attempt further summarization.
Exposure Panel Reportt
Topic 1. What are the sources, modes and levels of
exposure in various segments of the population?
a. What are the available monitoring (collection and
analytical) methods and what are the reliability,
accuracy, sensitivity, specificity, comparability and
limitations of these methods?
b. What is known about the levels and sources of
exposure in residences, public buildings, occupa-
tional areas, outdoor air, water, soil, consumer
products and medical procedures? How do these
exposures vary in duration, concentration and
frequency?
c. What factors (environmental and physiological)
affect exposure in man and experimental animals?
* Italic number/letter designations (e.g., 2a) refer to the specific
topic areas; the same number is used more than once ifthe discussion
again becomes relevant to a particular topic.
t Exposure Panel: Ian Nisbet (Chairman); Bernd Seifert (Alternate
Chairman/Secretary); Jean L. Balmat; John M. Fajen; Richard
Gammage; Eugene R. Kennedy; Michael Silverstein.
d. What is the size and composition of populations
exposed to various ranges of concentrations of
formaldehyde by various routes?
Topic 2. What data that are currently lacking would
be most important in resolving controversies about
exposure?
TIpic 1: Sources, Modes and
Levels of Exposure
la. Many methods have been used for measuring
formaldehyde levels in air and other media. A selection
ofthese methods has been critically reviewed by Balmat
(1) for the Formaldehyde Institute. The information in
Table 1 has been extracted and condensed from this
review to provide a concise summary ofthe 19 methods
that provide the basis for the monitoring data reviewed
by the panel. To facilitate comparisons, columns 4 and 5
in Table 1 provide estimates of the sensitivity of each
method for short-term (15-min) and long-term (usually
8-hr) sampling (devices intended for sampling over
periods ofseveral days may achieve higher sensitivities
than those listed in Table 1). These reported sensitivi-
ties do not necessarily represent values measured using
standardtestatmospheric concentrations, but arecalcu-
lated from reported limits of quantitation, assuming
recommended sampling rates. The last two columns list
the main advantages and disadvantages ofeachmethod,
including known interferences, classified as positive (+)
or negative (-) where appropriate. Criteria for precision
and accuracy ofeach method have been established (1).
However, these criteria are valid onlywhenthe methods
are used according to their written procedures, and
deviations fromthese procedures in sample collection or
analyticalprocedures cangreatlyinfluence the precision
and accuracy of any procedure.
Evaluation of the reliability of monitoring data re-
quires critical assessment of the methodology used for
sampling and analysis and ofthe interfering compounds
likely to be present. As shown in Table 1, each method
hasadvantagesanddisadvantages. Choiceofaninappro-
priate method, improper conduct of the sampling or
analysis, or the presence of interferences may lead to
substantial positive or negative biases.
In thejudgment ofthe panel, adequate methods exist
forboth short-term and long-termmonitoringofformal-
dehyde concentrations in a variety ofconditions, includ-
ing occupational and residential situations. A number of
these methods have been standardized and evaluated
under laboratory conditions. However, panel members
expressed concern about several aspects of published
formaldehyde studies: (a) some reports included inade-
quate or no documentation of the methods used; (b)
some studies involved inappropriate choice or improper
modification of methods; (c) some methods (e.g., pas-
sive monitors) are coming into widespread use without
complete evaluation under field conditions. For this
reason, some studies probably have achieved substan-
tially less precision and accuracy than claimed for the
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Table 1. Sampling and analytical methods for formaldehyde.a
Analytical technique Sensitivity, ppm
Method designation Sampling Analysis 15 min Long-term Advantages Disadvantages
Chromotropic acid, Midget impinger
P&CAM 125
Paraosaniline, original Midget impinger
Pararosaniline,
modified
Pararosaniline,
TGM-555
MBTH
Acetylacetone,
spectrophotometric
Acetylacetone,
fluorimetric
2,4-DNPH,
aqueous ethanol
2,4-DNPH
coated adsorbent
P&CAM 318
NIOSH S327
OSHA, acidic
hydrazine
P&CAM 354
MIRAN
Draeger
Passive monitor
3 M
DuPont
Air Quality
Research
Envirotech
Midget impinger
Continuous
Absorber
Midget impinger
Midget impinger
Midget impinger
Adsorbent tube
Reactive
adsorbent
Midget impinger
Midget impinger
Reactive
adsorbent
Continuous
Reactive
adsorbent
Reactive
adsorbent
Reactive
adsorbent
Reactive
adsorbent
Moist
adsorbent
Spectrophotometry
Spectrophotometry
0.16
0.02
Spectrophotometry 0.045
Colorimetric 0.05
Spectrophotometry 0.10
Spectrophotometry 0.10
Fluorimetry
HPLC
0.04
0.04
(1 hr)
0.0005
(8 hr)
Sensitive and selective,
simple technique
High sensitivity,
simple technique
0.001 High sensitivity,
(8 hr) simple technique,
uses no Hg compound
NA High sensitivity,
near real-time
monitoring
0.003
(8 hr)
Simple, good sample
stability
Mild pH, sensitive and
simple technique
Mild pH, sensitive and
simple technique
0.00006 0.000015
(1 hr)
1.32 0.10
(3 hr)
HPLC
Ion chromatography 0.8
Polarography 1.62
Polarography 0.
Gas chromatography 7.32
Infrared
Visual
Sensitive, specific,
good collection
efficiency
Specific, solid
adsorbent
0.025 Specific, solid
(8 hr) sorbent
2 0.27 Few steps in procedure,
(1.5 hr) stable sample
0 0.01
(2.5 hr)
0.5
(4 hr)
Sensitive
Selective, sorbent
tube, stable sample
0.4 NA Real-time analysis
0.5 NA Real-time analysis
Spectrophotometry 3.2
(CA)
Spectrophotometry 8
(CA)
Spectrophotometry 6.7
(CA)
Spectrophotometry 0.72
(PUR)
0.1
(8 hr)
0.25
(8 hr)
0.21
(8 hr)
0.06
(3 hr)
Ease of sampling
Ease of sampling,
simple analytical
procedure
Ease of sampling
Ease of sampling
a(CA)-chromotropic acid; (PUR)-Purpald.
Interferences: phenol (-),
other organics (-)
Interferences: SO2 (+),
uses toxic materials,
uses double impingers,
poor sample stability
Interference: SO2 (+),
uses double impingers,
poor sample stability,
results are temperature
dependent
Interference: SO2 (+),
uses toxic materials,
time consuming and
involved maintenance
Poor specificity
Interferences: other
aldehydes (+), amines
(-), SO2 (-), unstable
chromogen
Interferences: other
aldehydes (+), amines
(-), SO2 (+), unstable
chromogen
High level of analytical
sophistication
High level of analytical
sophistication, user
must prepare tubes,
short shelf-life, variable
blank level, poor
sensitivity
High level of analytical
sophistication, poor
sample stability, inter-
ferences: formic acid
(+), variable recovery
High level of analytical
sophistication, poor
sensitivity, interference:
other aldehydes (+)
High level of analytical
sophistication, inter-
ference: acetaldehyde
(+), high blanks
High level of analytical
sophistication, poor
sensitivity
Subject to multiple
interferences (+)
Questionable accuracy and
precision
Sensitive to humidity and
face velocity
Poor sensitivity, variable
blanks
Limited shelf life, results
sensitive to humidity
Results not easily
interpreted, color
reagent unstable,
turbidity correction,
interferences: other
aldehydes (+)
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methods. In general, negative biases (due to interfer-
ences and sample instability) are likely to be more
frequent than positive biases. However, in the panel's
judgment, these errors are probably less serious than
errors introduced by the inadequacies and biases in
sampling that are discussed below.
Methods for biological monitoring of exposure to
formaldehyde by measuring increases in concentrations
offormate in urine have been proposed (2-4). However,
natural variability in formate levels is too high for these
methods to be useful except in populations exposed to
ambient formaldehyde levels greater than 1 ppm.
Ib. Occupational Exposure. The panel reviewed
four surveys and compilations of data on occupational
exposure to formaldehyde as well as a number of
primary studies. The largest single source of data is a
study conducted for the Synthetic Organic Chemical
Manufacturers' Association (SOCMA) (5), in which 50
industries with the potential for significant worker
exposure to formaldehyde were identified and 17 indus-
tries were surveyed. Company monitoring data were
tabulated for 10 industries and estimates were made of
the frequency and range of exposures in all 17 indus-
tries. However, the utility ofthis information is severely
limited since only 89 of the 3365 companies to which
questionnaires were sent provided monitoring data, and
the report did not specify the methods ofanalysis orthe
circumstances in which the data were collected. For
these reasons, the panel felt that these data could not
be scientifically evaluated. The panel alsoexcluded from
its review several other studies for which methods of
analysis or other critical pieces of information were
omitted.
Table 2 summarizes the remaining data available to
the panel. Many of these data have previously been
compiled by the U.S. Environmental Protection Agency
(6) and Clement Associates (7). We have added results
from recent studies by the National Institute for
Occupational Safety and Health (NIOSH) (8) and sev-
eral additional published reports. The compilation by
Hattis et al. (9) was not available to the panel.
The panel regards the ambient monitoring data sum-
marized in Table 2 as reasonably reliable measures of
the concentrations of formaldehyde in the workplaces
that were sampled, except for measurements made by
the charcoal tube (CT) method, which are especially
subject to negative bias. Thus, at least at the time of
sampling, the data indicate substantial exposure of
workers to formaldehyde in several industries. Speci-
fically, sample means of 1 ppm or more have been
reported in the following industries and occupations:
formaldehyde production; resin and plastic materials
production; apparelmanufacture; plywoodparticleboard
and wood furniture manufacture; paper and paperboard
manufacture; urea-formaldehyde foam insulation
(UFFI) dealers andinstallers; mushroomfarms; funeral
services; and pathological and biology laboratories.
High concentrations of formaldehyde have also been
reported in individual samples from iron foundries and
plastic molding facilities. However, the panel notes that
published data are available for only 34job categories in
29 industries and occupations. For no job category are
the data sufficient to characterize temporal or within-
plant variability, or to characterize exposure in more
than a small handful of plants. Hence, the panel
concludes that the available data, although useful in
showing the range of exposures encountered in some
workplaces, are not sufficiently systematic or represen-
tative to characterize the entire spectrum ofexposures
in U.S. industry.
In addition to the data summarized in Table 2, the
SOCMA (5) survey suggested that substantial exposure
to formaldehyde also occurs in several other industries,
including industrial and specialty chemicals and manu-
facture of hardwood plywood, particleboard and abra-
sive products. In addition, both the SOCMA survey and
the National Occupational Hazard Survey (35) identified
a number of other industries with potential formalde-
hyde exposures, for which the panel has not encoun-
tered any monitoring data.
lb. Indoor Exposure. Table 3 summarizes data
from six studies offormaldehyde levels in residences in
different parts of the United States, Canada and the
United Kingdom. Although there is some question
about the randomness and representativeness of some
of the samples, the panel judges that the mean levels
from the large-scale studies whose results are tabulated
inTable 3 provide reasonable estimates ofthe long-term
average concentrations offormaldehydeinvariousbroad
categories of housing types.
In conventional homes more than aboutfive years old,
mean concentrations offormaldehyde are usually below
0.05 parts per million (ppm), and only a small fraction
exceeds 0.1 ppm (the American Society of Heating,
Refrigeration and Air-Conditioning Engineers
[ASHRAE] ceiling guideline for comfort and the stand-
ard established in several foreign countries). In special-
ized residences (mobile homes, UFFI homes, new
houses, energy-efficient and perhaps weatherized
homes), mean levels of formaldehyde are significantly
higher and not infrequently exceed 0.1 ppm. Mean
levels appear to be highest in mobile homes (Table 3).
Levels offormaldehyde are highest in new residences
and decline steadily as the rates of emission from
insulation or building materials decline. The first half-
life is 4 to 5 years for mobile homes and for new houses
(39) where pressed-wood products are the primary
source of formaldehyde. For UFFI homes the first
half-life is usually less than 1 year (41,42).
Although mean formaldehyde levels in different
classes of residences are reasonably well established,
temporal patterns of fluctuation are poorly character-
ized and not well understood. The cross-sectional stud-
ies in Table 3 were not designed to investigate patterns
of variability, and the ranges cited there reflect both
between-house differences and within-house variations.
Limited studies of within-house fluctuations (43,44)
haverevealed both diurnal variations (up totwofold) and
seasonal variables (up to tenfold in some homes).
Highest levels occur in the summer and in the heat of
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Table 2. Formaldehyde monitoring data in occupational settings.
Sampling methods
Exposure levels, ppm Area or No. Duration/
Industry Job Range Mean Median pers. obs. Period Methodsa frequency Ref. Comments
Formaldehyde Production - 1.4 - P 4 hr TWA CT,IC (-0)b
production operators
(SIC 2869)
Lab tech
Resin and Production
plastic operators
materials
production Resin plant
(SIC 2821)
Resin plant
UF resin
production
(2 plants)
1.31
1.39
0.05-0.37 0.24
0.09-0.17 0.13
0.12-0.55 -
0.18-5.4 -
0.2-0.74 -
0.6-0.34 -
UF resin 0.12-5.4 0.90
production 0.20-0.74 0.39
0.06-0.34 0.19
p
p
A 8
A 2
A
A
A -
A
p 18
p 5
p 5
- 4 hr TWA CT,IC
4hrTWA CT,IC
405 min
BI,CT
GC
BI,CO Intermittent
SS,IC
SS,IC
SS,IC
SS,IC
BI,CA
BI,CA
BI,CA
(10)b
(10)b
(11)b
(12)b Manufacture
glue for
plywood,samples
taken over glue
vat
(13) Resin production
Resin drumming
Drum washing
Foam agent
blending
(14)b Cooks
Drum washer
Foaming agent
blender
Textiles 0.04-0.73 0.31
warehouse 0.08-0.51 0.25
Textile < 0.1-1.3 -
facilities < 0.1-1.4 -
Textile 0.11-1.33 0.69
manufacture 0.15-1.2 0.53
A,P 11
A,P 11
0.8 A,P 28
0.7 A,P 15
0.64 P 6
0.45 A 13
CT,SP
BI, SP -
+3 hr
Grab
8 hr/day
Apparel Permanent
(SIC 23-) press
Permanent
press
Warehouse
Sewing
machine
operators
Clothing
pressers
0.15-0.38 0.31
0-2.7 0.74
0.11-0.57 0.39
0.04-0.19 0.12
0.51-0.91 0.72
0.3-1.8 1.2
0.005-0.95 0.07
- A 9
A 32 -
0.37 P 13 30-45 min
0.15 A 9 164-341 min
0.71 P 16 7-8 hr
1.2 P 41 30 min
0.054 P 40 3-4 hr
BI,I
BI,I
8 hr/day
8 hr/day
(18)" Early date; area
samples taken
in workroom
(19)" Early date; area
samples taken
in cutting,
pressing,
sewing, and
storage areas
(15)
(15)
8 hr/day (20)
1-2.5 A (16)b
Wood Particle-
furniture board
manufacture veneering
(SIC 2511,
2512, 2521,
2531, 2541)
Plastic Injection
molders mold
(SIC 3079) operators
0.008-0.25 0.12
0.9-6.4 2.75
0.2-0.55 0.40
0.2-2.5 0.70
0.01-0.1 0.037
- A 11
A
A 9
A 13
- BI,CA
BI,CA
BI,CA
BI,CA
P 9 100-350 CA
min
(13) Plant
Veneer press
Veneer core press
Core, veneer,
adhesives
(21) Breathing zone
samples
Textile
finishing
(SIC 226-)
(15)b
(16)b
(17)
All workers Plywood
particle-
board
(SIC 243-)
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Table 2. (continued)
Sampling methods
Exposure levels, ppm Area or No. Duration/
Industry Job Range Mean Median pers. obs. Period Methodsa frequency Ref. Comments
Plastic Area 0.01-0.53 0.20 A 8 55-425 CA - (21) Area samples
molders samples
(sic 3079) Operators
(cont'd)
< 2
Near 2-4
grinder
hopper
Sand mold 0.1-0.7
production ND-1.1
Paper and Paper
paperboard treatment
(SIC 26-) resin im-
pregnated)
Ireated
paper
products
Coating
preparation
<2 <2 p 28
min
3 3 A 3
DT
DT
0.31 0.2 P 28 4 hr
0.17 0.1 A 29 4 hr
0.04-0.16 0.08 p
0.03-0.07 0.06 A
0.01-0.23 0.05 - P
0.02-0.28 0.05 P
0.14-0.99 - 0.59 A
0.14-0.90 - 0.34 P
< 0.01-3
0.8-0.42
1
0.51
0.01 A 7
0.42 A 4
8 hr/day (22)
15 4 hr BI,CT 8 hr/day (11)
CA
7 4 hr BI,CT 8 hr/day
CA
30 4 hr BI,CT 8 hr/day
CA
10 4 hr BI,CT 8 hr/day
CA
64 ( 6)b
37 -
Grab - ca. 30 sec (23)
20 times/day
30-200 min -
(21) Breathing zone
samples; limit of
detection is
2 ppm
(21) Wear machines
processing
acetal resins
Filter treating of
paper
Filter treating of
paper
Series B collating
Press build-up
By mix and
storage tanks;
data indicated
no exposure in
work area
where majority
of work time
spent
Foundries Bronze
steel, foundry,
iron and core machine
nonferrous operators
(SIC 332-,
336-)
Rubber hose
production
(SIC 3069)
Asphalt
shingle
production
(SIC 2952)
0.24-0.80 0.53
0.12-0.69 0.39
Iron foundry, < 0.02-18.3
cpre machine
operators
Iron foundry, 0.07-0.33 0.16
core machine
operators
Molding 0.03-0.13 0.09
0.07-0.78 0.21
ND-0.04 0.04
Producers 0.03-0.07 0.05
0.55 P 4 3-4 hr BI,CA 8 hr/day
0.39 A 11 ca. 2 hr BI,CA -
0.43 P 14
p 3
P 6
A 6
p 10
0.05 A 2
BI,CA 8 hr/day
BI,CO
BI,CO
BI,CO
BI,CO
(24)
(16)b
(25) Complete core
production cycle
took 1 hr
(26) Molding for
products to
measure
temperature,
PF resins
(27)b Formaldehyde
used as a
preservative
(28)b Area samples
near process
machinery
Fiberglass Installers
insulation
installation
(SIC 3296)
0.007-0.033 0.023
(TWA)
0.019 P 13 8 hr/day (29) Rapid worker
turnover rate
reported, with
most employees
leaving within
6 mo
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Table 2. (continued)
Industry Job
Urea-formal- See
dehyde comments
foam
insulation
dealers and
installers
Suburban
shopping
center
insulated
with UF
foam
Fertilizer
manufactur-
ers (SIC
2873)
Exposure levels, ppm Area or No.
Range Mean Median pers. obs. Period
0.07-2.0 - -
0.8-1.6 1.05
0.3-3.1 1.44
< 0.5-3.0 1.56
0.2-1.9 0.9
A 36
A 30
A 16
-P,A 11
Sampling methods
Duration/
Methodsafrequency Ref. Comments
IC (13) Application of UF
foam to com-
mercial and
residential
buildings; ex-
posures for
applicators,
laborers,
trucking, and
warehouse area
BI,CA (16)" Area samples in
CT,IC stores
DT
(16)" For production of
time-released
nitrogen
fertilizers (urea
forms), release
formaldehyde as
they release
nitrogen
< 0.51-10 + 2.68
ND-2.70
ND-4.93
A 12 DT Intermittent (30)b Maximum value
P 3 Short-term CT,IC Intermittent was sample
- A 3 CT,IC Intermittent taken at source;
formaldehyde
used as
fumigant/
disinfectant
Funeral Embalmers 0.09-5.26 0.74
homes
(SIC 7261)
Embalmers 0.20-3.99 1.1
1.30-3.93 2.7
A 187
0.54 A,P 8 70-190
min
CA (31) Wayne State
University
study of 6
funeral homes;
mean concen-
trationincreased
to 1.34 ppm
when ventila-
tion off
(32)b Area and personal
samples; ven-
tilation working
Area and personal
samples;
ventilation
inoperative
CT
2.49 A,P 5 300 min CT
Pathologists Autopsy
(SIC 8071) room
Autopsy
room
Biology Biology
instructors lab
(SIC 8071)
0.06-7.9 4.8
2.20-7.9 4.35
2.75-14.8 8.3
A 10
A 6
A 8
BI,CA Intermittent (33)b
Intermittent (16)b
BI,CA Intermittent (6) Minimum concen-
trations with
doors and
windows open;
maximum con-
centrations with
doors and
windows closed;
18 dissected
cats saturated
with formalin in
room
Mushroom
farm
(SIC 0721)
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Table 2. (continued)
Sampling methods
Exposure levels, ppm Area or No. Duration/
Industry Job Range Mean Median pers. obs. Period Methodsa frequency Ref. Comments
Hospital 2.2-2.3 2.25 P 2 BI - (8)
lab 1.9 P 1 CT
(SIC 8071) 2.0-2.0 2.0 A 2 CT
Government 2.4 P 1 CT - (8)
lab 0.8 A 1 CT
(SIC 8071)
Dialysis ND-0.90 0.42 A 9 - CT (8)
unit 0.27-0.63 0.41 P 5 CT
(SIC 8081) 0.04-0.50 0.51b A CEA
Animal < 0.38-1.04 - P 15 CA
dissecting 0.05-0.40 0.15 A 6 BI
lab 0.11-0.29 0.18b A 3 CEA
(SIC 8071)
Garment < 0.14-0.63 0.23-0.33 P 40 CT (8)
manufactur- < 0.03-0.40 0.19-0.26 A 43 - CT
ing(3 plants) 0.03-0.40 0.21 A 43 BI
(SIC 2321) 0.05-1.12 0.46 A 42 CEA
Chemical 0.04-1.6 0.55 P 3 BI (8)
manufac- 0.03-0.43 0.17 A 5 BI
turing
Glass 0.42 0.42 P 1 CT (8)
manufac- 0.45-0.64 0.54 A 2 CT
turing
(SIC 3211)
Hospital 0.37-0.73 0.55 - A 2 BI (8)
(SIC 8062)
Paraformal- < 0.25-0.85b0.56b P 10 CA (8)
dehyde 0.28-3.40 1.17"b A 8 CEA
packaging
(SIC 2879)
Offices 0.02-0.12 0.06 - A 39 BI (8)
(3 locations) < 0.04 < 0.04 A 9 CT
(SIC 8111)
Autopsy Resident 1.58c P 10 CA (4)
rooms
(SIC 8071) Pathologist 1.24c P 10 Ca
Technician 0.57c p 9 CA
Assistants 0.16c P 2 CA
0.13-13.57 0.72 A 23 CA
aAbbreviations for analytical procedures: AA = acetylacetone procedure; BI = bisulfite impingers; CA = chromotropic acid procedure;
CL = chemiluminescence procedure; CO = colorimetric analysis; CT = charcoal tubes; SS = solid sorbents; DT = Draeger tubes; FS =
Fourier transform spectrometer; GC = gas chromatography; IC = ion chromatography; MB = MBTH procedure; SP = spectrophotometric
procedure; CEA = CEA instruments Model 555.
bAs reported by USEPA (6).
cAverage.
the day; doubling of formaldehyde levels has been
observedwithtemperatureincrementsof3-80C(39,45).
In an intensive study, over a period of 1 year, of 40
homes, more than half of which were less than 5 years
old, a level of 0.1 ppm was exceeded in more than half
the homes during at least one 24-hr period (39).
However, the panel judged the available data inade-
quate to characterize the frequency or magnitude of
short-term peak (acute) exposures of various groups
within the population.
The information provided by past surveys is limited
by failure to standardize or report sampling design or
details of protocols, such as location and timing of
samples, ventilation rates, human activity, etc. Sam-
pling of nonresidential indoor environments, such as
offices, public buidings, schools, retail stores, and
vehicles, has been sparse.
Indoor sources of formaldehyde have been identified
both by association with high ambient levels and by
direct measurement of emission rates. The strongest
sources are articles fabricated with urea-formaldehyde
resins that are used in large amounts in the indoor
environment. Examples include UFFI, hardwood ply-
wood (decorative) paneling, and particleboard under-
lays or decking. Medium-density fiberboard is a suf-
ficiently strong emitter (46) that even smaller articles
such as furniture can elevate indoor levels of formalde-
hyde significantly (38). rAansient increases in formalde-
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Table 3. Reported levels of formaldehyde in indoor air in residences.
No. of Formaldehyde, ppm
Type of residence residences Range Mean Reference
House without UFFIa 41 0.01-0.1 0.03 (36)
House with UFFI 636 0.01-4 0.12 (36)
(complaint and
non-complaint)'
Houses without UFFI 378 (3% > 0.lppm) 0.035 (37)
House with UFFI 1146 (10% > 0.lppm) 0.054 (37)
(complaint and
non-complaint)b
Mobile homes 431 0.01-3 0.38 (38)
Mobile homes - 0-1.77 0.38 (38)
(Washington, complaint)b
Mobile homes 0-3.0 0.4 (38)
(Minnesota, complaint)b
Mobile homes 0.02-4.2 0.9 (38)
(Wisconsin, complaint)b
East Tennessee homes 40 < 0.02-0.4 0.06 (39)
Age 0-5 yr 18 0.08 (39)
Age 5-15 yr 11 0.04 (39)
Age >15 yr 11 0.03 (39)
California, Colorado 64 0.02-0.11 0.05 (40)
and S. Dakota homes
(conventional)
California homes 52 0.03-0.3 0.1 (40)
(mobile, energy-efficient, weatherized)
U.K. buildings without UFFI 50 < 0.02-> 0.3 0.047 (41)
U.K. buildings with UFFI 128 0.01-> 1 0.093 (41)
aUFFI: urea-formaldehyde foam insulation.
bComplaint: homes in which residents had complained of symptoms putatively associated with exposure to formaldehyde.
cNumber not stated.
hyde levels can also be caused by burning cigarettes or
gas-fired space heaters. In extreme cases (heavy smok-
ing or poorly tuned heaters), these transient increases
can exceed 0.1 ppm (47).
lb. EnvironmentalExposures. Environmental lev-
els of formaldehyde have been summarized by the
National Research Council (NRC) (38) and other
reviewers. Concentrations reported in ambient air have
generally been below 10 to 15 parts per billion (ppb),
except for situations ofheavy traffic and/orphotochemi-
cal smog, when concentrations up to 90 to 150 ppb have
been reported (38,48). These urban concentrations
appear to have decreased since the 1960s (38,48,49) and
are likely to decrease further as automobile emissions
are progressively reduced. Rain water in Western
Europe contained 0.3 to 1.4 ,ug/L formaldehyde in 1969
and0.1 to0.17 ,ug/L formaldehyde inthemid-1970s (49).
The panel has not reviewed these datain detail because
outdoor exposures appear to be much smaller than
indoor exposures.
Ib. ConsumerProducts andMedicalDevices. Ta-
ble 4 lists data on the occurrence of formaldehyde in
consumerproducts, drugs, and disinfectants. Formalde-
hyde is used quite widely in cosmetics and household
disinfectants. However, the panel was not able to find
any data onthe extent ofexposure tothese products via
skin contact or inhalation. Formaldehyde is also used to
disinfect medical devices such as kidney dialysis units,
giving rise to potential exposures of users and medical
Table4. Formaldehyde inconsumerproductsandmedicalproducts.
Type of product
Household products
Household disinfectants
(diluted for application);
U.S. labeling required at > 1%
Cosmetics (used as preserv-
atives and in shampoos;
FDA 1981 listed 805 pro-
ducts containing
formaldehyde)
Level recommended by CTFA
Highest permitted content in
EEC (except fingernail
hardener at 5%); EEC
labeling required at
0.05%
Disinfectants for medical use
Concentrates
Diluted for use
Formaldehydecontent,
up to 1%
up to 7%
generally < 1%
(1% of products
in range 1-10%)
< 0.2%
0.2%
Mostly 5-10%
(range: 1-30%)
< 1%
Reference
(50)
(50)
(51)
(51)
(52)
(50)
(50)
personnel. The panel was concerned about a report
from Europe ofhigh concentrations (up to 15-25 ppm)
offormaldehyde in incubators used for intensive care of
premature infants (53).
Ic. Theprincipalphysiological factoraffectingrespi-
ratory intake of formaldehyde is the breathing rate
(minute volume), which is dependent on physical activ-
ity and is higher (per unit of body weight) in children
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Table 5. Extent of exposure to formaldehyde in 23 industries and occupations in the U.S.
Workers exposed
Tlype
Industry (SIC code) (full/part-time) No.
Formaldehyde production (SIC 2869) Full 271-913a
Part 145-487a
Resin and plastic materials and manufacture Full 4,728
(SIC 2821) Part 1,272
Industrial and specialty chemicals and Full 2,680
manufacture (SIC 284-, 286-, 287-, 289-) Part 2,220
Paints, dyes, and pigments manufacture Full 7,480
(SIC 2851, 2865) Part 29,920
Adhesive and sealants manufacture (SIC 2891) Full 2,380
Part 420
Textile finishing (SIC 226-) Full 17,800
Part 2,200
Apparel manufacture (SIC 23-) Full 771,420
Part 125,580
Hardwood plywood manufacture (SIC 2435) Full 7,500
Softwood plywood manufacture (SIC 2435) Full 7,500
Plastic board manufacture (SIC 2492) Full 2,831
Part 1,069
Mobile home manufacture (SIC 2491, 2452, 3792) Full 31,500
Wood furniture (SIC 25-) Full 47,322
Part 2,178
Paper and paperboard manufacture (SIC 26-) Full 6,000-45,000a
Plastic molding (SIC 3079) Full 15,073
Part 1,527
Abrasive products manufacture (SIC 3291) Full 3,996
Part 2,004
Foundries (SIC 332-, 336-) Full 28,638
Part 14,362
Producers of rubber and misc. plastic products Full 6,128-27,584a
(SIC 30-)
Urea-formaldehyde foam insulation dealers and Full 2,000-15,000a
installers
Fertilizer producers (SIC 2873) Full 500-900a
Funeral services (SIC 7261) Part 52,000-70,200a
Pathologists Part 12,400a
Biology instructors (college/university) Part 13,000a
Biology instructors (high school) Part 22,000a
Total for all industries 1,341,084
aFrom USEPA (6); all other estimates from SOCMA (5).
than in adults. The panel did not review the uptake of
formaldehyde through the skin or mucous membranes.
Environmental factors (especially temperature) in-
fluencing emission rates of formaldehyde have been
discussed in the previous section. Little appears to be
known about the physical or chemical form offormalde-
hyde present intheambientair. Inoccupational settings,
exposure can be reduced by ventilation and other work
practices. The panel found no information on the
effectiveness of gloves or other protective clothing.
Id. Occupational Exposures. Table 5 (54) lists
estimates ofthe numbers ofworkers exposed to formal-
dehyde in 23 industries and occupations in the U.S. For
17 industries, estimates were derived by SOCMA (5) on
the basis of industry-wide questionnaires. Companies
responding to the questionnaires provided data on the
number of employees in various job categories poten-
tially exposed to formaldehyde, and these were scaled
up to the entire industry, assuming that the proportion
of exposed workers was the same in all plants. For six
industries and three occupations, estimates were de-
rived by EPA (6) by use ofdata from the Bureau ofthe
Census, fromthe National Occupational Hazard Survey,
and from various assumptions about the number of
workers perplant. Except forthe Bureau ofthe Census
data onpathologists, the panelregards the EPA data as
quite tenuous. The SOCMA data are more soundly
based in data from the industries they cover, but are
nevertheless subject to substantial biasesbecause ofthe
low response rate (2.7%) to the questionnaire. Thus,
except for the estimate for pathologists, each of the
estimates in Table 5 could be in errorby afactor ofup to
2 or 3.
EPA (6) cited data from the Bureau of the Census
indicating that there are about 1.4 million biology and
nursing students in the U.S., most or all of whom are
likely to be exposed to formaldehyde intermittently
during laboratory studies. Other categories of labora-
tory workers, such as laboratory and medical techni-
cians, have not been enumerated.
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For reasons stated above, it is not possible to break
down the occupationally exposed populations according
to the levels of their exposure to formaldehyde. The
data in Table 5 represent a cross section of industrial
populations, and only limited information is available on
the duration of their exposure or on rates of job
turnover. The number of workers exposed at any one
time is only a fraction of the total number of workers
exposed during their working lives, but this fraction
cannot be estimnnted from the data available.
Id. ResidentialExposures. EPA (6) estimated that
about 2.2 million persons were living in mobile homes
less than five years old and that 1.3 to 1.6 million people
were living in homes insulated with UFFI during the
preceding five years. The Consumer Product Safety
Commission (CPSC) estimated that 1.75 million people
were living in holnes insulated with UFFI during the
preceding 9 years. These estimates were based on
construction and installation data and-reasonable esti-
mates of family size, and the panel regards them as
reasonable. We assume that the remainder of the U.S.
population (220 million) is exposed to formaldehyde at
levels characteristic of conventional homes (Table 3).
Forreasons stated above, it is not possible to character-
ize temporal patterns or short-term peak exposures to
formaldehyde.
Topic 2: Currently Lacking Data
2. The panel did not identify substantial controver-
sies about exposure, although a number of gaps and
deficiencies in the available data limit the accuracy and
completeness ofexposure assessment. The most impor-
tant data needs identified by the panel were the
following.
Systematic data are needed on the extent and magni-
tude of occupational exposure to formaldehyde, includ-
ing representative, industry-wide information about
personal exposures. Priority attention should be given
to industries with a large number of persons exposed
(e.g., textiles and clothing, and biological laboratories),
workplaces with reportedly high concentrations (e.g.,
foundries and funeral services), and plants in which
epidemiological studies are being or have been conduct-
ed. Animportantfirst stepwouldbesystematic compila-
tion and review of data already collected by employers,
since the SOCMA (5) survey indicated that extensive
data already exist in company files.
Systematic data on the variability in concentrations
offormaldehyde in indoor air are required to determine
the frequency and magnitude of short-term peak
exposures. This will require systematic sampling de-
signs, stratified among various categories of houses,
with sampling designed to detect both short-term
(hourly) and long-term (seasonal) variations. It will also
require better standardization of protocols and valida-
tion of analytical methods.
Epidemiology Panel Report*
Topic 1. What is the epidemiologic evidence concern-
ing the relationship between formaldehyde exposure
and human illness (neoplastic and nonneoplastic)?
a. What are the limitations and/or strengths of the
availableepidemiologicdata(e.g., power, confound-
ing variables)?
b. Can any or all of the data from epidemiologic
studies on the relationship between cancer and
formaldehyde be combined in order to provide a
greater data base for statistical evaluation?
c. Are there any epidemiologic hypotheses that can
be developed from case reports ofillness following
exposure to formaldehyde?
d. What levels ofexposure orwhat types ofexposure
to formaldehyde have been reliably associated
with human biological responses as evidenced
from epidemiologic data?
e. Does the epidemiologic evidence indicate that
some segments of the population are particularly
sensitive to any adverse health effects offormalde-
hyde? If so, which segments and at what levels of
exposure?
Topic 2. After reviewing completed and ongoing
studies, what attainable additional studies might clarify
any exposure disease relationships?
This report, which discusses the epidemiologic evi-
dence concerning the relationship between formalde-
hyde exposure and human illness, addresses three
issues. First the panel considered the evidence relating
to neoplasms; next, nonneoplastic illness; finally, recom-
mendations are made regarding further research direc-
tions. The scientific papers published, in press, and in
manuscript, that were considered comprise the refer-
ences. With the single exception ofnasal cancer, where
case reports are quoted, our discussion is limited to
studies in which the material can be related to a
definable population. As the Consensus Workshop in-
cludes panels on carcinogenicity, biochemistry, expo-
sure and risk estimation, this panel has only to a limited
extent attempted an evaluation of the epidemiologic
data in the light of other biological information, or in
relation to estimates of exposure for different occupa-
tions. Nevertheless, wheneverpossible, qualitativeinfor-
mation onlevelofexposurebyoccupationwasconsidered.
Topic 1. Formaldehyde and Human Illness
1, la. Formaldehyde and Cancer. The plan has
been to consider in turn each category of neoplasm to
which attention has been drawn in the literature. Most
of the studies reviewed use the occurrence of death as
the measure of outcome and almost all refer to the
* Epidemiology Panel: E. A. Acheson (Chairman); Kenneth J.
Rothman (Alternate Chairman/Secretary); Aaron Blair; John F
Gamble; Peter F Infante; Keith R. Long; Edward A. Mortimer, Jr.;
Marvin A. Schneiderman.
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experience of the adult male working population. This
panel considered no evidence relating to persons first
exposed in childhood or old age, to women or to the
fetus.
Ib. As shown in Table 6, information on all sites was
not available for all studies. There is a potential problem
involved in simply summing observed and expected
numbers and then computing an overall observed-to-
expected ratio. With this direct summing one or two
large studies then provide the weight of evidence. If
some unrecognized distortions or biases had affected
one or more ofthese large studies, the summary would
also be biased and thus be potentially misleading. Some
readers may wish to make their own separate or
different summaries using the data. Several summary
approaches are possible. For example, a summary could
be prepared which omits one (or more) of the separate
studies, based perhaps on the quality of the study,
geography, etc. The panel advised caution against
basing evaluation on the "total" column in Table 7
without considering the inherent differences between
the professional and industrial cohorts with regard to
exposure and possible compounding factors.
la, lb. Although the summary of observed and
expected numbers provides a convenient basis for
evaluation, it involves a number of important assump-
tions which limit its validity and usefulness. The bulk of
the expected numbers has been calculated on the basis
ofan analysis ofproportionate mortality, and these have
been summed with those from studies using other types
of data. Some would regard this as inappropriate.
Further, it should be emphasized that a substantial
proportion ofthe person-years atriskrelatestoindividu-
als within the industrial cohorts who were exposed to
very low levels of formaldehyde or, as in the case of
professionals, who may have been intermittently ex-
posed to higher levels. Historical exposure estimates
were made in only two studies (55,56). Moreover, in a
proportion of men the period between exposure and
completion of follow-up has been brief. The overall
effect of these factors and of shortcomings in some of
the studies is to make interpretation of associations
between formaldehyde and cancer difficult. Where such
data existed, the induction period was considered
(Table 6), since the inclusion of persons with short
potential induction times and very low levels of expo-
sure biases the relative risk of the direction of unity.
Finally, few studies had information about smoking and
all studies lacked data about consumption of alcohol.
The occupations studied fall into two distinct catego-
ries and these have been considered separately. The
observed and expected cases of cancer in studies of
professional people who use formaldehyde in the preser-
vation of human tissues (embalmers, anatomists and
pathologists) (57-63) are shown separately from those
for industrial workers involved in the production and
use offormaldehyde. These two groups differ not only in
substances other than formaldehyde to which they may
have been exposed, but may also differ in the pattern
and intensity of exposure to formaldehyde. The panel
noted that in industry many of the workers had been
exposed for only short periods (i.e., less than one year)
while for professional workers the possibility of expo-
sure at varyingintervals was present formany years. In
addition, personal habits, which almost certainly influ-
ence cancer mortality, differ between the professional
and industrial groups.
Ic, Id. Selected Sites of Cancer. NASAL CANCER
No case ofnasal cancerhas been reported in any ofthe
epidemiological studies listed in Table 7 [O obs; 3.0 exp;
95% confidence limits (CL) forthe standardized morbid-
ity ratio (SMR) 0-123] (55,59,61-63). This expected
figure and, therefore, the confidence interval for the
SMR, take no account of induction period or degree of
exposure. Inotherepidemiologic studies ofnasalcancer,
the evidence suggests that the risk does not begin to
rise until 15 to 25 years after first exposure. In a
study of British chemical workers (64), it can be seen
that the study had a 46% chance of detecting a fivefold
increase of risk of this rare tumor if risk commenced
immediately after the beginning of exposure and was
limited to persons exposed to "high levels"; there was
only a 28% chance ifthe risk did not begin to rise until
20 years after first exposure. These data therefore
suggest that it is too early to exclude an important
increase in risk after a prolonged induction period. In a
case-control study of 167 men with nasal cancer carried
out jointly in Denmark, Finland and Sweden (65) "a
scrutiny ofoccupations for which exposure to formalde-
hyde possibly may have occurred gave no indication of
any association." In a case-control study of 160 patients
with nasal cancer in North Carolina and Virginia (66)
(available for review only in abstract form), no mention
was made of any association with formaldehyde.
The panel found two case reports of nasal cancer in
persons exposed to formaldehyde. One individual was
employed for 25 years in a fabric finishing plant where
textiles were permeated with the formaldehyde-based
resin. He had previously soldered components of air-
craft engines for about 2 years (67). Soldering, welding
and flamecutting have been associated with an in-
creased risk ofnasal cancer (65). The second individual
had been employed for 32 years at a plant where phenol
formaldehyde and formaldehyde resins were manufac-
tured (68). As usual, interpretation of these case-
reports is problematic.
BUCCAL CAVITY AND PHARYNX. No important excess
ofcancers ofthese sites has been observed in relation to
the calculated expected numbers in any ofthe published
studies (55,59-64,69). In a reclassification ofthe deaths
in the cohort first studied by Marsh there were atotal of
seven buccal and pharyngeal cancer deaths observed as
compared with an estimated 3.1 expected (68). Two of
these deaths occurred subsequent to Marsh's date of
conclusion of follow-up.
BRAIN. A substantial excess of deaths from cancer
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Table 6. O/E data by site and by study.a
No induction period considered Induction period considered
Site Study 0 E O/E 0 E O/E
Nasal passages
Professional
Industrial
Buccal cavity and
pharynx
Professional
Industrial
Brain
Professional
Walrath (New York)
Walrath (California)
Stroup
Levine
Harrington
Matanoski
Acheson
Liebling, Marsh
Tabershaw
Fayerweather
Walrath (New York)
Walrath (California)
Stroup
Levine
Harrington
Matanoski
Acheson
Liebling, Marshb
Tabershaw
Fayerweather
Walrath (New York)
Walrath (California)
Stroup
Levine
Harrington (Study No. 2)
Matanoski
0 0.5
0 0.6
0 0.4
0 0.2
ND ND
ND ND
0 1.3
ND ND
ND ND
ND ND
8 7.1
8 6.1
1 6.8
1 2.1
ND ND
2 1.7
0
0
0
0
ND
ND
0
ND
ND
ND
1.3
1.6
0.2
0.5
ND
1.2
5 6.1 0.82
7 3.1 2.3
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
9 5.8 1.6 3 1.8 1.7
9 4.7 1.9 7 2.7 2.6
10 3.7 2.7 6 1.7 3.5
3 2.6 1.2 ND ND ND
4 1.2 3.3 ND ND ND
5 4.6 1.1 ND ND ND
Industrial
All lymphatic and
hemopoetic
Professional
Industrial
Leukemia (only)
Professional
Acheson
Liebling, Marsh
Tabershaw
Fayerweather
Walrath (New York)
Walrath (California)
Stroup
Levine
Harrington (No. 1)
Harrington (No. 2)
Matanoski
Acheson
Marsh
Tabershaw
Fayerweather
Walrath (New York)
Walrath (California)
Stroup
Levine
Harrington (No. 1)
Harrington (No. 2)
Matanoski
5 12.5
ND ND
1 0.7
ND ND
25 20.6
19 15.5
18 14.6
8 6.5
8 3.8
2 3.0
ND ND
20 26.3
2 2.3
3 2.0
ND ND
12 8.5
12 6.9
10 6.7
4 2.5
1 1.5
1 1.1
ND ND
0.40
ND
1.4
ND
1.2
1.2
1.2
1.2
2.3
0.7
ND
0.8
0.9
1.5
ND
1.4
1.7
1.5
1.6
0.7
0.91
ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
11 9.1 1.21
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
1 0.95 1.00
ND ND ND
10 4.3 2.3
7 4.1 1.7
ND ND ND
ND ND ND
ND ND ND
ND ND ND
Industrial Acheson
Liebling, Marsh
Tabershaw
Fayerweather
9
ND
ND
ND
11.4
ND
ND
ND
0.8
ND
ND
ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
Lung
Professional
Walrath (New York)
Walrath (California)
Stroup
Levine
72 66.8
41 42.8
12 43.0
19 20.2
1.1
1.0
0.3
0.94
35 34.7 1.0
28 30.8 0.9
6 29.3 2.0
19 18.4 1.0
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Table 6. (continued)
No induction period considered Induction period considered
Site Study 0 E O/E 0 E O/E
Harrington (No. 1)
Harrington (No.2)
Matanoski
10 27.4
9 22.0
12 21.4
0.4
0.41
0.6
ND ND ND
ND ND ND
ND ND ND
Industrial
Prostate
Professional
Acheson
Skin
Professional
Acheson
Marsh
Tabershaw
Fayerweather
Walrath (New York)
Walrath (California)
Stroup
Levine
Harrington (No. 1)
Harrington (No. 2)
Matanoski
Acheson
Liebling, Marsh
Tabershaw
Fayerweather
Walrath (New York)
Walrath (California)
Stroup
Levine
Harrington (No. 1)
Harrington (No.2)
Matanoski
205
6
3
ND
15
23
20
3
ND
ND
ND
ND
ND
2
ND
215.0
7.1
5.2
ND
16.4
13.1
18.7
3.4
ND
ND
ND
ND
ND
0.55
ND
8 3.6
2 3.4
2 3.5
0 0.9
ND ND
ND ND
ND ND
1.0 86 72.1 1.2
0.9 3 3.7 0.8
0.6 ND ND ND
ND 12 14.0 0.9
0.91
1.8
1.1
0.88
ND
ND
ND
ND ND ND
16 9.5 1.7
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND ND
ND ND ND ND
3.6 ND ND ND
ND ND ND ND
2.2
0.6
0.6
0
ND
ND
ND
4 1.3 3.1
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
Industrial
Bladder
Professional
Industrial
Kidney
Professional
Industrial
Acheson
Liebling, Marsh
Tabershaw
Fayerweather
Walrath (New York)
Walrath (California)
Stroup
Levine
Harrington (No. 1)
Harrington (No. 2)
Matanoski
Acheson
Marsh
Tabershaw
Fayerweather
Walrath (New York)
Walrath (California)
Stroup
Levine
Harrington (No. 1)
Harrington (No. 2)
Matanoski
Acheson
Liebling, Marsh
Tabershaw
Fayerweather
ND ND ND ND ND ND
ND ND ND ND ND ND
0 0.4 0 ND ND ND
ND ND ND ND ND ND
7 7.3 1.0
8 5.8 1.4
5 7.2 0.7
ND ND ND
1 2.1 0.5
2 1.9 1.1
ND ND ND
ND ND ND
1 0.3 3.3
ND ND ND
ND ND ND
8 5.4
4 4.0
1 4.0
1 1.7
ND ND
ND ND
7 3.6
ND ND
ND ND
1 0.4
ND ND
1.5
1.0
0.25
0.6
ND
ND
1.9
ND
ND
2.5
ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
3 0.6 5.3
2 2.4 0.83
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
Digestive system
Professional
Walrath (New York)
Walrath (California)c
Stroup
Levine
Harrington (No. 1)
Harrington (No. 2)
Matanoski
68
68
38
17
12
8
ND
65.2
55.7
66.4
22.6
19.8
15.5
ND
1.0
1.2
0.6
0.8
0.6
0.5
ND
ND ND ND
33 25.4 1.3
ND ND ND
ND ND ND
ND ND ND
ND ND ND
ND ND ND
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Table 6 (continued)
No induction period considered Induction period considered
Site Study 0 E O/E 0 E O/E
Digestive system Acheson ND ND ND ND ND ND
Industrial Marshc 8 6.3 1.3 ND ND ND
Tabershaw 0 4.1 0.0 ND ND ND
Fayerweatherd ND ND ND 6 7.5 0.8
aData from: Acheson (55); Fayerweather (56); Harrington or Harrington (No. 1) (57); Harrington (No. 2) (58); Levine (59); Matanoski (60);
Stroup (61); Walrath (New York) (62); Walrath (California) (63); Liebling (66); March (64); Tabershaw (65). ND = no data.
bIncluding two "post closing" deaths.
cStomach, colon and pancreas.
dColon and rectum.
Table 7. Observed and expected deaths for professionals and industrial workers exposed to formaldehyde,
with exact 95% confidence limits (CL).
Professional Industrial Total
Site of cancer Obs/Exp CL Obs/Exp CL Obs/Exp CL
Nasal 0/1.7 0-2.17 0/1.3 0-2.84 0/3.0 0-1.23
Mouth 20/23.8 0.51-1.30 12/9.2 0.67-2.28 32/33.0 0.66-1.37
Brain 40/22.6 1.26-2.41 6/13.2 0.17-0.99 46/35.8 0.94-1.71
Lymphatic and
hematopoietic 80/64.0 0.98-1.53 25/30.6 0.53-1.21 105/94.6 0.91-1.34
Leukemia 40/27.2 1.05-2.00 9/11.4 0.36-1.50 49/38.6 0.94-1.68
Other lymphatic
and hematopoietic 40/36.8 0.78-1.48 16/19.2 0.48-1.35 56/56.0 0.76-1.30
Lung 175/243.6 0.62-0.83 214/227.3 0.82-1.08 389/470.9 0.75-0.91
Prostate 61/51.6 0.90-1.52 2/0.6 0.40-12.04 63/52.2 93-1.54
Skin 12/11.4 0.54-1.84 0/0.4 0-9.22 12/11.8 0.52-1.78
Bladder 23/24.3 0.60-1.42 1/0.3 0.18-18.6 24/24.6 0.62-1.45
Kidney 21/18.6 0.70-1.73 1/0.4 0.06-13.93 22/19.0 0.72-1.75
Digestive System 211/245.2 0.74-0.98 8/10.4 0.33-1.52 219/255.6 0.75-0.98
Other causes
Cirrhosis of liver 83/59.3 1.11-1.74 10/9 0.53-2.04 93/68.3 1.10-1.67
Nonneoplastic
respiratory disease 109/163.7 0.55-0.80 243/241.1 0.88-1.14 352/404.8 0.78-0.96
of the brain is noted among the professional workers
exposed to formaldehyde (40 obs, 22.6 exp; 95% CL for
the SMR 126-241) (58-63). Among industrial workers,
on the other hand, there is a substantial deficit (6 obs,
13.2 exp; 95% CL for the SMR 17-99) (55,70). The
latter result, however, is derived from only two studies
of which one contributes five observed cases and 12.5
expected. An excess of an approximately similar
order of magnitude is seen in each of the three
professional groups, namely embalmers, anatomists
and pathologists, and within each of three separate
groups of embalmers; the SMR increased when induc-
tionperiod was takeninto consideration (see Table 6) (55,
70). Among anatomists 10 cases were observed and 3.7
expected; all the tumors were glioblastomas or astro-
cytomas. Among pathologists, all four brain cancers
were ofthe glioma or astrocytoma cell type. Data from
some autopsy series indicate that about 30% to 50% of
primary intracranial neoplasms are of these cell types.
Brain cancer is difficult to diagnose and may be more
effectively detected among persons with better access
to sophisticated medical care, particularly among groups
such as medical faculty members (71). In discussing his
study of medical professionals, Harrington (58) re-
marked that, a . . . social class gradients are relatively
unimportant in this tumor . . ., and there is no excess
in medical practitioners as a group." When the expected
numbers in the study of anatomists (61) were based on
either the mortality experience of psychiatrists, or
based on the records of Olmsted County, in which the
Mayo Clinic is located, the excess brain cancermortality
remained. Olmsted County has a very high autopsy
rate, and brain cancer mortality is not likely to have
been seriously underestimated. Thus, detection bias
would not seem to account for the excessive brain
cancer risk among anatomists.
The association between professional groups engaged
in preservation of human tissues and brain cancer does
not necessarily implicate formaldehyde. Aside from
formaldehyde and human tissues themselves, however,
it is unclear what other important occupational expo-
sures these professional groups shared. The British
study, which shows a deficiency of brain tumors among
industrial workers (55), provides evidence against an
association, although professional and industrial work-
ers studied have differed in level, duration and fre-
quency of exposure to both formaldehyde and other
substances, chemical and biological.
LYMPHATIC AND HEMOPOIETIC SYSTEM. When taken
as a single group, no significant excess of deaths from
these cancers was observed (105 obs, 94.6 exp; 95% CL
for the SMR 91-134) (55,57-59,61-63,70). However, an
excess exists that approaches significance for profes-
sional workers (80 obs, 64 exp; 95% CL for the SMR
98-156). This excess is primarily attributable to an
excess of deaths from leukemia in this group (40 obs,
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27.2 exp; CL for the SMR 105-200), particularly among
those with aninduction time of15years ormore (17 obs,
8.4 exp; 95% CL for the SMR 118-324). In the past
leukemia has been reported more frequently in the
higher social classes. Among the anatomists (61), an
excess of leukemia deaths, in particular, deaths due to
chronic myeloid leukemia, persisted when compared
with the mortality experience of psychiatrists. Thus,
detection bias would not seem to account for the
excessive leukemia risk among anatomists. The number
of cases of leukemia reported among industrial groups
exposed to formaldehyde is approximately as expected.
Remarks about exposures and working practices ofthe
various groups made in the previous paragraph also
apply here.
LUNG. A deficiency of deaths from cancer of the
lung is noted which is statistically significant amongthe
professional workers (175 obs, 243.6 exp; 95% CL for
the SMR 62-83) (57-63) and both groups combined (389
obs, 470.9 exp; 95% CL for the SMR 75-91), but not
among the industrial workers (214 obs, 227.3 exp; 95%
CL for the SMR 82-108) (55,64,70). The most likely
explanation for the deficiencies is that exposed profes-
sional workers have been compared with a reference
population that has smoked more; data on smoking
habits are not available in any of these studies. In the
British study (55), a significant increase in mortality
from lung cancer was found in one of the six factories
studied (British Industrial Plastics) (SMR = 124, 95%
CL 104-148) in comparison with an expected number
calculated from national death rates. This factory con-
tributed overhalfofthe lung cancerdeaths and also had
the highest average exposures; a trend of increasing
mortality (as measured by the SMR) with increasing
exposure toformaldehyde was found inthe samefactory
and its significance was borderline at the 5% level. No
such relation was found in any ofthe other factories or
when all six factories were considered together. The
number ofmen, however, exposed to"medium" or"high"
levels offormaldehyde in the other factories was small.
No relation was found between lung cancer mortality
and exposure to formaldehyde as measured by length of
service. Similarly, no relation was found between lung
cancer mortality and interval since first exposure to
formaldehyde. Men who entered the BIP factory be-
tween 1936 and 1945 (when exposure levels were
probably highest) had the highest mortality from lung
cancer. Asthe data now stand, there is some evidence of
a dose-response relation between exposure to formalde-
hyde and lung cancer; the evidence derives from the one
British factory where the largest number of cohort
members experienced the highest formaldehyde expo-
sure levels.* Ifformaldehyde is a human carcinogen, it
* Dr. Acheson, who could not attend the second meeting of the
panel in Boston, suggested, based upon follow-up data, from studies
he conducted which were not available at the time of the second
meeting (72,73), that this sentence be replaced with "There is
evidence within this factory ofa relation between degree ofexposure
to formaldehyde and lung cancer, but the trend disappears when
account is taken of length of exposure."
might only be detectable through study of populations
who experience high exposure levels, given the steep
dose response exhibited by experimental animals.
In individual studies, attention has been drawn to
small excesses of deaths from cancer of the prostate,
skin (including melanoma), kidney, bladder, and of the
digestive system. As can be seen from Table 7, in none
of these sites, with the possible exception of prostate
cancer, do the figures approach statistical significance in
either professionals or industrial workers. There is at
present scant evidence of an association between expo-
sure and cancer of any of these sites.
Results from the DuPont case-control (56) study were
evaluated and compared with findings from SMR and
proportionate morbidity ratio (PMR) studies. Exposure
to formaldehyde forthe481 cancerdeaths and 481 living
controls was estimated from work histories. Approxi-
mately20% ofboththe control series and the cases were
exposed toformaldehyde. The authors adjusted forage,
sex, pay class, plant site and smoking history but
presented crude odds ratios having found that adjust-
ment made little difference. Numbers of many cancers
were insufficient for meaningful analysis. No nasal
cancers were reported. Among the seven cancers ofthe
buccal cavity and seven melanomas ofthe skin, only one
case ofeach was exposed to formaldehyde. Odds ratios
were not elevated substantially for cancers ofthe brain,
kidney, lung, or lymphatic and hematopoietic system.
Risk gradients were noted for cancer of the prostate
and bladder by cumulative exposure index (CEI).
Compared with a value of 1.0 among nonexposed, odds
ratios were 3.0 for CEI
- 20 and 3.6 for CEI > 20 for
cancer of the prostate. For bladder cancer, the odds
ratios were 2.6 for CEI
- 20 and 5.2 for CEI > 20. A
case-control study of lung cancer in Danish doctors
could not be evaluated because of an error in the
analysis (74).
The data are sparse and conflicting and do not yet
provide persuasive evidence of a causal relation be-
tween exposure to formaldehyde and cancer in man. As
far as nasal cancer is concerned, the evidence is against
a substantial (e.g., 10-fold) immediate increase in risk,
but sufficient information is not yet available to exclude
such an effect ifrisk starts to increase 20 years or more
after first exposure. An increase in risk ofbrain cancer
and leukemia is noted among each ofthree professional
groups who preserve human tissues with solutions
containing formaldehyde and other chemicals.
In view of the small numbers of person-years of
follow-up in subjects followed for 20 years or more and
various methodological limitations of the studies, it is
not possible from the available epidemiological data to
exclude the possibility that formaldehyde is a human
carcinogen.
le. Although on general grounds there is reason to
believe that there is a wide variation in the susceptibil-
ity of individuals to carcinogens there is insufficient
evidence to date by which to identify any particular
subgroup as having greater than average susceptibility
to a putative carcinogenic action of formaldehyde.
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Id. Formaldehyde andOtherConditions. MORTAL-
ITY. No excess mortality fromdisease oftherespiratory
system (other than cancer) as a whole has been noted
although lack ofinformation on smoking severely limits
interpretation. No detailed examination of mortality
from particular respiratory diseases has been under-
taken (Table 7). A statistically significant excess mortal-
ity from cirrhosis of the liver has been observed in the
professional groups (83 obs 59.3 exp; 95% CL for the
SMR 111-174) (57-59,62,63).'No such excess was found
in industrial workers (10 obs, 9.0 exp; 95% CL for the
SMR 53-204), but these figures were derived from one
study (55). The possibility of an excess consumption of
alcohol should be considered as a possible explanation
for the excess among embalmers, although there is no
direct evidence to support this conjecture.
MORBIDITY The panel summarized studies measur-
ing primarily symptoms and/or changes in pulmonary
function (74-82). Symptoms (particularly irritation of
the eyes, nose and throat) were consistently reported
more frequently in the exposed populations, and were
reported even when there were no reductions in pulmo-
nary function. No important reductions in forced vital
capacity were observed. Reductions in forced expir-
atory volume in one second (FEV) and forced expir-
atory volume % (FEV/FVC) when observed were small.
These were not detected when exposure to formalde-
hyde was solely as a vapor. There was either a weak or
absent association of reduced pulmonary function test
with exposure in the few studies where this factor was
analyzed. Workshift (acute) changes in pulmonary func-
tion test (PFT) have been assessed only when other
dust was present and/or the formaldehyde itself was a
particulate or incorporated in particles. Acute PFT
reductions were not consistently present, were small
and showed no regular association with exposure.
Although some symptoms were present, the changes in
PFT were clinically insignificant, and there is no
convincing evidence formaldehyde exposure results in
restriction or obstruction at the doses studied. There is
some suggestion that the symptoms are reversible and
ofminor import. However, because ofthe demonstrated
irritant potential offormaldehyde, selection bias may be
occurring in the exposed populations so that these
studies are likely to underestimate adverse effects of
formaldehyde exposure.
lopic 2. Future Studies
Further case-control and cohort mortality studies are
needed, both of industrial and professional workers
exposed to formaldehyde and of persons exposed to
formaldehyde in mobile and other homes. These studies
should include estimates of the degree of exposure to
formaldehyde and other chemicals; the analyses should
take into account various possible induction times for a
formaldehyde effect, as well as possible confounding by
smoking habits and alcohol consumption. The possibil-
ity that there may be an inverse relation between
degree ofexposure to formaldehyde and smoking habits
should be examined.
The panel wished to draw particular attention to the
consistent excesses of malignant brain tumors (and
leukemia) reported in several groups of professionals
who use formaldehyde in the preservation of human
tissues. Studies should be undertaken to measure the
patterns of exposure to formaldehyde in these occupa-
tions, and to identify other chemical and biological
exposures.
Longitudinal studies ofthe effects (ifany) ofexposure
to formaldehyde gas and particulates on pulmonary
function are needed as the data currently available are
derived from cross-sectional studies.
Carcinogenicity/Histopathology/
Genotoxicity Panel Report*
Topic 1. What conclusions can be drawn from the
available experimental data relative to the carcinogeni-
city/genotoxicity offormaldehyde? Are there data from
studies that permit projections to be made about
potential human responses?
a. What role does the cytotoxicity of formaldehyde
playinitscarcinogenicityinexperimentalanimals?
b. What is the significance of benign tumors and
potential preneoplastic lesions in the carcinogenic
response in rats exposed to formaldehyde by
inhalation?
c. What do genotoxicity studies tell us about the
potential of formaldehyde to be an initiator or
promoter for carcinogenesis or a mutagen in
somatic or germ cells?
d. What nonneoplastic changes occur when experi-
mental animals and man are exposed to formalde-
hyde? What is the health significance of these
changes?
Topic 2. What critical questions remain to be an-
swered?
Topic 1: Conclusions from
Experimental Data
1. Data on the carcinogenicity of formaldehyde
vapor are available for the rat, mouse, and hamster.
Carcinogenicity for the nasal epithelium has been
demonstrated in two strains of rats exposed by inhala-
tion for 6 hr/day, 5 days/week, for up to 2 years, to
concentrations of approximately 14 ppm formaldehyde
(83,84.t The same exposure regimen in one experi-
ment, but at a concentration of 5.6 ppm, produced a
greatlyreducedincidence ofnasal cancer, 2 out ofatotal
* Carcinogenicity/Histopathology/Genotoxicity Panel: RichardGriese-
mer (Chairman); Craig Boreiko; Frederick J. de Serres; Victor J.
Feron;J. JustinMcCormick; James A. Swenberg; Benjamin E Trump;
A. Upton; J. Ward.
t Thenumberofrats with nasal carcinoma at concentrations of14.3
ppm was an adjusted incidence of 103 out of 206.
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of235 rats ofboth sexes (83). About 80% ofboth sexes
at this dose level survived 2 years and, therefore, were
atrisktolate developinglesions. Nonasaltumors, other
than polypoid adenomas, were found inthe same experi-
ment in rats exposed to concentrations of 2 ppm.
For mice, only one adequate study has been reported
in which 2 out of a total of 215 mice exposed to a
concentration of 14 ppm developed nasal cancers after
24 months of exposure (83). Although not statistically
significant in comparison with matched control mice,
the findingis considered strongly suggestive incompari-
son to historic control mice in which nasal cancers are
rare. The difference in susceptibility of rats and mice
might be attributed to greaterreductions in respiratory
minute volume in mice than rats during exposure to the
irritant vapor (85).
Eighty-eight male Syrian hamsters exposed to 10
ppm formaldehyde vapor, 5 hr/day, 5 days/week fortheir
lifetime had no detected respiratory cancers (86).
However, onlytwo microscopic sections ofthe nose were
examined for each animal. In another experiment by
the same group ofinvestigators, male hamsters exposed
to 30 ppm formaldehyde for 5 hr a day, once a week for
lifetime also had no tumors observed in the respiratory
tract. When male hamsters received a 5-hr exposure to
30 ppm formaldehyde 2 days prior to each of 10 weekly
injections of diethylnitrosamine (DEN), the average
number of tracheal tumors per tumor-bearing animal
was reported to be increased as compared with those
hamsters receiving DEN alone. Inspection of the data
presented in the report, however, showed a correspond-
ing decrease in lung tumors in hamsters exposed to
both agents, suggesting that the effect on the trachea
may be within the limits of experimental variability.
The reported cocarcinogenicity requires confirmation.
The available data indicate that hamsters are much
less susceptible to the carcinogenic effects offormalde-
hyde than rats and that mice are intermediate in
response. It should be emphasized, however, that the
data available for species comparisons are limited to
very few experiments. It may be relevant that acetal-
dehyde, a structurally related compound, is carcino-
genic for the nose and larynx of Syrian hamsters (87)
and for the nasal passages of rats (88).
No compound-related skin cancers were found in any
of the inhalation bioassays.
Several studies on the pathogenesis offormaldehyde-
induced nasal cancer have been completed (89). Data
from these are included in this panel's report as well as
the report of the Structure Activity/Biochemistry/
Metabolism Panel. Collectively, these suggest that the
toxiceffects offormaldehyde areproportionately greater
at high concentrations (i.e., 6-15 ppm) than at lower
concentrations (i.e. < 2 ppm). For example, increasing
the exposure concentration of formaldehyde from 6 to
14 ppm, less than a 3-fold increase, resulted in a 50-fold
increase in squamous cell carcinomas in rats. Possible
mechanisms for this include impairment of mucociliary
clearance, detoxification, and DNA repair leading to
greater effective target site doses. This panel considers
differences in ambient air concentrations versus dose to
target sites to be a likely explanation for the apparent
nonlinearity in concentration response.
la. Rodents exposed to formaldehyde by inhalation
showed clear indications of cell damage in the nasal
turbinates at concentrations that induced squamous cell
carcinomas (90). The cytotoxic response was character-
ized by cell death, restorative cell proliferation and
hyperplasia, and occurred in the same regions of the
nasalpassagesthatdevelopedsquamouscellcarcinomas.
Thisresulted in alteration ofthe nasal epithelium from a
tissue with low cell replications (i.e., 0.1-0.5% of the
cells) to one with increased cell replication in the early
time points sampled. Concentration has been shown to
play a greater role than the concentration-time product
in both acute studies and following exposure ofrats for
up to six months. No squamous cell carcinomas were
observed at concentrations inducing less cytotoxicity.
The implications ofthese findings are that cytotoxic-
ity might influence both initiation and promotion. If
more cells of the target tissue replicate, there is a
greater availability of single-stranded DNA for adduct
formation, decreased time for repair of DNA adducts,
and a greater chance of fixation of mutagenic events.
Increased cell proliferation also contributes to tumor
promotion. Thus, there is a greater likelihood oftumor
development with the increased cell proliferation associ-
ated with cytotoxic exposures. Other chemicals classi-
fied as tumor promoters (i.e., nitrilotriacetic acid,
phenobarbital, saccharinand2,3,7,8-tetrachlorodibenzo-
p-dioxin) also induce tumors primarily at doses which
result in cytotoxicity and chronic hyperplasia in target
organs. These factors are likely to contribute to the
nonlinearity of the dose response, i.e., proportionately
greater response at higher doses.
lb. Benign Tumors. Carcinogens induce both be-
nign and malignant tumors. Carcinogens which induce
benign tumors almost always induce malignant tumors
in the same experiment or other experiments. Benign
tumors in rodents may progress to malignant tumors. It
is impossible to predict whether or not a specific benign
tumor will progress to a malignant tumor.
In the case of formaldehyde (83), a high incidence of
malignant tumors (squamous cell carcinomas) was in-
duced in rats exposed to 14 ppm formaldehyde gas.
Papillomas, which the panel believes represent the
benign counterpart of the squamous cell carcinoma,
were not observed. A second type of benign lesion,
polypoid adenoma, occurred in all exposure groups and
one control animal. Six of the 20 lesions originally
diagnosed as polypoid adenomas in the study conducted
at the Chemical Industry Institute ofToxicology (CIIT)
(83) were reviewed by pathologists on the panel and in
the audience. They considered the lesions to represent a
mixture of polypoid adenomas, nonneoplastic polyps
and hyperplasias. (Subsequent independent review of
the lesions originally diagnosed as polypoid adenomas
in the CIIT study essentially confirmed the presence of
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polypoid adenomas in the study, although a few lesions
were considered to be borderline between adenoma and
hyperplasia.) The panel recommends that this group of
lesions not be combined with squamous cell carcinomas
for risk estimation because ofthe differences in the cell
type oforigin. The polypoid adenomas can be evaluated
separately and in combination with the nonsquamous
carcinomas that were observed in the 14 ppm rats.
Ib. PotentialPreneoplasticLesions. Preneoplastic
lesions may be induced by carcinogens. The morpho-
logic, histochemical and biologic properties of these
lesions are best studied by serial sacrifice experiments
and reversibility studies. In these types of studies,
specific lesions may be characterized and a sequence of
the histopathogenesis ofcancer postulated. Some infor-
mation ofthis type is available for formaldehyde. Based
on incidence in serial sacrifice studies, epithelial dyspla-
sia and squamous metaplasia in rats and mice exposed
to formaldehyde appear to regress after stopping the
carcinogen exposure. It is uncertain if these reversible
lesionsarepotentiallypreneoplastic, buttheirreversibil-
ity suggests that they are not committed to progress.
More severe and typical lesions occurred only in the
highest dose groups where tumors occurred. Adequate
data are not available to draw any conclusions on
regression or progression of the latter potentially
preneoplastic lesions in the formaldehyde bioassay.
Ic. The 1977 review of Auerbach et al. of the
literature on the biological effects of formaldehyde (91)
indicated that the ability of formaldehyde to cause
genetic alterations in Drosophila larvae, fungi, and
bacteria was known as early as the 1940s. Since 1977,
new studies have demonstrated that formaldehyde can
induce single-strand breaks in DNA (92-94), DNA-
protein crosslinks (92-96), sister chromatid exchanges
(97,98), and chromosome aberrations (99). It has also
been shown to induce mutations in bacteria (100-102),
yeast (103-105), Drosophila (106), mammalian cells
(97,107) and human cells (108). In vitro evidence of
formaldehyde's carcinogenic potential is provided by its
ability to transform BALB/c 3T3 mouse cells (97), BHK
21 hamster cells (107) and C2H-1OT1/2 mouse cells
(100,109) to enhance the transformation of Syrian
hamster embryo cells by SA7 adenovirus (110), and to
inhibit DNA repair (111).
In reviewing the above literature, we have found that
the recent work is more likely to find formaldehyde a
mutagen than earlier studies and is also more likely to
show a dose-response relationship. These results are
most probably attributable to the greater sophistication
in the way the later assays were carried out. It should
be noted that in the above studies, the relationship
between cytotoxicity induced by formaldehyde and
mutagenicity (108) or transformation (100,107,109) in-
duced by this agent istypical ofmost mutagens/carcino-
gens that are positive in these assays. The data we have
reviewed are consistent with formaldehyde acting as a
weak mutagen (i.e., less than a 10-fold increase over
background).
Various studies have been undertaken to determine
whether formaldehyde has agenotoxic effect in vivo. In
mice, the dominant lethal test was found to be negative
(112). However, in a more recent dominant lethal assay
usinghigherdosesand adifferent mouse strain, margin-
ally positive results were obtained, but only in the first
and third week of the seven weeks studied (113).
Negative results were obtained when the induction of
micronuclei (114 or chromosomal aberrations (97,113)
were used as an endpoint.
A small increase in sister chromatid exchanges has
been reported in the bone marrow of mice exposed to
high (> 25 ppm) formaldehyde concentrations. Unfor-
tunately, technical problems were encountered during
the formaldehyde exposures and the actual concentra-
tions required to elicit this effect are not known
(95,115).
The observation that formaldehyde is both genotoxic
and carcinogenic suggests that in vivo exposures cause
irreversible genetic alterations causally related to the
acquisition of malignancy. In vitro studies suggest,
however, that the genotoxic properties offormaldehyde
are relatively weak. One can thus question whether
promotional influences play a major role in the etiology
offormaldehyde-induced neoplasms. Studies conducted
to date suggest that formaldehyde possesses only weak
activity for the promotion oftransformation in cultures
of C3H/1OT1/2 cells (116) and similar weak promoting
activity on mouse skin (117; Ward, personal communi-
cation). A second study on mouse skin failed to detect
promotion following the application of nonirritating
doses of formaldehyde (118). In addition, the exposure
of DEN-treated hamsters to 30 ppm formaldehyde (86)
was reported to increase the incidence ofDEN-induced
tracheal adenomas. Promoters exhibit marked tissue
and species specificity and the possibility that formalde-
hyde might possess strong tumor-promoting properties
in the rat nasal cavity cannot be excluded. TIeatment
with carcinogenic concentrations of formaldehyde in-
duces extensive cell proliferation, a phenomenon re-
ported to be sufficient forthe promotion oftumorigene-
sis on mouse skin (119,120).
Most importantly, perhaps, the mouse spot test is
reported tobenegativeintwoseparate studies (115,120),
although the full datawere not available to the panel. In
one ofthese studies (115), difficulties were encountered
in regulating the levels of formaldehyde exposure and
levels in excess of 25 ppm probably occurred. Further-
more, while genotoxic effects were not observed in this
study, there was some suggestion of embryotoxicity as
evidenced by the production ofwhite midventral spots.
Still, since this assay is considered agood assessment of
the ability of an agent to cause systemic effects, these
negative results suggest that germ-cell assays would
also be negative. Thus, there may not be a need for
additional studies such as the specific locus test and the
heritable translocation test.
Id. There is no convincing evidence in experimental
animals that inhalation exposure causes significant
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primary toxicologic effects in organs other than the
upper respiratory tract.
Topic 2. Future Studies
Formaldehyde-DNA adducts have recently been par-
tially characterized. Also, formaldehyde-induced DNA-
protein crosslinks are reported to exist (Structure
Activity/Biochemistry/Metabolism Panel). However, the
biologicalrelevance oftheseformaldehyde-induced DNA
lesions has not been ascertained. Future studies should
determine whether such adducts preferentially form on
single stranded DNA within cells, what repair mecha-
nisms remove such lesions, and whether the DNA
lesions are associated with the cytotoxic, mutagenic,
and transforming activity of formaldehyde.
Comparative molecular dosimetry studies following
formaldehyde inhalation exposure are urgently needed
to evaluate the relationship between exposure and dose
to target site.
Additional carcinogenicity studies in rats at doses
above, below, and between 2 and 14 ppm would be
beneficial in better defining the dose-response curve.
Since rodents are obligate nose breathers, compara-
tive toxicity/carcinogenicity studies in primates which
have oronasal breathing patterns similar to man would
be useful to further validate dosimetry studies as a
means of carcinogenic risk assessment.
An animal model for initiation/promotion in the nasal
epithelium should be developed.
Since formaldehyde and acetaldehyde are nasal
carcinogens, information should be collected on struc-
ture-activity relationships of other aldehydes.
Summary
Formaldehyde gas is carcinogenic for rats and proba-
bly for mice, producing nasal tumors after inhalation.
Limited experiments in Syrian hamsters have not
demonstrated carcinogenicity. In rats, the carcinogenic
response appears nonlinear, being disproportionately
higher at the higher concentrations (14 ppm).
Cell killing and the reparative process that occurred
in the inhalation bioassays may contribute to carcino-
genicity, but the specific role ofcytotoxicity in formalde-
hyde carcinogenicity is unknown. Cytotoxicity is not
unique to formaldehyde bioassays and may play a role in
the carcinogenicity of other chemicals as well.
A sample of the benign lesions observed in the
Chemical Industry Institute ofToxicology (CIIT) study,
originally diagnosed as polypoid adenomas, was re-
viewed by the panel and was considered to be a mixture
of polypoid adenomas, nonneoplastic polyps and hyper-
plasias. Uncertainties about the nature of the remain-
ing lesions in the study made the lesion unsuitable for
use in risk assessment. Subsequent to the Consensus
Workshop, an independent review essentially confirmed
the original diagnoses in the CIIT study, indicating that
they were then suitable for use in risk assessment,
either separately (from squamous carcinomas), or in
combination with nonsquamous carcinomas.
Formaldehyde is genotoxic in a number ofassays and
is weakly mutagenic in human cells in culture as well as
in other mammalian cells, Drosophila, fungi and bac-
teria. Formaldehyde is a weak promoter in cell culture
and on mouse skin. In vivo studies in mice are, in the
main, negative, but marginally positive results have
sometimes been seen at very high doses.
There is no convincing experimental evidence that
formaldehyde has primary toxic effects at body sites
distant from the site of exposure.
Immunology/Sensitization/
Irritation Panel Report*
Topic 1. What is the significance of reports that
formaldehyde causes irritation and/or sensitization fol-
lowing topical or inhalation exposure?
a. Is formaldehyde a primary sensitizing agent or
does it elicit a response only in presensitized
populations?
b. If irritation, primary or secondary sensitization
occurs, who are the susceptible populations?
c. What are the possible mechanisms for formalde-
hyde-induced irritation/sensitization?
d. Do threshold levels exist for irritation/sensiti-
zation? Ifso, whatarethelevels andtheconcentra-
tion ranges? Do thresholds differ for different
populations (sensitized)?
e. Is there evidence for effects of formaldehyde on
the immune system?
Topic 2. What experiments would be most important
to resolve any controversies in this area?
ToDpic 1. Significance of
Sensitization Reports
Any assessment of reports on irritation by and/or
sensitization to formaldehyde requires some definition
of terms. Allergy can be defined as the acquired,
specific, altered capacity to react. The general criteria
suggestive ofthis are: aperiodofexposuretononirritant
or irritant concentrations, i.e., the period of sensitiz-
ation; the elicitation of reactions by small amounts, far
below those capable of inducing sensitivity or irritant
effects. This is a distinguishing feature between irrita-
tionand sensitization. Last, onlya'fewexposed subjects
are likely to be sensitized. This is in contrast to irritant
effects which are likely to occur in most subjects who
are more heavily exposed to irritant concentrations.
Demonstration of relevant, appropriate, humoral anti-
bodies or sensitized lymphocytes provides strong evi-
dence that the reaction is allergic.
Four different types of allergy can be induced.
* Immunology/Sensitization/Irritation Panel: Jack Pepys (Chair-
man); Paul Nettesheim (Alternate Chairman/Secretary); Yves Alaire;
James R. Beall; Jack H. Dean; K. C. Gupta; Michael D. Lebowitz;
Howard Maibach; Roy Patterson.
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Type I. Immediate, anaphylactic reactions, coming
on in minutes, are maximal in about 10 to 15 min and
last about 1 to 1.5 hr. These reactions are mediated by
IgE antibody, mainly in atopics, but also by IgG
(short-term sensitizing) antibody. "Atopy" is defined
here as the production of specific IgE to one or more
common allergens with or without symptoms, a feature
found in many studies in about 40% of individuals
tested.
TypeII. The antigens are altered bodyconstituents,
and where chemical haptens are involved, the antibod-
ies are directed against the hapten-carrier complex.
Type III. Immune-complex complement-dependent
allergy is mediated by precipitating antibodies. The
reactions come on after several hours, are maximal at
about 5 to 8 hr and resolve in about 24 hr. They are
preceded in skin tests by an immediate, Type I introduc-
tory reaction.
Type IV Delayed-type allergy is mediated by sensi-
tizedT-lymphocytes. Itisthe allergy ofcontactdermati-
tis and develops after about 24 hr, being maximal at
about 48 to 96 hr and resolves slowly. The different
types of allergy may be present together.
Studies with reactive low molecular weight chemicals
have shown the participation ofTypes I and III allergy
in allergic respiratory diseases such as rhinitis, asthma,
etc. (121,122). Asthma is defined here as bronchial
hyperactivity to specific immunological or nonspecific,
nonimmunological factors. These can have effects one
upon the other in clinical circumstances. Clinical obser-
vations and controlled bronchial provocation tests have
shown a heterogeneity of patterns of asthmatic reac-
tions. These can be immediate or nonimmediate. The
immediate reactions have features of Type I, IgE and
IgG (STS) reactions.
Nonimmediate asthmatic reactions have three forms.
One comes on after 1 hr, is maximal at about 2 to 3 hr,
and resolves in 5 hr. The next, and most common, comes
on after several hours, is maximal at about 5 to 8 hr and
resolves by 16 hr. Then there is the nocturnal reaction,
coming on in the early hours ofthe morning and capable
of recurrence at the same time each night for many
nights, following a single challenge exposure as re-
ported by Hendrick and Lane (123) in nurses using
formalin for disinfection in a dialysis unit. The different
patterns ofasthmatic reaction may be present together.
There is no evidence, however, that these patterns are
necessarily due to the types of allergy they may
resemble.
1. There are numerous reports that formaldehyde
vapor exposure causes direct irritation ofboth the skin
and respiratory tract (36,38,124-144). By comparison
the evidence for allergic airway responses to formnalde-
hyde isless extensive (75,121,126,131,136,138,145-159).
Sufficiently well-controlled scientific studies are not
available to definitively establish the development of
respiratory tract allergy to formaldehyde gas per se.
There are a few clinical reports in which tests were
made for respiratory sensitivity to either formaldehyde
gas or formaldehyde products, or both, and in which
allergic reactions were elicited (123,152,160-165). The
interpretation of the findings is uncertain since ques-
tions about the nature ofthe materials, the methods of
testing and the statistical analysis of the data remain
unanswered.
la. Formaldehyde is definitely a primary skin sensi-
tizing agent inducing allergic contact dermatitis (Type
IV allergy) and probably immunologic contact urticaria
(probably Type I allergy) (38,75,121,135,136,145,149,
154,155,166-170).
There is extensive experience suggestingthat human
beings with allergic contact dermatitis to one chemical
are, in some situations, more likely to develop allergic
contact dermatitis to another. On the other hand, other
situations exist in which sensitization to one chemical
iterferes with sensitization to a second. This panel is not
aware ofany controlled studythat documentsthe ability
ofany other chemical to influence the sensitization rate
to formaldehyde.
It is not known whether populations already sensi-
tized to chemicals other than formaldehyde are at
greater risk for inhalant sensitization to formaldehyde
orits products. Assessment ofarole forpresensitization
in people exposed to formaldehyde needs study in terms
of atopy.
lb. Irritation and allergic contact dermatitis to
formaldehyde occur. Although there is extensive litera-
ture ontheeffects ofage, sex, race, and otherfactors on
the ability of chemicals to induce allergic contact
sensitization and irritation, there is no specific informa-
tion on these matters for formaldehyde.
With respect to inhalant sensitization to formalde-
hyde, it is not known whether there are susceptible
groups inthe population. Conceivably, asthmatics might
be more sensitive to the irritant action offormaldehyde,
triggering bronchial reactions (38,75,121,127,136,153,
161,163).
In chronic dialysis patients sensitization to formalde-
hyde has been reported resulting from its release into
the bloodstream from equipment and tubing sterilized
with formaldehyde (171-175).
Ic. CutaneousExposure. Formaldehyde skinirrita-
tion is nonimmunologic; studies as to how its mecha-
nismdiffersfrom otherforms ofcutaneous irritation are
not available. Formaldehyde allergic contact dermatitis
presumably requires conjugation with protein and is
taken to be a classical type ofdelayed hypersensitivity.
Formaldehyde-induced contact urticaria has been docu-
mented and is presumably a Type I allergy. Nonim-
munologic contact urticaria which requires multiple
applications onthe same site hasbeendocumented (144).
Information on mechanisms is lacking.
Ic. Inhalation Exposure. Irritation and potential
predisposition to infections are seen. Two types of
irritation can be caused by formaldehyde: sensory; and
inflammation (175,176).
Sensory. Receptors ofeyes, nose and throat may be
affected (36,38,124,127,177-179). Man and animals can
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developshort-termtolerance (31,125,130,180,181). There
is evidence in experimental animals that with repeated
exposure increased responses are obtained (130).
It requires higher concentrations of formaldehyde in
the air to stimulate bronchial receptors, since the
water-soluble formaldehyde reacts with and is retained
in the upper respiratory tract (175).
At even higher concentrations, receptors in the
peripheral lung tissues (175), in the conducting airways
and the alveoli, have been stimulated in animals
(131,177,182,183). To achieve this, nasal catheters were
used to bypass the upper airways. Stimulation of
receptors in the peripheral lung might occur if small
particulate material from urea, phenol or other formal-
dehyde products and pressed wood dusts were depos-
ited in these regions of the lung followed by hydrolytic
release offormaldehyde (182,184). Other chemical com-
ponents would have to be excluded as possible causes
before the effects could be attributed to released
formaldehyde.
Atleastthree mechanisms existwhereby lowmolecu-
larweight chemicals may cause sensory irritation (185),
i.e., nucleophilic addition, disulfide bond cleavage and
physical interaction. In the case of formaldehyde,
nucleophilic addition is probably the most important
mechanism. The reactivity is directed for example
toward SH or NH2 groups in proteins. Formaldehyde
reacts with SH and NH2groups in areversible way. The
interaction with SH is less reversible than that with
NH2 (186).
Inflammation (with Cellular and Tissue Damage).
Experiments in animals show that cellular damage
and inflammation is induced with increasing severity at
concentrations of formaldehyde of 1 to 15 ppm. Expo-
sure for several hours isrequired and is accompanied by
impaired ciliary activity (176,187).
Earlier studies implicate formaldehyde as a potential
factor predisposing particularly children to respiratory
tractinfections(181,188-190). Appropriateepidemiologi-
caland animal studies need tobe designed usingspecific
criteria for infection and better protocols of the type
used toinvestigate otherirritantgases, such as O3, SO2,
and NO2 (177,191-193).
ic. Systemic Sensitization. Sensitization arising
from release offormaldehyde into the circulation during
dialysis has been reported. This is associated with
frequent eosinophilia and some severe hypersensitivity
and asthmalike reactions (194,195). The presence of
auto-anti-N-like antibodies reacting with formaldehyde
conjugated red blood cells is evidence of Type II
auto-allergy (171-174,196-201). The anaphylactic reac-
tions are suggestive of lype I allergy.
Id. CutaneousExposure. Thresholdlevelshavebeen
reported for cutaneous irritation and allergic contact
dermatitis inthe guineapigand man. Forhumanskin, a
single application of1% formalin inwaterwith occlusion
willproduce anirritantresponse inapproximately 5% of
the population (144). The threshold for open application
has not been determined. The threshold level for the
induction of allergic contact dermatitis in man has only
beenimprecisely determined as lessthan 5% formalinin
water. The approximate thresholds for elicitation of
allergic contact dermatitis in sensitized subjects to
formaldehyde range from 30 ppm for patch testingto 60
ppm for actual use concentrations offormalin. Because
of the small data base these values must be regarded
with caution until further studies become available
(144).
The threshold for induction of immunologic contact
urticaria has not been determined. For the induction of
repetitive nonimmunologic contacturticariaisunder 1%
formalin in water or less (144).
Id. Inhalation Exposure. Precise thresholds have
not been established for the irritant effects of inhaled
formaldehyde. However, within the range of 0.1 to 3
ppm, most people experience irritation of the eyes,
nose, and throat (78,79,124,125,127,130,153,179,181,
202-205). Between 10 and 20 ppm, symptoms are
severe, and it becomes difficult to take a normal breath
(206). Lower airways and pulmonary effects are likely to
occurbetween 5 and 30 ppm. Exposuresbetween 50 and
100 ppm cause serious injury to the respiratory tract,
such as pulmonary edema, inflammation, pneumonitis
and pneumonia (130,136). Asthmalike symptoms have
been elicited by irritant concentrations.
There is no information regarding threshold values
forsensitizationtoformaldehydeasaninhalantallergen.
le. Only two animal studies on the potential toxic
effects of inhaled formaldehyde on the immune system
have come to our attention (207,208). No impairment of
immune functions was found except in one ofthe studies
where lethal concentrations were used (208).
Topic 2. Future Studies.
Cutaneous. Future studies should include defining
the operational criteria for scientific documentation of
the diagnosis of allergic contact dermatitis in man;
determining the amount of formaldehyde required to
induce and elicit the following reactions in man: irritant
dermatitis, allergic contact dermatitis, nonimmunologic
contact urticaria and contact urticaria; ascertaining the
cross reaction pattern in allergic contact dermatitis in
animal and man to formaldehyde-related chemicals;
utilizing the above information, ascertaining popula-
tions susceptible to irritation, allergic contact dermati-
tis and immunologic and nonimmunologic contact urti-
caria; determining the relationship in allergic contact
dermatitis between the degree of patch test reactivity
and intolerance to actual product use.
Inhalation. Controlled cohort epidemiological stud-
ies of exposed and unexposed persons with particular
emphasis on the formulation and application of proto-
cols should be conducted. The application of standard-
ized procedures is recommended.
Clinical studies should use basic protocols for pulmo-
nary function studies and for testing for specific and
nonspecific sensitivity. Comparisons of gaseous and
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particulate materials for provocation test purposes are
needed. Prospective comprehensive surveillance stud-
ies correlated with formaldehyde exposure measure-
ments should be made, with detailed criteria to docu-
ment the health hazards.
Sulfur dioxide and 03 exposure of animals has been
shown to promote airway infection to bacterial and viral
agents. Similar studies should be conducted with
formaldehyde. Appropriate epidemiological studieswith
acceptable criteria for respiratory infection should be
conducted to determine the effects of formaldehyde on
respiratory infections in humans.
A larger data base should be established on sensory
and irritant thresholds in normal subjects in all age
groups including individuals with respiratory tract
symptoms.
Laboratory studies need to be conducted to search for
serological and cellular antibody activity in groups who
are or appear to be sensitive to formaldehyde and in
particular in the hemodialysis patient population in
whom allergic sensitivity to formaldehyde has been
reported. This may provide a basis for immunological
studies ofrespiratory tract responses to formaldehyde.
Animal models need to be developed for observations
ofbiological effects ofdiffering formaldehyde exposures
and for studies of the mechanisms of formaldehyde
irritation and sensitization.
Chemical characterization of formaldehyde products
is needed. The behavior of such products in the atmo-
sphere and their biological effects and interrelation-
ships need to be investigated.
Structure Activity/Biochemistry/
Metabolism Panel Report*
Topic 1. Whatis known about the metabolism and fate
of exogenous and endogenous formaldehyde in experi-
mental animals and man?
a. What are the data concerningbinding offormalde-
hyde or its metabolic products to cellular macro-
molecules?
b. Are there common biological effects induced by
short-chain aldehydes that can be predicted on the
basis of structure activity relationships?
c. What are the quantitative relationships between
exposure levels and concentrations of formalde-
hyde in particular tissues and organs?
d. Are there compounds that exert an effect by
forming formaldehyde during metabolism?
Topic 2. What future studies would resolve uncertain-
ties in this area?
The Panel on Structure Activity/Biochemistry/Meta-
* Structure Activity/Biochemistry/Metabolism Panel: Sidney Wein-
house (Chairman); James E. Gibson (Alternate Chairman/Secretary);
Joseph Arcos; Ruth E. Billings; Henry d'A. Heck; Thomas R. Tephly;
Andrew G. Ulsamer; Phillip G. Watanabe. Background for the
information in this report maybe found in the database in Appendix I
to the Consensus Workshop document and in the references (38,49,
141,143,186,209-211).
bolism recognizes as a basic challenge the question of
how a vitally important intermediate in the normal
metabolism of cells, a compound which serves as a
building-block forthe synthesis ofpurines, pyrimidines,
many amino acids and lipids, a key molecule in one-
carbon metabolism which is present in normal tissues,
can induce cancer in animals on inhalation.
Topic 1. Metabolism of Formaldehyde
la. There is now a large and growing body of data
which infers that formaldehyde, like many other chemi-
cal carcinogens, acts as an electrophile with macromole-
cules such as DNA, RNA and protein to form reversibly
bound adducts or irreversible crosslinks and that the
modifications in DNAcausedthereby arerelevant tothe
neoplastic transformation.
lb. Formaldehyde is not unique as a carcinogenic
aldehyde, since other aldehydes, such as acetaldehyde,
acrolein, malondialdehyde and glycidaldehyde are also
carcinogenic. It is likely, though not certain, that all of
these aldehydes have a common mode ofaction: through
modification of DNA by formation of adducts or cross-
links. Differences in the degree and tissue targets of
carcinogenesis are readily attributable to differences in
activities and localizations of activating and/or compet-
ing enzyme systems, and to differences in physical
properties, solubilities and partition between cell
membranes.
la. SupportingaroleofDNAmodificationinformal-
dehyde toxicity is its clear-cut mutagenic activity. It is
mutagenic in three strains ofSalmonella typhimurium
and initiates neoplastic transformations in C3H/1OT1/2
mouse fibroblasts when treated together with the
tumor promoter, 12-0-tetradecanoyl phorbol 13-acetate
(TPA). Formaldehyde at concentrations of0.017to 0.083
mM also caused transformation ofBALB/c3T3 and baby
hamster kidney cells and caused mutations in cultured
human lymphoblasts at concentrations greater than
0.13 mM and chromosomal aberrations in diploid human
fibroblasts at 2 to 8 mM.
Reactivity. Formaldehyde reacts virtually instanta-
neously with primary and secondary amines, thiols,
hydroxyls, and amides to form methylol derivatives,
which in some instances can lose water to form the
corresponding Schiffbases. The thiols have a somewhat
higher affinity for formaldehyde than amines and ad-
ducts with glutathione or beta-mercaptoethanol are
quite stable.
Formaldehyde forms unstable adducts with DNA,
RNA and proteins, but when crosslinked, these are far
more stable. DNA-protein adducts have been demon-
strated in several eukaryotic and prokaryotic celltypes,
and are formed at the same concentrations offormalde-
hyde that cause mutation and cell transformation.
Metabolism. Formaldehydeisnormallyformedendo-
genously, as the N5,N10-methylenetetrahydrofolic acid,
which equilibrates rapidly with other tetrahydrofolate
derivatives. The major sources are serine and glycine;
however, othersourcesareN-methylaminoacids, methio-
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nine and other methyl-containing substances, and all of
these can be formed by the many reversible reactions
involving tetrahydrofolate derivatives. Metabolic reac-
tions involving tetrahydrofolic acid (THFA) derivatives
allow formaldehyde carbon to enter virtually every
metabolite in the cell.
The total concentration of formaldehyde, free and
bound, in freshly collected livers of F-344 rats is 0.1 to
0.2 pumole/g fresh weight, very little of which is in the
form of N ,N10-methylene THFA.
Oxidation. The major pathway of formaldehyde
oxidation is to formic acid, for which three enzymatic
pathways are known. By far the most important is
catalyzed by formaldehyde dehydrogenase, which oxi-
dizes the formaldehyde-glutathione adduct with NAD+
to yield S-formylglutathione and NADH. The former is
hydrolyzed to formate and glutathione by a hydrolase
present in excess. The affinity of formaldehyde for
formaldehyde dehydrogenase in respiratory and olfac-
tory mucosa is 2.5 ,uM, which is in the range ofnormal
formaldehyde concentration, whereas the nonspecific
aldehyde dehydrogenase, has an affinity 200-fold lower;
completely outside the range for physiological sig-
nificance. Formaldehyde is also oxidized to formate by
hydrogen peroxide, catalyzed by catalase, but the
quantitative significance and sites of action are not
known.
ic. Formaldehyde disappears from the plasma with
a half-time of about 1 to 1.5 min. Removal is so rapid
that an increase cannot be detected in the plasma of
animals or humans immediately following inhalation
exposure to high concentrations. In intact animals, a
high percentage of the formaldehyde administered is
converted to CO through formate with smaller amounts
excreted inthe urine as formate and severalotherminor
metabolites.
Despite its rapid removal, the possibility exists that
transient increases in formaldehyde may occur in the
intact animal. The panel could not exclude the possibil-
ity that formaldehyde may be transported to, and exert
toxic effects at, distant sites following inhalation, but
definitive evidence for effects offormaldehyde per se at
distant sites is lacking.
Id. Formaldehyde from Xenobiotics. Besides its
formation from normal metabolites, formaldehyde is
produced in the oxidative demethylation of drugs and
other foreign substances by the microsomal cytochrome
P-450 monooxygenases. Such endogenous formaldehyde
may exert toxic effects; for example, hexamethylphos-
phoramide is a potent nasal carcinogen and a mutagen
acting, presumably, by conversion of its methyl groups
intracellularly to formaldehyde. Other substances that
may be toxic by virtue of conversion to formaldehyde
would be methanol and methyl chloride, but existing
evidence for a toxic role of formaldehyde is to the
contrary.
Significance ofNonlinear Carcinogenic Response
to Formaldehyde Exposure. At 15 ppm, formalde-
hyde is an effective nasal carcinogen in the rat, but
there are few tumors at 6 ppm. This non linearresponse
to dosage, in contrast with the linear response of
DNA-protein crosslinks at 6 ppm and above, suggests a
role for nongenetic factors in formaldehyde carcino-
genesis. However, it should be recognized that only
certain specific sites on DNA might lead to carcino-
genesis. Moreover, therapid and nondiscriminate attack
of formaldehyde on tissue components could involve
membrane function, transport and repair processes,
and it is known that mucociliary removal of formalde-
hyde is inhibited at high concentrations. In view ofthis
complexnetworkofreinforcingandcompetingreactions,
it is not surprising that the carcinogenic response is not
linear or that it does not parallel the degree of cross-
links. Although the cause is still uncertain, this appar-
ent nonlinearity cannot be construed to indicate the
existence of a threshold for exogenous formaldehyde
carcinogenicity. Although nongenetic factors may play a
role, more sensitive methods will be required to deter-
mine whether a linear relationship between dose and
response exists at low exposure levels. The mutagenic-
ity of formaldehyde in a variety of experimental sys-
tems and the formation ofDNA adducts and cross links
both in vivo and in vitro point to modification ofDNA or
in the repair of damaged DNA as critical steps in the
induction of cancer by formaldehyde.
The exclusive formation of nasal tumors in animals
exposed to formaldehyde does not signify any special
susceptibility and can only be attributed to its location
at the site of entry of gaseous formaldehyde.
The reason why endogenous formaldehyde, formed
constantly during normal metabolism and occurring at
low concentrations in body fluids, is apparently not
harmful still remains a mystery. The mystery is com-
pounded by the fact that exposure to formaldehyde does
not lead to any appreciable rise in body fluid levels.
More information is required on the metabolism and
pharmacokinetics ofexogenous formaldehyde. Although
there are differences in formaldehyde carcinogenicity
among different species, at present there is no reason to
assume that humans would be more or less susceptible
than the rat. As with many other carcinogens, there are
no interspecies differences in metabolism that would
provide information on possible differences in the direc-
tion or magnitude of carcinogenic responses.
Topic 2. Future Studies
Information is needed on relationships between ambi-
ent formaldehyde levels in air and its concentration at
target cells.
Effects of airborne formic acid should be studied to
see whether it may be responsible for formaldehyde
effects.
Information is required on penetration, transport and
tissue distribution ofinhaled gaseous formaldehyde and
the time course offormaldehyde concentration in blood
and tissues after administration by various routes.
Comparative studies on related aldehydes would be
desirable to reveal their toxic effects, metabolism and
reactions with macromolecules.
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There is a need for human studies and for a model of
the human upper respiratory airway system to deter-
mine rate constants for absorption, transport, and
metabolism. This should include studies of formalde-
hyde bound to airborne particulates.
Information is needed on degranulation of rough
endoplasmic reticulum caused by formaldehyde and its
effectonthemembranethiol-disulfideexchangeenzymes.
Otherquestions concern whether chromosome breaks
are related to formaldehyde dose; whether formalde-
hyde induces DNA repair enzymes and mixed function
oxidases in nasal epithelium; whether the nasal carcino-
gen, hexamethylphosphoramide iscarcinogenic systemi-
cally and whether abnormal dietary fatty acids can so
alter membrane structure as to affect cross-linking in
glutathione-depleted animals.
It would be desirable to learn whether modification of
glutathione concentration affects toxicity of formalde-
hyde in vivo and in vitro.
The following questions emerge: Does exposure to
airborne formaldehyde lead to excretion ofmutagens in
the urine? What are the structures of the modified
bases in DNA-formaldehyde adducts? What are the
nature and degree of inhibition of DNA repair after
modification by formaldehyde?
Reproduction/Teratology Panel Report*
Topic 1. Is there evidence that formaldehyde pro-
duces reproductive toxicity or is teratogenic in experi-
mental animals or man?
a. Is there evidence that formaldehyde causes germ
cell mutations in experimental animals which are
clinically significant?
b. Ifthere is evidence forreproductive orteratogenic
effects, are there biological models to explain the
activity?
c. Is there evidence for reproductive or teratogenic
effects from substances related to formaldehyde or
known to be metabolized to formaldehyde?
Topic 2. What experimental or epidemiologic studies
would be important to resolve any controversies in this
area?
Ibpic 1. Reproductive Toxicity
There is a paucity ofdata addressing possible repro-
ductive and developmental hazards of formaldehyde in
experimental animals or man. Our answers to the
questions posed about adverse reproductive effects
should be viewed as far from conclusive regarding
either the safety or lack thereof due to exposure to
formaldehyde.
There has been one adequate study of possible
teratogenic effects in mammals. Marks and colleagues
* Reproduction/Teratology Panel: GodfreyP Oakley,Jr. (Chairman);
Rochelle Wolkowski-Tyl (Alternate Chairman/Secretary); Sarah H.
Broman; Thomas F Collins; Carole A. Kimmel; Thomas A. Marks.
(212) intubated pregnant mice on days 6 through 15 of
gestation with 0, 74, 148 or 185 mg/kg/day. At the
highest dose, 22 of34 pregnant mice died. At that dose,
there was an increased incidence of resorptions, but
that increase was not statistically significant. At no
dose did the incidence ofmalformations differ between
the treated and control groups. There were also no
treatment-related differences in the mean number of
implantations, stunted fetuses, live fetuses per litter, or
average fetal body weight per litter. At a dose which
killed more than 50% ofthe dams, no adverse reproduc-
tive outcomes were observed except for the increase in
the incidence of resorptions that was not statistically
significant.
Ic. Although the Marks study (212) exposed ani-
mals to high enough doses to kill the dams, it is not
likely that embryos were exposed to formaldehyde itself
due to the very short biological half-life (142). Another
approach used to investigate whether formaldehyde is
teratogenic has been to give hexamethylenetetramine
(HMT), which is metabolized to formaldehyde in vivo.
Hurni and Ohder (213) exposed pregnant beagle dogs to
1250, 600 or 0 ppm HMT in the feed during days 4
through 56 of gestation. At 1250 ppm, 10 of 56 pups
were stillborn, the growth rate between birth and
weaning was decreased, and there was an increase in
early postnatal mortality. There were no malformed
pups. In a study in rats by Della Porta et al. (214),
exposure to HMT at 1% in drinking water from 2 weeks
before pregnancy through weaning produced no mal-
formed animals. Pups drinking the same solution after
weaning had a temporary decrease in weight gain. In a
two-generation study by Natvig et al. (215), rats fed a
diet of 1600 ppm HMT (100 mg/kg/day) showed no
difference in weight gain or fertility in the first or
second generation. Staples (216) reviewed studies involv-
ing hexamethylphosphoramide. This compound did not
cause reproductive problems in rats gavaged with up to
200 mg/kg/day or by inhalation of 0.334 ppm. Staples
(216) also indicated that glycerol formal (a condensation
product of glycerin and formaldehyde) has been re-
ported to be teratogenic in rats after administration
subcutaneously or intramuscularly at all dose levels
tested from days 6 through 15 ofgestation. The panel is
not aware ofany human exposure or ifthis compound is
metabolized to formaldehyde in vivo.
1. Otheradverse reproductive effects were reported
by Hagino (217), who found prolonged diestrus, but no
impairment of reproductive function in female rats
stressed with strong formalin vapor (concentration not
specified). Ovarian involution and endometrial atrophy
were found in female mice exposed to 40 ppm formalde-
hyde byinhalation -an exposure levelthat killed 80% of
the animals (211,218). The panel members reviewed
several other studies in experimental animals (216,219)
and agreed that there were sufficient methodologic
problems to render them of little value.
The human data are extremely meager. Shumilina
(220) studied workers exposed and not exposed to
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urea-formaldehyde resins. Concentrations of 1.2 to 3.6
ppmformaldehydewereobservedintheexposedgroups.
The methods of data collection were not very well
explained in the translated article, so thatthe panel had
many questions about methodology and the interpreta-
tion of these data. The author concluded that exposed
women had a three-fold increase in menstrual disorders
and produced more babies with birth weights between
2500 and 3000 g than did controls. However, the panel
noted that only a few neonates weighed less than 2500 g
and the rates did not differ for exposed and nonexposed
women. The panel members did not view this evidence
as very strong since many factors that could not be
evaluated from the report could have explained the
finding. In a better designed survey, Ols0n and D0ssing
(77) found that 30% of women working in an environ-
ment of 0.43 mg/m3 formaldehyde had a history of
menstrual irregularities, whereas areasonably matched
control group had no history of menstrual irregularity.
The exposed women reported eye irritation, headache
and use ofanalgesics more frequently than did controls.
The panel felt that these two papers, rather than
showing acause-and-effect relationship between formal-
dehyde exposure and menstrual disorders, point to a
reproductive effect that needs further evaluation.
Hemminki et al. (221,222) studied spontaneous abor-
tions among hospital staffengaged in sterilizing instru-
ments with chemical agents. They reported no increase
in spontaneous abortions associated with use of for-
maldehyde.
There is indirect evidence that would argue against
formaldehyde being a major human teratogen. Overthe
last 30 years, the annual production and domestic use of
formaldehyde in the United States has gone up fivefold
fromonebillionpoundstoaboutfivebillionpounds. Birth
defects have been reasonably stable over the last 30
years, although in the last decade, there have been
some exceptions to this rule. The reported incidence of
ventricular septal defects and patent ductus arteriosus
has increased and that of anencephaly and spina bifida
has declined (223).
la. Panel members did not find evidence of germ-
cell mutations of clinical significance in mammals. One
study by Fontignie-Houbrechts (113) indicated an in-
creased pre- and post-implantation loss in the first week
of mating, following exposure of males to 50 mg/kg by
injection, and increased preimplantation loss in the third
week. However, Epstein et al. (112) found no evidence of
increased dominant lethal effects in mice exposed at
doses up to 40 mg/kg, IP. Cassidy (224) reported
increased sperm abnormalities in rats following expo-
sure to 200 mg/kg, but not to 100 mg/kg, given orally.
Thus, the data are not consistent and do not adequately
test the possibility that formaldehyde causes germ-cell
mutations.
Human germ-cell mutations causing nondisjunction
could result in an increase in Down's syndrome. The
constancy of maternal age-specific rates of Down's
syndrome over the last 30 years, in face of increased
exposure, suggests that exposure to formaldehyde is
not causing nondisjunction in humans (225).
In summary, the panel could find no evidence clearly
demonstratingthatformaldehyde caused adverse repro-
ductive outcomes. What it found was a paucity of
information from which to make inferences and data
thatsuggested hypotheses tobetestedinfuture studies.
This panel feels that formaldehyde poses little, if any,
risk as a potential human teratogen. This judgment is
based on the irritation potential of formaldehyde at
extremelylowambientconcentrations (0.05ppm), exist-
ing data from in vivo mammalian studies, and toxico-
kinetic and metabolism data indicating an extremely
short half-life (not detected to 1.5 min) of the parent
compound, and relatively short half-life (80 to 90 min) of
the only known metabolite (formate) in the blood,
regardless of the route of exposure (142).
Topic 2. Future Studies
Animal Studies. There was consensus that no ade-
quate reproductive studies exist using inhalation expo-
sure which isthe primaryroute ofhuman exposure. The
panel has no toxicokinetic information to suggest that
inhalation studies would actually result in exposures as
high as in the intubation study which was negative
(212). However, classic teratology studies using inhala-
tion exposure would resolve the question ofteratogenic-
ity with such exposure. We understand that such a
teratology study is being initiated soon in Canada (Dr.
W J. Martin, Chairman, Formaldehyde Council of
Canada, communication to the panel). In addition, the
panel believes it would be reasonable to do the following
studies: combine or modify several existing protocols to
evaluate reproductive effects; sperm morphology and
vaginal cytology (226); fertility assessment by continu-
ous breeding (226); evaluate animals at the end of the
continuous breeding experiment to seek signs of func-
tional impairment in offspring.
Ifdatafromthe above experiments indicate reproduc-
tive and/or developmental risk, further studies should
be performed. Studies should be done to investigate
possible differences in the kinetics and metabolism of
formaldehyde with differing routes of exposure in
experimental animals. These studies should provide
data for comparison between animal studies and human
exposure data for risk assessment.
Epidemiology Studies. There are several possible
epidemiologic approaches to studying the relationship
between formaldehyde and adverse reproductive out-
comes. In one approach, a group ofexposed women and
a group of unexposed women would be located and
adverse reproductive effects sought. Women who might
have orhad industrial exposures and women who live in
house trailers would be reasonable subjects for such a
study. If such a study were to be done, every effort
should be made todetermine whethermenstrual irregu-
larityresulted from exposures. The panelrealizesthat a
great deal of care will be needed in the design and
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execution ofthis study if a valid answer is to be found.
Other reproductive outcomes should be studied. The
panel realizes that a very large number ofsubjects will
be needed to get a reasonable evaluation on whether
exposure causes birth defects or developmental delays.
Evaluation of the rate of low birth weights should be
feasible.
Paternal exposure could be causingadverse reproduc-
tive outcomes. Studies of male workers and controls
would evaluate this possibility.
A more practical and cheaper way to seek to identify
human reproductive outcomes associated with exposure
is to seek histories ofexposures where there have been
adverse reproductive outcomes. The panel suggests
that existing case-control studies of birth defects be
reviewed for evidence ofexposure. The panel believes it
would be reasonable to do a case-control study of birth
defects specifically seekingrelationships with exposure.
Behavioral/Neurotoxicity/
Psychological Effects Panel Report*
Topic 1. What is known about the effects offormalde-
hyde on the biochemistry and/or morphology of the
nervous system?
Topic 2. Does formaldehyde induce behavioral or
psychological changes? If so, what is the evidence and
what methods can be used to measure the changes?
Topic 3. Whatcritical experimental questions remain?
What epidemiological studies might be important in
this area?
1. Effects ofFormaldehyde on the Biochemistry of
the Nervous System. Not much work has been done
on the effects of formaldehyde on the biochemistry of
the nervous system. Heck et al. (227) have shown that
there was radioactivity in the brain after the animals
were exposed to '4C-formaldehyde for 6 hr. The concen-
tration ofradioactivity in brain after exposure ofF-344
ratstoairborne14C-formaldehyde for6hr(formaldehyde
concentration range 5-24 ppm) was 0.37 (dpm/g
tissue/dpm/g plasma), compared to 4.95 in the esopha-
gus and 2.05 in lung. The chemical nature of the
radioactive labeled compound remained to be studied.
It is unlikely to be formaldehyde itself because it is a
very reactive compound. Since formaldehyde readily
forms condensation products with a number ofbiogenic
amines, it is possible that these condensation products
may be found in the brain. This aspect has been
reviewed by Golberg (228). Another possibility is that
formaldehyde may be converted rapidly to formic acid.
The latter may join one-carbon metabolism by the
tetrahydrofolate pathway, and in turn be incorporated
into amino acids such as methionine and serine (229).
Formation of methionine could account for the labeled
choline observed by DuVigne et al. (230).
* Behavior/Neurotoxicity/Psychological EffectsPanel: LeonGolberg
(Chairman); Marc Schenker (Alternate Chairman/Secretary); Jean
Chen Shih; Michael J. Colligan; Anna Seppalainen.
1. NeurochemicalStudies. Formaldehyde is mainly
metabolized to formate. Formate anion is an inhibitor of
cytochrome oxidase (231-233) and the inhibition of
cytochrome coxidasebyformate increases withdecreas-
ing pH. Because of man's evolutionary loss of the
enzymes uricase and formyltetrahydrofolate reductase,
man cannot utilize formate in many syntheses via the
folate pathway (234). This enhances the human toxicity
of chemicals that are metabolized to formate. The
central nervous system is especially vulnerable to
hypoxia which may be a relevant feature quite apart
from acidosis in possible nervous system toxicity of
formaldehyde (235).
Exposure to formic acid vapor (20 ppm for 3 and 8
days, 6 hr daily) caused increased cerebral acid protein-
ase activity in rats (235). Cerebral glutathione in-
creased initially, probably as a reactive phenomenon,
but decreased at 8 days with increased acid proteinase
activity, both reflecting increased lipid peroxidation (in
cerebral hypoxia). Acid proteinase activity in cell frac-
tions increased above the control range during the third
week ofexposure to rats to 20 ppm offormic acid vapor
5 days/week, 6 hr daily (236). Hypoxic labilization ofthe
lysosomal complex was suggested as an explanation for
the finding.
Dimethylformamide, a general solvent in industry, is
demethylated invivo toproduce monomethylformamide
and formaldehyde (237). When rats were exposed
through drinkingwaterto 13.7 mM dimethylformamide,
acid proteinase activity increased in the glial cell
fraction after 2 and 7 weeks while under the same
conditions cerebral glutathione concentration was be-
low the control range (238).
High concentrations offormaldehyde (196 + 32 ppm),
moderate levels of formic acid (11 + 3 ppm) and low
concentrationsofacrolein(0.07 ± 0.03pm)weredetected
in the air containing oxidative thermodegradation prod-
ucts of polyacetal plastic (Deldrin, DuPont) (239). Rats
were exposed to this mixture for 6 hr, once or three
times. They gasped for air for hours after the exposure.
The fumes decreased the cerebral RNA concentration,
together with decreases in the succinate dehydrogenase
and acid proteinase activities.
Irritant Action of Formaldehyde on Sensory
Nerves. 1. The effect ofexposure toformaldehyde was
studied in anesthetized rats by Kulle and Cooper (239),
who judged the response by an increase in action
potential firing rate of nasopalatine and ethmoidal
nerves ofthe trigeminal nasal sensory system. Brief (2
min) exposure over a range of 0.5-2.5 ppm formalde-
hyde delivered through a nose cone yielded responses
like those elicited by ozone and amyl alcohol. Exposure
to 0.5, 1.0, 1.5 or 2.0 ppm formaldehyde for 1 hr,
repeated up to four times, revealed a progressive
depression in the response to amyl alcohol with increas-
ing formaldehyde concentration. The effects of a 2.0
ppm exposure were similar whether presented sepa-
rately or as the final exposure ofa series. Return to air
inhalation for 1 hr brought about a partial recovery of
the neural response to amyl alcohol.
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The authors assert that even 1.0 ppm formaldehyde
elicits "a significant depression in the rat trigeminal
nerve response to a standard odorant" However, it is
important to realize that the rats were under urethane
anesthesia and had been treated with atropine before
surgery, with further supplements as required to limit
the production of mucus. Similar exposure to 5 ppm
ozone for 1 hr actually increased neural responsiveness
to amyl alcohol.
There is a considerable body of information on the
acute irritant effects offormaldehyde on healthy human
subjects. In one such study, Weber-Tschopp et al. (202)
reported that irritant effects such as eye blinking rate
as well as subjective irritation and annoyance increased
as afunction offormaldehyde concentration. Thethresh-
old for such effects was judged to lie between 1 and 2
ppm.
IC. MORPHOLOGICAL CHANGES IN RESPONSE TO FOR-
MALDEHYDE EXPOSURE. Potts et al. (240) injected for-
maldehyde intravenously over several hours to achieve a
total dose of 0.9 g/kg in monkeys. No histologically
detectable effect was observed in the central nervous
system. On the other hand, Bonashevskaya (241) re-
ported lesions in the cerebral amygdaloid complex after
exposure to formaldehyde. Structural and cytochemical
shifts occurred inthe amvTgdaloid complex ofrats after3
months at 1 to 3 mg/mi formaldehyde in hermetically
sealed chambers. The shifts were described as "dis-
turbed uniformity" in the content of Nissl bodies and
RNA in the limits of the same amygdaloid nucleus.
Some neurons showed extensive accumulation, and
others reduction ofthese constituents. Measures taken
to monitor the concentrations of formaldehyde in the
exposure chambers were not reported.
2. A number of reports exist which link chronic
formaldehyde exposure to a range of psychological/
behavioral problems including depression, irritability,
memory loss and decreased attentional capacity, and
sleep disturbances. Unfortunately, these studies, re-
viewed by Sauer (242), for the most part have involved
field surveys using subjective self-report symptom
inventories. Control data, describing the incidence of
such symptoms from unexposed cohort samples, are
often inadequate or completely absent. This is an
extremely thorny problem when dealing with formal-
dehyde, which in addition to any direct toxic effects
possibly associated with it, produces distinct olfactory
cues which when detected by the individual may stimu-
late a spectrum of secondary psychological reactions
(e.g., expectancies, irritations, anxieties, fears, etc.).
These reactions may in turn exacerbate, mask, or
interfere with the more direct neurologic, biochemical,
and physiological responses to the substance.
For purposes ofexposition, this suggests that formal-
dehyde may affect the psychological functioning of the
individual in three ways: (1) directly, as a result of the
immediate toxic properties of the substance on the
peripheral and central nervous systems; (2) indirectly, as
a result ofthe individual's monitoring and awareness of
the aforementioned changes and his/her interpretation
and reaction to such changes, which, in turn, feeds back
intothe centralnervous system; and (3) as aresult ofthe
individual'spsychologicalreactionandconcomitant CNS
response tothe olfactory properties ofthe substance. In
practice, these processes are interdependent, yet this
simple analysis of a complex series ofresponses under-
lines the need to control for "expectancy" effects in
formaldehyde research to permit a differentiation ofthe
direct effects of formaldehyde on psychological func-
tions from its secondary effects.
EPIDEMIOLOGIC CONSIDERATIONS. Severalepidemio-
logic studies have evaluated neuropsychological symp-
toms potentially due to occupational or environmental
exposure to formaldehyde (243-245). While a high
prevalence of symptoms has frequently been observed
and ascribed to formaldehyde, serious deficiencies in
study design, assessment of exposure and outcome
measurement limit the interpretation of these studies.
Dally and co-workers reported symptoms prevalences
amongresidents ofhomes in Wisconsin that had health-
related complaints, possibly due to formaldehyde expo-
sure (243). The median formaldehyde concentration was
0.47 ppm (range < 0.1-3.68 ppm) and a positive
(inverse) association was present between age of the
structure and formaldehyde concentration. The great-
est prevalence ofsymptoms was forirritation ofmucous
membranes, but of the 256 subjects, 53% reported
headaches and 38% reported difficulty in sleeping.
The major weakness in this study is selection bias of
the population, i.e., only subjects from homes where
complaints were registered were studied. An appropri-
ate control population was not included. Responses may
also have been biased by other considerations such as
reports in the press and ongoing litigation. No attempt
was made to evaluate respondentbias norwere responses
related tomeasured levels offormaldehyde orotherpoten-
tial covariates collected during the investigation.
Similar criticisms exist for the studies of Sardinas et
al. (244) and Garry and co-workers (245). Both ofthese
investigations, in Connecticut and Minnesota, respec-
tively, found a high prevalence ofheadache but failed to
include controlpopulations or account for selection bias.
A report ofsymptoms in 20 infants under 12 months of
age by Woodbury and Zenz (246) also found frequently
reported problems with sleeping (14/20), but no associa-
tion was present with measured concentrations of
formaldehyde and this study suffers from the same
biases as the adult studies.
Thun and Altman (78) have pointed out some of the
difficulties in prevalence surveys of symptoms in resi-
dents from homes with urea-formaldehyde insulation
(UFFI) foam, including the presence of odor affecting
response, respondent and recall biases, and the objec-
tive outcomes measured. In this case-control study, no
significant difference was found in the occurrence of
headaches or insomnia in residents of homes with
UFFI, compared to neighborhood controls (247).
A controlled evaluation of symptom prevalence was
undertaken by Ols0n and D0ssing (79). They adminis-
tered a questionnaire based on the linear analogue
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self-assessment method to 66 subjects who worked in a
mobile day care center and 26 controls working in
permanent centers. Mean concentrations of formalde-
hyde were 0.43 and 0.008 mg/m3, respectively, with no
difference in temperature, humidity orventilation rates.
A significantly greater prevalence and greater symptom
intensity of nose and throat irritation, unnatural
tiredness, and headaches was present in the exposed
subjects. No difference was noted in disturbed memory
or concentration or in the control questions on the
questionnaire. This study overcomes some of the pre-
viously mentioned problems, but responses still may
have been influenced by awareness ofthe subjects ofthe
study goals and hypotheses. Nevertheless, this is a
controlled study using a standardized questionnaire and
the findings need further investigation.
Reported symptoms need to be evaluated by formal
tests of neuropsychologic function. Schenker and co-
workers (248) found in a pilot study that residents of
homes with UFFI who complained of memory impair-
ment did not have abnormalities on formal tests of
memory function, although many showed deficits in
tests ofattention span orthe ability to sustain attention.
This result needs to be evaluated in a controlled,
population-based study.
One study has briefly considered neurologic function-
ing in a controlled laboratory exposure. Anderson (124)
reported on 16 healthy young subjects to 0.3, 0.5, 1.0
and 2.0 mg/m3 formaldehyde for 5 hr. He found subjec-
tive and physiologic responses with exposure, but no
effect on performance tests (speed and accuracy of
multiplication and addition, and of card punching) at
any of the exposure concentrations. Details of the
performance tests were not presented, and the power of
the study was not reported.
A preliminary report by Kilburn and co-workers (249)
described a study using a standardized battery of
neuropsychological tests on histology technicians. Sub-
jects were also exposed to xylene and toluene at work,
and there was no measurement ofindividual exposures.
Response rates and characteristics of the exposed and
control populations are not reported, and no consider-
ation was given to potential respondent bias in symp-
toms or exposures. No data are presented on the tests
of neuropsychologic function. This study utilizes stan-
dardized tests of neuropsychologic function, but the
results cannot be considered indicative ofeffects due to
formaldehyde exposure.
Conclusions. The effects offormaldehyde and/orits
metabolites on the biochemistry of the nervous system
have not been clearly defined. Various possibilities exist
whereby such effects might be mediated.
Some evidence exists that exposure to formic acid
(the principal metabolite offormaldehyde) in vaporform
at high concentrations exercises nervous system toxic-
ity in intact rats.
The irritant effects offormaldehyde may be reflected
in altered function of sensory nerves such as the
trigeminal nasal sensory system. The presence of mor-
phological changes in the CNS has been observed in one
study and not in another.
The difficulties inherent in any study ofpsychological/
behavioral effects of formaldehyde have not yet been
overcome in the course of conducting field surveys.
Epidemiologic studies evaluating neuropsychological
symptoms potentially due to occupational or environ-
mental exposure to formaldehyde have failed to over-
cometheproblemscommonlyassociatedwithsuchstudies.
However, some studies merit further investigation.
Topic 3. Future Studies
Biochemical. While the neurotoxicity of formalde-
hyde is still a controversial issue, the study on the
biochemical effect of formaldehyde on the central ner-
vous system will provide fundamental knowledge for
understanding its possible neurotoxicity.
Effort should be made to identify and to characterize
the structure of the radioactive compound found in rat
brain after the animals were exposed to 14C-formalde-
hyde. Radioactive formate, radioactive choline and
radioactive condensation products between biogenic
amines and formaldehyde are the possible compounds.
Among these compounds the condensation products are
of particular interest. Tetrahydrobetacarboline should
be found if indoleamines and formaldehyde formed a
condensation product. Tetrahydroisoquinolines should
be found if catecholamines and formaldehyde form
condensation products.
Once the structures of the radioactive compounds
have been determined, the distribution of these com-
pounds in brain, the effects of these compounds on
neurotransmitter receptors, uptake, biosynthetic and
degradative enzymes could be systematically studied.
Furthermore, the effects ofthose compounds on animal
behavior could be examined.
Electrophysiological. Acute effects of formalde-
hyde have been studied on the trigeminal nasal sensory
system (239). Several authors (250,251) have suggested
that electrophysiological methods of studying the cen-
tral nervous system are helpful in evaluating toxic
effects of, for example, formaldehyde. Long-term
experimental exposure to various concentrations of
formaldehyde could be carried out on rats and/or
rabbitsandelectroencephalography (EEG)withindwell-
ing electrodes in hippocampal and cortical (occipital)
areas could be performed. Spontaneous EEG activity
could be analyzed at various time intervals during the
exposure and evoked potential studies using flash light
stimulus (visual evoked potentials) as well as sound
stimulus (brainstem auditory evoked potentials) could
and should be applied at various intervals of continous
exposure.
No studies have demonstrated peripheral nervous
system effects of formaldehyde. Possible PNS effects
could be checkedbyapplyingnerve conduction measure-
ments in chronically exposed rats.
Given the fact that a sound, systematic data base
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describing the impact offormaldehyde on psychological/
behavioral functioning is currently nonexistent, it was
agreed that considerable research is needed alongthese
lines. Furthermore, it was felt that the primary empha-
sis should be placed on long-term, or prolonged expo-
sures to disentangle the potential toxic effects of
formaldehyde from the transient, irritative ones, and to
simulate the exposure conditions of relevant popula-
tions at risk in the environment, such as inhabitants of
mobile homes having urea-formaldehyde insulation and
individuals experiencingworking-life occupational expo-
sures. The emphasis on chronic exposure studies sug-
gests two particular research paradigms: (1) animal
studiesinwhichcontrolled, measured doses offormalde-
hyde are administered over variable periods of time to
assess the effects on select, well-defined behavioral and
performance parameters; and (2) field/epidemiological
studies in which groups of people undergoing long-
range, measurable formaldehyde exposures as part of
their daily routine (e.g., medical students, anatomists,
plywood/fiberboard workers, mobile home dwellers) are
assessed in terms of relevant psychological/behavioral
parameters relative to appropriate baseline-exposed
cohort samples.
With respect tothe animal studies, itwas feltthatthe
test battery should encompass a range of measures
involving relatively simple and direct sensory responses
(e.g., absolute and difference sensory thresholds), mo-
tor behaviors (e.g., balance and tremor assessments),
sensory-motor activities (reaction times, avoidance
learning, etc.) and cognitive processes (short- and
long-term memory, discrimination learning, etc.). Infor-
mation stemming from this research will identify
system-specific as well as general responses to formal-
dehyde, and help to identify parameters for follow-up
research in the human field studies. With respect to the
latter, given the limited knowledge regarding the
impact of formaldehyde on human psychological/be-
havioral functioning, it was felt that a broadbrush
approach was most appropriate. The human perfor-
mance test battery should assess an array ofpsychologi-
cal functions ranging from relatively simple sensory
responses (e.g., threshold determination, attention,
vigilance) through perceptual motor operations (e.g.,
simple and choice reaction times, tracking, short-term
memory) to complex cognitive operations (e.g., concept
formation, dual-task strategies, logical reasoning). Vi-
sual evoked potential (VEP) recordings could be accom-
modated to study acute effects in the visual sensory
system.
Workers handling formaldehyde containing material
might be locally exposed through the skin. This could
induce local neurotoxic effects in peripheral nerves.
Inhalation exposure could in the long-term also affect
the peripheral nervous system (PNS). As the distal
ends of long nerves are usually the first portions to
suffer in chemical neurotoxicity the PNS should be
checked upon. A feasible approach could be to measure
the distal sensory conduction velocity from fingers to
wrist in the arm nerves. Measurements of the ampli-
tude of the elicited sensory action potential might
increase the sensitivity ofthe method. Such abattery of
tests could be coupled with traditional paper and pencil
tests (e.g., Wechsler Intelligence Scales) for which
there are standardized population norms, but it is felt
that the critical comparison is against a cohort of
base-line exposed controls comparable to the target
group along relevant socioeconomic, educational, and
occupational dimensions.
Tiaditional psychodiagnostic inventories ofpsychopa-
thology (e.g., MMPI, Beck Depression Scale) or mood
state (e.g., Profile of Mood States) would also be
appropriate. Cross-sectional designs should attempt to
identify not only "exposed" and background orbaseline-
exposed cohorts, but should attempt to quantify the
level and duration of exposure for all groups to permit
maximum statistical analysis. Prospective studies, if
feasible, should involve repeated testing of both the
target and control cohorts to control for aging and
historical effects.
Finally, attempts should be made to gather "real-life
data" (e.g., academic performance, sleep diaries, behav-
ioral sampling) tocomplementthe psychological testing.
Occupationally and environmentally exposed popula-
tions should be studied because they provide a unique
opportunity to investigate the potential neurotoxicity of
formaldehyde. Such studies allow investigation ofsensi-
tive populations (e.g., children), long-term exposures,
and acute exposures at formaldehyde concentrations
that cannot be used in acontrolled laboratory setting. It
is important that appropriate control populations be
included in these studies and adjustment be made for
potential confounders such as socioeconomic status. The
studies should include a spectrum ofneuropyschological
tests, including standardized and validated tests when
possible. Attempts are currently underway to develop
such a test battery, and similar studies have been done
on working populations with exposure to solvents or
heavy metals. A difficult and expensive component of
such studies is the measurement of formaldehyde
exposure, but such measurements are an important
componentofepidemiologicinvestigations. Severaloccu-
pational populations exist that represent possible study
groups. Medical students or otherusers ofanatomy and
pathology laboratories could be studied to evaluate
effects of short term exposures (3-6 hr) on neuro-
psychologic test performance. The fabric industry uses
formaldehyde in coating certain products and appropri-
ate unexposed comparison groups may exist within the
industry to allow controlled evaluation of workplace
exposure. Numerous other industries have workplace
exposure to formaldehyde and should be evaluated for
the nature of the formaldehyde exposure and the
feasibility of epidemiologic investigation. Home expo-
sures to formaldehyde may occur from insulation prod-
ucts or from building materials themselves. Some
schools may have elevated formaldehyde exposures
because of new construction or from the use oftrailers
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for classrooms. These situations allow the design of
controlled epidemiologic studies to evaluate
behavioral/neurotoxicologic/developmental effectsamong
large populations including young children. Similar
studies have been performed to evaluate neuropsycho-
logic effects, in children, of lead toxicity or dietary
alterations.
Risk Estimation Panel Report*
Topic 1. How can all the available data be integrated
to make reasonable risk estimates (neoplastic and
nonneoplastic) for humans exposed to formaldehyde at
various levels and through different routes?
a. In making estimates, what data and assumptions
lead the Panel to choose one method over another?
b. In making risk estimates, how can data be used
from:
1. metabolism studies
2. biological endpoints (importance of benign
tumors)
3. individual variabilities
4. epidemiology
5. high or low dose extrapolation models
6. interspecies variation
Topic 2. Are any practically achievable data likely to
resolve any of the uncertainties?
Risk assessment is generally regarded to consist of
three main functions: hazard identification, exposure
assessment, and risk estimation. Hazard identification
is the qualitative determination ofan actual or potential
toxic effect in humans or in animals that is also
presumed to pose a threat to humans. This includes
identifying toxic biological endpoints, investigating
mechanisms that may alterthe response in humans, and
identifying data sources that may be useful in perform-
ingquantitative risk assessments. Hazard identification
also involves the determination of the degree of the
hazard, i.e., is it life threatening or not; reversible or
not. These topics were addressed by the other panels at
the workshop. Exposure assessment is the activity of
identifying the routes and extent of exposure of the
human population to toxic substances. This function
involves identifying sources of toxic substances, expo-
sure levels, and length of exposure, which may be
occupational, environmental, or from consumer pro-
ducts, which may be intermittent or continuous. These
levels of exposure may be used in time-dose-response
functions to estimate risks (the animal or human
probability of a toxic health effect by a specific age or
the average time without a toxic response). The ex-
pected number of individuals with a disease in a
population requires estimates ofthe numbers ofindivid-
uals in various exposure groups multiplied by the
probability of disease for those groups.
* Risk Estimation Panel: David Gaylor (Chairmnan); Mary F Lyon
(Alternate Chairman/Secretary); Roy Albert; Charles C. Brown;
Murray S. Cohn; Robert Sielken, Jr.; Mike Wright.
Risk estimation is the quantitative aspect of risk
assessment which attempts to mathematically relate
risk to exposure. In some instances, this can be done
with human data. Generally, only animal data are
available. Since it is necessary to determine ifthere are
toxic effects using relatively small numbers ofanimals,
doses well above human exposure levels are generally
employed in animal bioassays. The process ofquantita-
tive risk estimation usuallyinvolves two main functions:
(1) extrapolation ofrisks from high to low doses and (2)
extrapolation of risks from animal exposures (e.g.,
laboratory animals exposed to a constant level continu-
ously for life) to human populations that are genetically
and environmentally heterogeneous and exposed to
varying levels at various times during their life.
1. The firsttaskofthe Risk Estimation Panelwasto
review the reports from the other panels to establish
what potential risks to human health exist due to
exposure to formaldehyde. The second task was to
identify time-dose-response datasetsthatcould be used
for quantitative risk estimation of formaldehyde. The
third task of the panel was an attempt to utilize
whateverbiological and mechanistic actions offormalde-
hyde were identified by the other panels to assist in the
choice of time-dose-response models for low dose risk
estimates.
Ib.2. ImmunologylSensitizationlIrritation. For-
maldehyde produces irritation of the nose, eyes and
throat when inhaled, and of the skin when applied
topically in solution. In most individuals, this is simple
irritation and not due to an allergic reaction. However,
the Immunology/Sensitization/Irritation Panel found
that allergic contact dermatitis and other forms ofskin
sensitization did occur in some individuals. There was
not sufficient evidence to confirm that respiratory tract
allergy occurred, although there were some suggestive
findings.
There were difficulties in assessing the proportion of
individuals who were unduly sensitive to skin contact.
Data were also inadequate to establish clear threshold
doses for the various effects. For normal individuals, it
was possible to give arange ofdoses overwhich various
harmful effects were seen, but there generally were not
adequate dose-response data.
In view ofthe frequent lack ofdata on dose-response
and on the proportion of individuals who are unduly
sensitive, the Risk Estimation Panel did not attempt at
presenttoperform aquantitative riskestimationforthe
irritant or sensitization effects of formaldehyde, al-
though some risks clearly exist at some current levels of
exposure.
1b.2. Behavior/NeurotoxicitylPsychological Effects.
The Behavior/Neurotoxicity/Psychological Panel re-
ported that exposure to formaldehyde produced neuro-
chemical changes in the brain ofrats, and also possible
effects in peripheral nerves but further studies ofthese
phenomena were needed.
In humans, there have been reports of various
symptoms insubjectsexposed toformaldehyde eitherin
354CONSENSUS WORKSHOP ON FORMALDEHYDE
the home orat work. However, there was great difficulty
in interpretating these data. In some cases, there were
no adequate controls. In other cases, the possibility of
subjective effects due to the smell of formaldehyde
could not be excluded. Commonly, the exposure level
was not known.
In view of the difficulties and uncertainties in these
studies, the Risk Estimation Panel feels that there are
no adequate data for attempting to assess quantitative
risks of behavioral or psychological effects resulting
from formaldehyde exposure in man at the present
time.
lb.2. Reproduction and Teratology. The data con-
cerning adverse effects of formaldehyde on reproduc-
tion and on fetal development were reviewed by the
Reproduction/Teratology Panel. Data on possible induc-
tion ofgerm cell mutations were considered by both the
Reproduction/Teratology Panelandthe Carcinogenicity/
Histopathology Genotoxicity Panel.
The Reproduction/Teratology Panel found no clear
evidence of any adverse effects of formaldehyde on
either reproduction or development of the fetus.
However, there were grounds for suggesting that fur-
ther work was needed to elucidate certain points.
Concerning mutation in mammalian germ cells, both
the Reproduction/Teratology Panel and the Carcino-
genicity/Histopathology/Genotoxicity Panel found no
good evidence of positive effects. The Carcinogenicity/
Histopathology/GenotoxicityPanelrecognizedformalde-
hyde as a weak mutagen, and both panels noted one
study in which marginally positive results were ob-
tained in a dominant lethal test. However, the mouse
spot test was negative. This led the Carcinogenicity/
Histopathology/Genotoxicity Panel to conclude that
more extensive tests of mutation in mammalian germ
cells were not at present warranted.
Onthe basis ofthese findings, there are nogrounds at
present for attempting any quantitative estimates of
riskto humans for adverse effects onreproduction, fetal
development, orhereditary defects resulting from expo-
sure to formaldehyde.
lb.2, lb.3, lb.4. Epidemiology. In comparing the
results ofexperimental animal studies to human epide-
miological observations, there is evidence that the
affected site in animals is not necessarily predictive of
the affected site in humans.
The Epidemiology Panel stated that there is some
evidenceofadose-responserelationshipbetweenformal-
dehyde exposure and lung cancer based upon the one of
six British factories where the largest number ofcohort
workers experienced the highest formaldehyde expo-
sure levels. The Risk Estimation Panel noted that
sufficient epidemiological data are not now available for
a quantitative risk estimate which relates the level and
duration offormaldehyde exposure to the risk ofeither
lung or nasal cancer.
Studies of three professional groups who preserve
human tissues with solutions containing formaldehyde
and other chemicals have shown an excess of brain
cancer and leukemia. The Epidemiology Panel sug-
gested further investigation ofthe questions raised. No
dose-response information is currently available for
quantitative risk estimation.
The Risk Estimation Panel recommends that no
quantitative risk estimate be based on the current
epidemiological information. However, we also recom-
mend that future estimates might be based on addi-
tional data provided by further analyses ofthese human
populations.
In addition, we recommend that the results of risk
assessments based on animal studies should be com-
pared to the information from each of these human
observational studies in order to evaluate the extent to
which there is any statistical consistency or inconsis-
tency of this extrapolation to human data.
la, lb.2. Endpoints forRiskEstimation. The Risk
Estimation Panel found that data from the CIIT rat
inhalation chronic bioassay are suitable formodelingthe
dose-response relationship. The datafromthe formalde-
hyde studies in Syrian hamsters and the CIIT mouse
inhalation study provide information on risk, but do not
provide sufficient dose-response information for quanti-
tative model fitting. The panel agrees with the conclu-
sionoftheCarcinogenicity/Histopathology/Genotoxicity
Panel that the malignant tumors represent an endpoint
which should be used in any quantitative risk assess-
ment based on the CIIT rat inhalation data. The Risk
Estimation Panel follows the Carcinogenicity/Histo-
pathology/Genotoxicity Panelrecommendation that, be-
cause of different cell types of origin, any evaluation of
polypoid adenoma be done separately from squamous
cell carcinomas. The Risk Estimation Panel also agrees
with the Carcinogenicity/Histopathology/Genotoxicity
Panel that nonneoplastic polyps and hyperplasias do not
at present represent endpoints suitable for the assess-
mentoftumorrisk. TheCarcinogenicity/Histopathology/
Genotoxicity Panel noted the difficulty ofdifferentiating
between polypoid adenomas, nonneoplastic polyps, and
hyperplasia, in the CIITratinhalation study. Arecently
completed re-examination by a Pathology Work Group
resulted in diagnoses that were in close agreement with
theoriginaldiagnosesofpolypoidadenomas. Papillomas,
which aregenerally considered tobethebenign counter-
part of the squamous cell carcinoma, were not seen in
the CIIT rat inhalation study. Nasal adenocarcinomas
were seen in the NYU formaldehyde study. The data
now available lead the Risk Estimation Panel to believe
that the target sites offormaldehyde are not primarily
distant from the site of exposure.
Ia, Ib.l, Ib.6, Ic. Species-to-SpeciesExtrapolation.
Risk estimation, when based on animal data, must
consider the relationship between risk observed in the
test species and risk projected in the species ofconcern
(252,253). In the case offormaldehyde, humans are the
species of concern and the test species used in the
quantitative modeling techniques are the rats in the
CIIT chronic inhalation study. Species differences have
been observed with respect to factors which may influ-
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encecarcinogenicrisk. Anexamplecomesfromthe CIIT
study itself, where at high concentrations of formalde-
hyde, mice modify their respiration more than rats.
There are, however, no indications that the response
by humans would be different than that exhibited by
rats, mainly due to the lack of experimental data
pertaining to this issue. Qualitatively, the metabolic
pathways of formaldehyde in rats and humans are
similar. The sites ofgreatest exposure may differ, since
rats are obliged to breathe solely through the nose and
humans may also breathe orally. Again, no information
exists demonstratingthatthe response wouldbe quanti-
tatively different as a result of differences in distribu-
tion of the inhaled dose.
The panel recommends that the suggestion of the
Structure Activity/Biochemistry/Metabolism Panel be
utilized in risk estimation: "Although there are differ-
ences in formaldehyde carcinogenicity among different
species, at present there is no reason to assume that
humans would be more or less susceptible than the rat."
The panel can only assume that rats and humans
exposed to the same concentration offormaldehyde for
the same proportion of lifetime will exhibit a similar
carcinogenic response, all other influences being equal.
The panel. recognizes that this assumption is based on
the lack ofinformation and may change as further data
become available.
The Structure Activity/Biochemistry/Metabolism
Panel noted that the nonlinear carcinogenic response to
dose observed in the CIIT Study was in contrast to the
linear response of DNA-protein crosslinks at 6 ppm
and above. The Carcinogenicity/Histopathology/Geno-
toxicity Panel considered impairment of mucociliary
clearance, detoxification, and DNA repair as leading to
relatively greater effective target site doses at higher
doses, resulting in a likely explanation for the nonlinear
carcinogenic dose-response. Following initial exposure,
high formaldehyde concentrations impair mucociliary
clearance, stimulate cell proliferation, and increase the
replication rate in respiratory epithelium (89). This, at
least initially, increases the single-strand fraction of
respiratory mucosal DNA, which is susceptible to
covalent binding with formaldehyde. The latter data,
however, do not indicate the concentration offormalde-
hyde at a target site relative to the concentration in air.
Therefore, the panel recommends the use of airborne
concentration for dose-response modeling at this time.
The actual target dose is not known at this time but
more information is being collected which bears on this
issue (254). Alternative expressions for the target dose
may be utilized.
la., Ib.1, Ib.5, Ic. LowDoseExtrapolation. Mathe-
matical risk estimation models are only mathematical
constructs which can assist in evaluating dose-response
relationships. Risk estimation models are no better
than the data and the biological and mathematical
assumptions on which they are based. Predictions of
human risk derived from animal data must be consid-
ered in conjunction with human (epidemiological) data
and qualitative biological data, such as the type of
tumor produced in experimental animals, the mecha-
nism by which tumors appear to be induced, interspe-
cies comparisons, the actual dose delivered to the target
tissues, and other factors.
At the present time there is general agreement that,
because of the complexity of the carcinogenic process
and the fact that we understand so little of the
pathogenesis of cancer, there is uncertainty in the
nature of the dose-response relationships for cancer
production at low levels of exposure, specifically at
those levels which do not produce observable effects in
animal experiments or in epidemiological studies.
The use of data obtained at high doses in long term
animalbioassays to predict carcinogenic risk at low dose
is one of the most controversial issues in risk assess-
ment methodology. This is also true in the case of
formaldehyde, where the CIIT rat dose-response curve
is highly nonlinear between the concentrations of2 and
15 ppm. The observed experimental data in the CIIT
inhalation study on rats can be fit reasonably well by
using a sufficiently flexible family of models (e.g.
Weibull, gamma-multihit, generalized multistage). The
corresponding estimated models provide estimates of
risk at any selected dose level. These estimates are
those which are most consistent with the presumed
family of dose-response models and their associated
assumptions about background. If no explicit low-dose
linear term is included in these models, these models
assume no dosewise additivity with other carcinogens
present in the environment orwith background carcino-
genic processes.
Upper and lower confidence limits on the risks being
modeled may be computed to reflect the variability in
the data under the presumed family of models. These
confidence limits do not reflect the uncertainty in the
choice of the family of models. Not all points in a
confidence interval or all points below an upper
confidence limit for the above presumed family of
models are equally likely to be the true value of the
quantitybeingbounded. Theseestimatesandconfidence
limits are helpful as longastheunderlyingdose-response
relationship is reasonably well described by the pre-
sumed family of models. The major difficulty is that,
because ofthe complexity ofcarcinogenic processes and
ourlimited understanding, there isusually considerable
uncertainty about the shape of the dose-response rela-
tionship for doses near zero and hence the appropriate-
ness ofthe low-dose behavior ofthe presumed family of
models. The panel realizes that the very low-dose
behavior ofdifferent families ofmodels can be dramati-
cally different.
The Risk Estimation Panel is aware of several possi-
ble reasons forthe nonlinearcarcinogenicdose-response
observed with formaldehyde in the CIIT study. The Car-
cinogenicity/Histopathology/Genotoxicity Panel states:
"Cytotoxicity might influence both initiation and promo-
tion. Ifmore cells ofthe target tissue replicate, there is
greater availability of single-stranded DNA for adduct
formation, decreased time for repair of DNA adducts,
and a greater chance of fixation of mutagenic events.
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Increased cell proliferation also contributes to tumor
promotion. Thus, there is a greater likelihood of tumor
development with the increased cell proliferation associ-
ated with cytotoxic exposures. These factors are likely
to contribute to the nonlinearity of the dose-response,
i.e., proportionately greater response at higher doses"
The Structure Activity/Biochemistry/Metabolism Panel
states: "Only certain specific sites on DNA might led to
carcinogenesis; moreover, the rapid and nondiscriminate
attack of formaldehyde on tissue components could
involve membrane function, transport and repair pro-
cesses, and it is known that mucociliary removal of
formaldehyde is inhibited at high concentrations. In
view ofthis complex network ofreinforcingand compet-
ing reactions, it is not surprising that the carcinogenic
response is not linear or that it does not parallel the
degree of crosslinks. Although the cause is still un-
certain, this apparent nonlinearity cannot be construed
to indicate the existence of a threshold for exogenous
formaldehyde carcinogenicity. Although nongenetic fac-
tors may play a role, more sensitive methods will be
required to determine whether a linear relationship
between dose and response exists at low exposure
levels."
The Risk Estimation Panel could not reach a consen-
sus on the way in which the uncertainty in choosing a
family of nonlinear models should be incorporated into
the risk assessment process.
Regardless ofthe model chosen, the panel is aware of
several general arguments often made in support of
low-dose linearity. Ehrenberg et al. (255) have pointed
out that the kinetics of the various chemical processes
involved in the uptake and metabolism ofchemicals, and
their reactions with target molecules, become first
order at low concentrations, leading to low-dose linear-
ity on the delivered dose scale. It has been suggested
that when the action of a given carcinogen adds to those
of other causes of cancer in a given target tissue, the
incremental effect of small delivered doses ofthe given
carcinogen is virtually linear regardless ofthe observed
shape of the dose-response relationship at the tested
doses (256-259). The rationale is that the carcinogen is
augmenting some background component in causing a
carcinogenic event. Formaldehyde shares with other
chemical carcinogens the properties ofgenotoxicity and
an ability to react directly with DNA (as concluded by
the Structure Activity/Biochemistry/Metabolism and
Carcinogenicity/Histopathology/Genotoxicity Panels).
Further, the latter panel found that formaldehyde can
transform, as well as mutate, various cultured cell lines
and enhance the transformation of Syrian hamster
embryo cells harboring adenovirus. Research at the
CIIT has shown, additionally, that formaldehyde can
initiate and promote the actions ofother promoters and
initiators in in vitro mammalian cultured cell transfor-
mation assays(109,116). Thesedatasuggestthatformal-
dehyde can interact with several carcinogenic agents or
processes.
The uncertainty over the shape ofthe dose-response
relationship in the low dose region and the correspond-
inguncertainty overthe appropriateness ofthe low-dose
behavior for the family of models used to model the
dose-response relationship in the experimental dose
region has encouraged many members of the panel to
suggest that a linear low dose nonthreshold extrapola-
tionbe used inriskassessment. A straight line connect-
ing the risks at the endpoints of a low dose region
provides an upper bound on low dose risks for dose-
response relationships which curve upward in the low
dose region (260-263). Low-dose linear extrapolation is
not equivalent to fitting a straight line or a one-hit
model to the experimental data. A highly nonlinear
model is required, in the case offormaldehyde, to fit the
experimental data. Linear extrapolation is only in-
tended to be used at the low doses where adequate
experimentalinformationis not directly available due to
the large numbers ofanimals required to measure small
levels of risk. A nonlinear model which adequately fits
the experimental data for the CIIT chronic rat inhala-
tion bioassay could be used in conjunction with a low
dose linear extrapolation procedure. The Risk Estima-
tion Panel is in general agreement that alinearlow-dose
nonthreshold extrapolation provides an upper limit on
cancer risk in rats exposed to formaldehyde by inhala-
tion inthe sense thatthe true risk in rats is not likely to
be greater than this limit. The Risk Estimation Panel
has not reached a consensus as to either the practical
application of these upper limits for human exposures
or the exact range of the low-dose region over which a
linear extrapolation might be reasonably performed.
Withregard tothe possibilityofathreshold dose for a
tumor response, in the absence ofany clear evidence at
this time for a threshold, the Risk Estimation Panel
believes that a threshold model for formaldehyde is not
indicated.
It is important to note that the quantal dose-response
models use only one biological endpoint, tumor inci-
dence, at any selected point in time and only consider
thedose-response relationship in terms ofthisendpoint.
More information may be obtained by incorporating
time-to-tumor onset information (263,264). The impact
of the dose level on the length of time until a tumor
occurs may be part of the risk characterization. It
should be noted that dose includes the components of
concentration of the agent and of the duration of
exposure (255). The CIITdatashowthatthe tumorrate
is strongly dependent on formaldehyde concentration,
but time-to-tumor onset may also be investigated. In
addition, the length oftime and the number ofanimals
that were at risk in the CIIT study is complicated
because animals were scheduled for interim sacrifices.
Thus, the numbers of animals at risk need to be
adjusted to take these sacrifices into account.
Conclusions. Available animal and human studies
provide information to qualitatively establish various
toxiceffectsofformaldehyde exposure, but quantitative
assessment is not indicated at this time for biological
effects other than carcinogenicity.
Although some epidemiological studies noted that
there may be an association between formaldehyde
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exposure and some forms ofcancer, the data from these
studies are not sufficient, at this time, for quantitative
risk modeling.
The CIIT and NYU animal studies (84) indicate that
cancer results in rodents from exposure to formalde-
hyde. Formaldehyde has also been shown to be geno-
toxic. The CIIT chronic inhalation bioassay in rats
provides a set of data suitable for quantitative risk
assessment. This data set, the use of a nonthreshold
low-dose linear extrapolation,' and the use of various
plausible assumptions based on the available biological
information regarding factors such as species to species
extrapolation, metabolism and pharmacokinetics, pro-
vide an upper bound for low-dose risk estimates in the
sense that the true risk in humans exposed to formalde-
hyde by inhalation is not likely to be greater than this
limit. Nonlinear models are needed to fit the CIIT rat
inhalation bioassay data over the experimental dose
range, but estimates of risk from these models may
vary at low doses. The panel could not reach a consen-
sus on the way in which the uncertainty in choosing a
family of nonlinear models should be incorporated into
the risk assessment process.
Topic 2. Future Studies
Required are long-term follow-up on epidemiological
studies along with measurements offormaldehyde dos-
age levels; improved measures of target dose; animal
bioassays to study tumor rates resulting from short-
term or intermittent formaldehyde exposures.
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Appendix 1: Data Base of the
Consensus Workshop on
Formaldehyde
The literature comprising the data base, listed following this
introduction, was made available, as reprints, as they were acquired,
to the panel chairmen up to six months prior to the workshop. They
were also available for all workshop participants at the meeting. The
data base was organized by author as well as by a keyword index of
important topics, and it was complemented by materials that the
different participants brought with them and used as part of their
participation in the panel. In some cases, studies in the data base
were specifically cited as references in the individual panel reports,
and no attempt has been made to remove these previously cited
studies from the appendix. Hard copies of all the reports in this
computerized data base have been retained by the NCTR Clearing-
house on Formaldehyde, as part of the agreement with the EPA.
Data Base for Formaldehyde
Consensus Workshop
Ablashi, D. V, Levine, P H., Prasad, U., and Pearson, G. R. Meeting
Report: Fourth International Symposium on Nasopharyngeal Carci-
noma Application of Field and Laboratory Studies to the Control of
NPC. Cancer Res. 43: 2375-2378 (1983).
Acheson, E. D., Winter, P D., Hadfield, D., and Macbeth, R. G. Is
nasal adenocarcinoma in the Buckinghamshire furniture industry
declining? Nature 299: 263-265 (1982).
Agatha, G., and Schubert, H. Studies on allergen identification in the
allergy to p-tertiary-butylphenol-formaldehyde resin (translation
available). Dermatol. Monatsschr. 165: 37-345 (1979).
Agathos M., and Bernecker, H. A. Handdermatitis bei medizinischem
Personal (Dermatitis of the hands among medical personnel).
Dermatosen 30: 43-47 (1982).
Aggarwal, A. R., and Garg, R. L. Formalin toxicity in hydatid liver
disease. Anaesthesia 38: 662-665 (1983).
Ahmad, I., and Whitson, T. C. Formaldehyde: how much ofa hazard?
Ind. Med. Surg. 42: 26-27 (1973).
Akabane, J. Aldehydes and related compounds. International En-
cyclopedia of Pharmacology and Therapeutics, Sect. 20, 2: 523-560
(1970).
Alarie, Y, Kane, L., and Barrow, C. Sensory irritation: the use ofan
animal model to establish acceptable exposure to airborne chemical
irritants. In: Toxicology: Principles and Practice, Vol. 1 (A. L.
Reeves, Ed.), Wiley and Sons, New York, 1982, pp. 48-92.
Albert, R. E. Letters: Carcinogen policy at EPA. Science 219:
796-798 (1983).
Albert, R. E., Sellakumar, A. R., Laskin, S., Kuschner, M., Nelson,
N., and Snyder, C. A. Gaseous formaldehyde and hydrogen chloride
induction ofnasal cancer in the rat. J. Natl. Cancer Inst. 68: 597-603
(1982).
Alderson, T. Mechanism of formaldehyde induced mutagenesis. The
uniqueness ofadenylic acid in the mediation ofthe mutagenic activity
of formaldehyde. Nature 187: 485-489 (1960).
Alexandersson, R., Kolmodin-Hedman, B., and Hedenstierna, G.
Exposure to formaldehyde: effects on pulmonary function. Arch.
Environ. Health 37: 279-283 (1982).
Altshuller, A. P, Cohen, I. R., Meyer, M. E., and Wartburg, A. F, Jr.
Analysis of aliphatic aldehydes in source effluents and in the
atmosphere. Anal. Chim. Acta 25: 101-117 (1961).
Altshuller, A. R, and McPherson, S. P Spectrophotometric analysis of
aldehydes in the Los Angeles atmosphere. J. Air Pollution Control
Assoc. 13: 109-111 (1963).
Amdur, M. 0. The response ofguinea pigs to inhalation offormalde-
hyde and formic acid alone and with a sodium chloride aerosol.
International J. Air Pollution 3: 210-220 (1960).
American Association of Textile Chemists and Colorists (AATCC).
Formaldehyde odor in resin treated fabric, determination of: sealed
jar method. AATCC Technical Manual, AATCC, Research Triangle
Park, NC, 1978, Test Method 112-1978, pp. 89-90.
American Conference of Governmental Industrial Hygienists
(ACGIH); Formaldehyde. In: Documentation of the Threshold Limit
Values, 4th Ed. American Conference of Governmental Industrial
Hygienists, Cincinnati, Ohio, 1980, pp. 197-199.
American Conference of Governmental and Industrial HygienistsCONSENSUS WORKSHOP ON FORMALDEHYDE 365
(ACGIH). Formaldehyde: TLVS-Threshold limit values for chemical
substances in work air adopted by ACGIH for 1982, pp. 2-9, 19-19,
40-41.
American Society for Testing and Materials (ASTM). Standard test
method for concentration of formaldehyde solutions. ANSI/ASTM
D2194-65 (reapproved 1974), pp. 337-338.
Andersen, I. Formaldehyde in the indoorenvironment-health implica-
tions and the setting of standards. In: Indoor Climate: Effects on
HumanComfort, Performance andHealthinResidential, Commercial,
and Light-Industry Buildings (P. 0. Fanger and 0. Valbjorn, Eds.),
Proceedings of the First International Indoor Climate Symposium,
Copenhagen, August 30-September 1, 1978, Copenhagen: Danish
Building Research Institute, 1979, pp. 65-87.
Andersen, I. B., Lundqvist, G. R., and Mohave, L. Indoor air
pollution due to chipboard used as a construction material. Atm.
Environ. 9: 1121-1127 (1975).
Andersen, K. E., Jhorth, N., Bundgaard, H., and Johansen, M.
Formaldehyde in a hypoallergenic non-woven textile acrylate tape.
Contact Dermatitis 9: 228 (1983).
Andersen, K. E., Bundgaard, H., and Johansen, M. Allergic contact
dermatitis from formaldehyde in Fucidin ointment. Contact Dermati-
tis 9: 78-79 (1983).
Andersen, S. K., Jensen, 0. M., and Oliva, D. Formaldehydek-
sponeringoglungecancerblandtdanske laeger(Exposure toformalde-
hyde and cancer ofthe lung in Danish doctors). Ugeskr. Laeger 144:
1571-1573 (1982).
Anon. Any Questions. Brit. Med. J. 9: 778 (1979).
Anon. Key chemicals: formaldehyde. Chem. Eng. News 60(13): 26
(1982).
Anon. EPA foramldehyde position challenged. Chem. Eng. News
60(21): 24 (1982).
Anon. No cancer link found in formaldehyde study. Chem. Eng. News
60(22): 8 (1982).
Anon. Court overturns ban on urea-formaldehyde foam. Chem. Eng.
News 61(17): 8 (1983).
Anon. Chemical profile: formaldehyde. Chem. Marketing Reptr.
January 23, 1978, p. 9.
Anon. Formaldehyde debate moves into center stage in Washington:
studysaid toclearchemical. Chem. Marketing Repr. 221: 7, 56 (1982).
Anon. Formaldehyde: Court gives safety agency until May 5 to appeal
reversal offoam insulation ban. Chem. Regulation Reptr. 7: 178-179
(1983).
Anon. Urea-formaldehyde foam gets the axe for home insulation.
Chem. Week 130(9): 12-13 (1982).
Anon. More grief for formaldehyde. Chem. Week 131(18): 13-14
(1982).
Anon. Washington Notes: get the urea-formaldehyde out. Consumer
Repts. 47: 266 (1982).
Anon. Re-regulations offormaldehydeinJapan. INDA. Japan Branch,
Mitsuwa Building, Osaka, Japan (1975).
Anon. The health hazards offormaldehyde. Lancet i: 926-927 (1981).
Anon. U.S. formaldehyde policy. Lancet i: 1233 (1983).
Anon. Formaldehyde and cancer. Lancet ii: 26 (1983).
Anon. Formaldehyde study shows gene effect in anatomy students.
New Physicians 6: 17 (1982).
Anon. Pending formaldehyde notice limits EPA investigation. Pesti-
cide Tbxic Chem. News 9(30): 20-21 (1981).
Anon. Formaldehyde carcinogenicity said to have been confirmed.
Pesticide Ibxic Chem. News 9(41): 3-4 (1981).
Anon. EPA Administrator Gorsuch given 60-days notice on formal-
dehyde, DEHP Pesticide Tbxic Chem. News 9(42): 11-12 (1981).
Anon. OTS recommends that formaldehyde not be given priority
attention. Pesticide Tbxic Chem. News 9(44): 9-10 (1981).
Anon. High threshold forTSCA Section 4(F) actions recommended by
OTS Clay. Pesticide Toxic Chem. news 9(44): 18 (1981).
Anon. Toxic Substances Officedeveloping studyplanonformaldehyde.
Pesticide Toxic Chem. News 10(5): 8-9 (1981).
Anon. EPA permethrin decision sets policy that positive mouse tests
do not matter. Pesticide Toxic Chem. News 10(12): 6-9 (1982).
Anon. Formaldehyde should not be a priority TSCA chemical,
Todhunter says. Pesticide Toxic Chem. News 10(13): 20-22 (1982).
Anon. Objections toformaldehyde riskassessment leadtoresignation.
Pesticide Toxic Chem. News 10(22): 22 (1982).
Anon. Formaldehyde seen as reflecting change in EPA risk assess-
ments. Pesticide Toxic Chem. News 10(26): 3-5 (1982).
Anon. Panel of MDS tells congressional subcommittee of formalde-
hyde effects. Pesticide Toxic Chem. News 10(27): 29 (1982).
Anon. Formaldehyde hearing sees selective use of peer review by
EPA. Pesticide Toxic Chem. News 10(28): 3-9 (1982).
Anon. National Center for Toxicological Research to review formal-
dehyde. Pesticide Toxic Chem. News 10(28): 9-10 (1982).
Anon. Regulatory caution before regulating formaldehyde sought.
Pesticide Toxic Chem. News 10(28): 25-26 (1982).
Anon. Formaldehyde controversy continues to simmer. Pesticide Toxic
Chem. News 10 (31): 4-42 (1982)
Anon. Todhuntersees"threshold" debate oncarcinogensasirrelevant.
Pesticide Toxic Chem. News 10(36): 3 (1982).
Anon. Government agencies clash over formaldehyde in mobile
homes. Pesticide Tbxic Chem. News 10(45): 17-18 (1982).
Anon. Formaldehyde study. Pesticide Tbxic Chem. News 10(50): 2
(1982).
Archer, M. C., and Labuc, G. E. On the mode of action of
N-nitrosomethylbenzylamine, an esophageal carcinogen in the rat.
In: Banbury Report 12, Nitrosamines and Human Cancer (P N.
Magee, Ed.), Cold Springs Harbor Laboratory, 1982, pp. 87-101.
Ariens, E. J., Hanselaar, A. G. J. M., Henderson, P Th., and
Simonis, A. M. Beware of formaldehyde in disguise. Eur. J. Clin.
Pharmacol. 23: 373-375 (1982).
Ashby, J., and Lefevre, P A. Formaldehyde generators: relationship
between stability, lipophilicity and carcinogenic potency. Carcinogene-
sis 3: 1273-1276 (1982).
Ashford, N. A., Ryan, C. W, and Caldart, C. C. A hard lookatfederal
regulation of formaldehyde; a departure from reasoned decision
making. Harvard Environ. Law Rev. 7: 297-370 (1983).
Auerbach, C. The mutagenic mode ofaction offormalin. Science 110:
419-420 (1949).
Auerbach, C., and Moser, H. An analysis of the mutagenic action of
formalin. Heredity 4: 272-273 (1950).
Auerbach, C., Moutschen-Dahmen, M., and Moutschen, J. Genetic
and cytogenetical effects of formaldehyde and related compounds.
Mutat. Res. 39: 317-362 (1977).
Ayer, H. E., and Yeager, D. W Irritants in cigarette smoke plumes.
Am. J. Publ. Health 72: 1283-1285 (1982).
Bardana, E. J., and Andrach, R. H. Occupational asthma secondary
to low molecular weight agents used in the plastic and resin
industries. Eur. J. Resp. Dis. 64: 241-251 (1983).
Barlow, S. Work and sex. Medical World 119: 16-17 (1981).
Barlow, S. M., and Sullivan, F M. Formaldehyde. In: Reproductive
Hazards of Industrial Chemicals: An Evaluation of Animal and
Human Data (S. M. Barlow and E M. Sullivan, Eds.), Academic
Press, New York, 1982, Chapter 24, pp. 334-345.
Barnes, E. C., and Speicher, H. W The determination of formalde-
hyde in air. J. Ind. Hyg. Tox. 24: 10-17 (1942).
Barrow, C. S. Sensory irritation. CIIT Activities, Chemical Industry
Institute of Toxicology 1: 3-6 (1981).
Barrow, C. S. Sensory irritation of inhaled aldehydes; structure366 CONSENSUS WORKSHOP ON FORMALDEHYDE
activity studies. CIIT Activities, Chemical Industry Institute of
Toxicology 2:3-5 (1982).
Barrow, C. S., and Steinhagen, W H. Sensory irritation by inhaled
formaldehyde in B6C3F1 mice and F-344 rats following single or
repeated exposure (abstract). Toxicologist 1: 5-6 (1981).
Barrow, C. S., and Steinhagen, W H., and Chand, J. C. F. form
aldehyde sensory irritation. In: Formaldehyde Toxicity (J. E. Gibson,
Ed.), Hemisphere Publishing Corp., Washington, D. C. 1983, Chap-
ter 3, pp. 16-25.
Basmadzieva, K., Balabaeva, L., Kolev, K., Agirova, M., Carakciev,
D., Krasteva, S., and Ivanova, H. The effect of formaldehyde on
animals with experimental emphysema. Khigiena Zdraveopazvane
(Hygiene and Sanitation) 24: 361-368 (1981).
Battelle Columbus Laboratories. Final report on a chronic inhalation
toxicology study in rats and mice exposed to formaldehyde. Battelle
Columbus Laboratories, Columbus, Ohio, 1981.
Baumann, H. Formaldehyd in UF-Schaum. Plastica 30: 72-75 (1977).
Baumann, K., and Angerer, J. Occupational chronic exposure to
organic solvents. VI. Formic acid concentration in blood and urine as
an indicator of methanol exposure. International Arch. Occup.
Environ. Health 42: 241-249 (1979).
Baur, X., and Fruhmann, G. Berufsbedingtes Asthma bronchiale
allergischer und irritativer Genese (Bronchial asthma of allergic or
irritative origin as an occupational disease). Praxis Klinik Pneumol.
33 (Suppl. 1): 317-322 (1979).
Benbrook, C. M. Letters: Carcinogen policy at EPA. Science 219: 798
(1983).
Bender, J. R., Mullin, L. S., Graepel, G. J., and Wilson, W E. Eye
irritation response ofhumans to formaldehyde. Am. Ind. Hyg. Assoc.
J. 44: 463-465 (1983).
Berger, J. M., and Lamm, S. H. Correspondence: Health hazards of
formaldehyde. Lancet i: 1264 (1981).
Bergmann, K., and Schneider, W Gas chromatographic method to
determine formaldehyde traces in automobile exhaust gases. Chrom-
atographia 15: 631-634 (1982).
Bergreen, P W, Ayala, A. G., and Johnson, D. E. Effect of topical
formaldehyde on canine bladder. Urology 7: 279-283 (1976).
Beritic, T., Kovac, S., and Dimov, D. Formaldehyde in present day
environmental toxicology (translation available). Arhiv Hig Rada
Toksikol. (Archives ofIndustrial Hygiene and Toxicology) 32: 363-394
(1981).
Bernstein, E Kutane Sensibilisierung gegen Formalin als beruffiche
Krankheit (Cutaneous sensitivity to formalin-solution of formalde-
hyde as anoccupational disease). Dermatol. Wochensch. 95: 1683-1686
(1932).
Bilimoria, M. H. The detection ofmutagenic activity ofchemicals and
tobacco smoke in a bacterial system (abstract). Mutat. Res. 31: 328
(1975).
Blackwell, M., Kang, H., Thomas, A., and Infante, P Formaldehyde:
evidence of carcinogenicity. Am. Ind. Hyg. Assoc. J. 42: A34-A46
(1981).
Blair, A. Formaldehyde. A presentation to the National Cancer
Advisory Board Meeting ofOct,ober 5, 1981 (unpublished comments).
Boettcher, B., Nanra, R. S., Roberts, T. K., Mallan, M., and
Watterson, C. A. Specificity and possible origin of anti-N antibodies
developed by patients undergoing chronic haemodialysis. Vox Sang.
31: 408-415 (1976).
Boggs, P. B. Letter to the Editor: Occupational asthma and rhinitis
caused by urea formaldehyde. Chest 83: 584 (1983).
Boleij, J. S. M., and Brunekreef, B. Indoorairpollution. Publ. Health
Rev. 10: 169-198 (1982).
Bonashevskaya, T. I. Amygdaloid lesions after exposure to formal-
dehyde. Arkhiv Anat. Gistol. Embriol. 65: 56-59 (1973).
Boreiko, C. J., Ragan, D. L., Abernethy, D. J., and Frazelle, J. H.
Initiation ofC3H/1OT1/2 cell transformation by N-methyl-N-nitro-N-
nitrosoguanidine and Aflatoxin Bi. Carcinogenesis 3: 391-395 (1982).
Bourne, H. G., Jr., and Seferian, S. Formaldehyde in wrinkle-proof
apparel produces ... tears for milady. Ind. Med. Surg. 28: 232-233
(1959).
Brabec, M. J. Aldehydes and acetals. In: Patty's Industrial Hygiene
and Toxicology, Vol. IIA. John Wiley & Sons, New York, 1981,
Chapter 37, pp. 2629-2699.
Breysse, P A. Small plants and their medical problems-the furni-
ture industry: the environmental problems of urea-formaldehyde
structures-formaldehyde exposure in mobile homes. Occupational
Safety and Health Symposia, 1979, Contract #210-79-0009, National
Institute of Occupational Safety and Health, Divison of Technical
Services, Cincinnati, Ohio, 1980, pp. 56-63.
Breysse, P A. The health cost of tight homes. J. Am. Med. Assoc.
245: 267-268 (1981).
Breysse, P. A. Formaldehyde in mobile and conventional homes.
Environmental Health and Safety News, Vol. 25, Dept. of Environ-
mental Health, School of Public Health and Community Medicine,
University of Washington, Seattle, Washington, 1977, pp. 1-19.
Breysse, P A. Formaldehyde exposure following urea formaldehyde
insulation. Environmental Health and Safety News, Vol. 26, Dept. of
Environmental Health, School of Public Health and Community
Medicine, University of Washington, Seattle, Washington, 1978, pp.
1-13.
Breysse, P A. Formaldehyde exposure in mobile homes and conven-
tional homes. Proceedings ofthe43rdAnnual Educational Conference
ofthe National Environmental Health Association, June 23-28, 1979,
pp. 1-16.
Breysse, P A. Formaldehyde exposure and pericarditis. Environmen-
tal Health and Safety News, Vols. 28 and 29, Dept. ofEnvironmental
Health, SchoolofPublic Health and Community Medicine, University
of Washington, Seattle, Washington, 1980-1981, pp. 1-15.
Brockman, H. E. Report onformaldehyde usingthe AD-3 test system
(Heterokaryon-12) of Neurospora crassa. NIH Contract No.
273-79-C-0015, National Institute ofEnvironmental Health Sciences,
Research Triangle Park, NC, 1980.
Brockman, H. E., Hung, C. Y, and DeSerres, E J. Potentmutagenic-
ity of formaldehyde in a nucleotide excision repair-deficient hetero-
karyon of Neurospora crassa (abstract). Environ. Mutagen. 3:
379-380 (1981).
Bross, I. D. J., Viadana, E., and Houten, L. Occupational cancer in
men exposed to dust and other environmental hazards. Arch.
Environ. Health 33: 300-307 (1978).
Brunn, W, and Klostermeyer, H. Detection and determination of
protein-bound formaldehyde. II. Improved recovery of formaldehyde
by reduction with sodium cyanoborhydride (NACNBH3) (translation
available). Z. Lebensmittel-Untersuchung Forsch. 176:367-370(1983).
Brusick, D. J., Myhr, B. C., Stetka, D. G., and Rundell, J. 0. Genetic
and transforming activity offormaldehyde. Litton Bionetics' Report,
Kensington, Maryland, April, 1980.
Bruynzeel, D. P, Van Ketel, W G., von Blomberg-van der Flier, M.,
and Scheper, R. J. Angry back or the excited skin syndrome: a
prospective study. J. Am. Acad. Dermatol. 8: 392-397 (1983).
Bryson, D. D. Correspondence: Health hazards of formaldehyde.
Lancet i: 1263-1264 (1981).
Buck, H. M. Spectrophysics and photochemistry ofthe formaldehyde
molecule. Part II. Rec. J. Roy. Netherlands Chem. Soc. 101: 225-233
(1982).
Budiansky, S. News: formaldehyde cancer risk: court not convinced of
dangers. Nature 304: 105 (1983).
Bundgaard, H. Formaldehyde pro-drugs as potential antitumor
agents. Arch. Pharmaci Chemi, Sci. Ed. 9: 133-136 (1981).
Campbell, M. A., and Fantel, A. G. Teratogenicity ofacetaldehyde in
vitro: Relevance to the fetalalcohol syndrome. Life Sci. 32: 2641-2647
(1983).
Casanova-Schmitz, M., and Heck, H. DA. Metablism offormaldehyde
in the rat nasal mucosa in vivo (abstract). Ibxicologist 3(1): abstract
243 (1983).CONSENSUS WORKSHOP ON FORMALDEHYDE 367
Cassidy, S. L., Dix, K. M., and Jenkins, T. Evaluation ofa testicular
sperm head counting technique using rats exposed to dimethoxyethyl
phthalate (DMEP), glycerol A-monochlorohydrin (GMCH), epich-
lorohydrin (ECH), formaldehyde (FA), or methyl methanesulphonate
(MMS). Arch. Toxicol. 53: 71-78 (1983).
Celanese Corporation. Considerations in establishing an appropriate
TLV for formaldehyde. Presented to ACGIH Subcommittee on Jan.
20, 1983, Celanese Chemical Co., Inc., New York, 1983.
Chaigneau, M., Lemoan, G., Chastagnier, M., and Chuong, P H. On
new results dealing with the persistence of residuals in medico-
surgical materials sterilized with formaldehyde (translation available).
Ann. Pharm. Franc. 40: 431-438 (1982).
Chanet, R., Izard, C., and Moustacchi, E. Genetic effects of
formaldehyde in yeast. I. Influence ofthe growth stages on killing and
recombination. Mutat. Res. 33: 179-186 (1975).
Chanet, R., Magana-Schwencke, N., and Moustacchi, E. Genetic
effects offormaldehyde in yeast: current status and limitations ofthe
radiation equivalence concepts. In: Radiobiological Equivalents of
Chemical Pollutants: Proceedings of the Advisory Group Meeting on
Radiobiological Equivalents of Chemical Pollutants. International
Atomic Energy Agency, Vienna, Austria, 1980, pp. 45-59.
Chanet, R., and Von Borstel, R. C. Genetic effects offormaldehyde in
yeast. III. Nuclear and cytoplasmic mutagenic effects. Mutat. Res.
62: 239-253 (1979).
Chang, J. C. F, and Barrow, C. S. Tolerance and cross-tolerance to
the sensory irritants chlorine and formaldehyde in F-344 rats
(abstract). Toxicologist 3(1): 73 (1983).
Chang, J. C. F, Gross, E. A., Swenburg, J. A., and Barrow, C. S.
Dose comparison between B6C3F1 mice and F-344 rats following
formaldehyde inhalation (abstract). Toxicologist 2(2): 11 (1982).
Chang, J. C. F, Gross, E. A., Swenberg, J. A., and Barrow, C. S.
Nasal cavity deposition, histopathology, and cell proliferation after
single or repeated formaldehyde exposures in B6C3F1 mice and F-344
rats. Toxicol. Appl. Pharmacol. 68: 161-176 (1983).
Chang, J. C. F, Steinhagen, W H., and Barrow, C. S. Effect ofsingle
or repeated formaldehyde exposure on minute volume of B6C3F1
mice and F-344 rats. Toxicol. Appl. Pharmacol. 61: 451-459 (1981).
Chang, J. C. F, Steinhagen, W H., and Barrow, C. S. Effect ofsingle
or repeated formaldehyde exposure on tidal volume in B6C3F1 mice
and Fischer-344 rats (abstract). Fed. Proc. 40 (Part 1): 739 (1981).
Chaw, Y F M., Crane, L. E., Lange, P, and Shapiro, R. Isolation and
identification of cross-links from formaldehyde-treated nucleic acids.
Biochemistry 19: 5525-5531 (1980).
Chemical Industry Institute ofToxicology (CIIT). Statement concern-
ing research findings, October, 1979. CIIT Docket #11109, Chemical
Industry Institute ofToxicology, Research Triangle Park, NC, 1979.
Chemical Industry Institute ofToxicology (CIIT). Progress report on
CIIT formaldehyde studies, January 16, 1980. CIIT Docet #32510,
Chemical Industry Institute of Toxicology, Research Triangle Park,
NC (1980).
Chemical Industry Institute ofToxicology (CIIT). Progress report on
CIIT formaldehyde studies, December, 1980. CIIT Docket #112DO,
Chemical Industry Institute of Toxicology, Research Triangle Park,
NC (1980).
Chemical Industry Institute of Toxicology (CIIT). Summary of final
report on formaldehyde study. CIIT Activities, Chemical Industry
Instituted of Toxicology 2(3): 1, 9 (1982).
Chen, T.-M., and Chafetz, L. Selective determination offree urinary
formaldehyde after oral dosage with methenamine mandelate. Invest.
Urol. 10: 212-214 (1972).
Chikamoto,, T., Ezaka, S., Morimoto, K., Oki, H., Tamura, Y, and
Sakoda, K. Aldehyde distribution in the atmosphere. Kyoto Pref.
Inst. Hyg. Environ. Sci. 23: 96-100 (1978).
Chin, T. Y and Heck, H. DA. Disposition of 14C formaldehyde in
Fischer-344 ratsfollowing inhalation exposure (abstract). Toxicologist
1: 78 (1981).
Clark, R. P Formaldehyde in pathology departments. J. Clin. Pathol.
36: 839-846 (1983).
Clarke, W J. Subchronic study report on formaldehyde. Tracor-Jitco
Inhalation Carcinogenesis Bioassay; Battelle Pacific Northwest
Laboratories, Richland, Washington, November, 1981, pp. 1-41.
Clay, D. EPA staff memo on applicability of TSCA 4(F) to formal-
dehyde. Inside EPA., September 25, 1981, pp. 4-5.
Cleveland, W S., Graedel, T. E., and Kleiner, B. Urbanformaldehyde:
Observed correlation with source emissions and photochemistry.
Atmos. Environ. 11: 357-360 (1977).
Cockcroft, D. W, Hoeppner, V H., and Dolovich, J. Occupational
asthma caused by cedar urea formaldehyde particle board. Chest 82:
49-53 (1982).
Coene, R. F Formaldehyde: evidence ofcarcinogenicity. Vet. Human
Toxicol. 23: 282-285 (1981).
Coldiron, V R., Ward, J. B., Jr., Trieff, N. M., Janssen, H. E., Jr.,
and Smith, J. H. Occupational exposure to formaldehyde in a medical
center autopsy service. J. Occup. Med. 25: 544-548 (1983).
Collins, C. J., and Guild, W R. Irreversible effects offormaldehyde on
DNA. Biochim. Biophys. Acta 157: 107-113 (1968).
Commission for the Study of the Carcinogenic, Mutagenic, and
Teratogenic Effects ofChemical Compounds on Health Risks Related
to Possible Methods ofFormaldehyde Use. Opinion ofthe commission,
meeting ofJune 1, 1981 (unpublished comments).
Connor, T. H. Detection ofchemical mutagens in the urine ofhumans:
studies of exposure to formaldehyde and cigarette smoke (abstract).
Dissertation Abstr. Intern. 43: 667 (1982).
Connor, T. H., Barrie, M. D., Theiss, J. C., Matney, T. S., and Ward,
J. B., Jr. Mutagenicity offormalin inthe Ames assay. Mutat. Res. 119:
145-149 (1983).
Consumer Product Safety Commission (CPSC). Urea-formaldehyde
foam insulation; public hearings. Fed. Reg. 44: 69578-69583 (1979).
Consumer Product Safety Commission (CPSC). Evaluation of health
risks of formaldehyde by government scientists. Fed. Reg. 45:
34031-34033 (1980).
Consumer Product Safety Commission (CPSC). 16 CFR Part 1405,
Urea-formaldehyde foam insulation; Proposed notice to purchasers.
Fed. Reg. 45: 39434-39444 (1980).
Consumer Product Safety Commission (CPSC). Part IV, Urea-
formaldehyde foam insulation; proposed ban; denial of petition. Fed.
Reg. 46: 11189-11211 (1981).
Consumer Product Safety Commission (CPSC). Part IV, Ban of
urea-formaldehyde foam insulation, withdrawal of proposed informa-
tion labeling rule, and denial ofpetition to issue standard. Fed. Reg.
47: 14366-14419 (1982).
Consumer Product Safety Commission (CPSC). 16 CFR Part 1306,
Ban of urea-formaldehyde foam insulation: confirmation of effective
date. Fed. Reg. 47: 57488-57489 (1982).
Consumer Product Safety Commission (CPSC). Questions and an-
swers on urea-formaldehyde foaminsulation. CPSC, Washington, DC,
March, 1982.
Consumer Product Safety Commission (CPSC), Environmental Pro-
tection Agency (EPA), Dept. ofHealth Education & Welfare, Dept. of
Agriculture. Scientific basis for identification ofpotential carcinogens
and estimation of risks: Request for comments on report. Fed. Reg.
44: 39858-39879 (1979).
Cooke, A., Oliver, R. F, and Edward, M. An in vitro cytotoxicity
study ofaldehyde-treated pig dermal collagen. Brit. J. Exptl. Pathol.
64: 172-176 (1983).
Coon, R. A., Jones, R. A., Jenkins, L. J., Jr., and Siegel, J. Animal
inhalation studies on ammonia, ethylene glycol, formaldehyde, di-
methylamine, and ethanol. Toxicol. Appl. Pharmacol. 16: 646-655
(1970).
Cooper, P Genetic effects offormaldehyde. Food Cosmet. Toxicol. 17:
300-301 (1979).368 CONSENSUS WORKSHOP ON FORMALDEHYDE
Couch, D. B., Allen, P F., and Eales, H. C. The mutagenicity of
formaldehyde to Salmonella typhimurium (abstract). Environ.
Mutagen. 4: 336-337 (1982).
Cralley, L. V The effect of irritant gases upon the rate of ciliary
activity. J. Ind. Hyg. Toxicol. 24: 193-198 (1942).
Csiba, A., Trezl, L., Tyhak, E. Graber, H., Vari, E., Teglas, G., and
Rusznak, I. Assumed roleofL-argTinineinmobilization ofendogenous
formaldehyde. Acta Physiol. Acad. Sci. Hung. 59: 35-43 (1982).
Dagani, D., andArcher, M. C. Colorimetric determination ofacetalde-
hyde in the presence of formaldehyde. Anal. Biochem. 87: 455-459
(1978).
Dahl, A. R., and Hadley, W M. Formaldehyde production promoted
by rat nasal cytochrome P-450-dependent monooxygenases with nasal
decongestants, essences, solvents, airpollutants, nicotine and cocaine
as substrates. Toxicol. Appl. Pharmacol. 67: 200-205 (1983).
Dahlquist, I., Fregert, S., and Gruvberger, B. Detection offormalde-
hyde in corticoid creams. Contact Dermatitis 6: 494 (1980).
Dalbey, W, and Nettesheim, P Influence of nitrogen dioxide or
formaldehyde on incidence of diethylnitroamine-induced tumors in
hamster respiratory tract (abstract). Toxicologist 1: 138 (1981).
Dalbey, W E. Formaldehyde and tumors in hamster respiratory tract.
Toxicology 24: 9-14 (1982).
Dalhamn, T., and Rosengren, A. Effect of different aldehydes on
tracheal mucosa. Arch. Otolaryngology 93: 496-500 (1971).
Decoufle, P Cancer risks associated with employment in the leather
and leather products industry. Arch. Environ. Health 34: 33-37
(1979).
Della Porta, G., Cabral, J. R., and Parmiani, G. Studio della tossicita
transplacentare e di carcerogenesi in ratti trattati con esametilenete-
tramina (Transplacental toxicity and carcinogenesis studies in rats
treated with hexamethylenetetramine). Tumori 56: 325-334 (1970).
DellaPorta, G., Colhaghi, M. I., and Parmiani, G. Noncarcinogenicity
ofhexamethylenetetramine in mice and rats. Food Cosmet. Toxicol. 6:
707-715 (1968).
Deppe, H. J. Emission of organic substances from wood raw
materials. Holz-Zentralbl. 108: 123-126 (1982).
Dmitriev, M. T., Zarubin, G. P, and Mishchikhin, V A. Prediction of
indoor air pollution levels during the use of synthetic polymer
materials. Gig. Sanitar. 12: 55-58 (1982).
Dormans, J. A., and Van Logten, M. J. The effects of ophthalmic
preservatives on corneal epithelium ofthe rabbit: a scanning electron
microscopical study Toxicol. Appl. Pharmacol. 62: 251-261 (1982).
Dost, F. N. Assessment ofpotential toxic hazards offormaldehyde. In:
13th Symposium on Particle Board. Washington State University,
Pullman, Washington, 1979, pp. 317-327.
Drill, V A., Friess, S. L., Hays, H. W, Loomis, T. A., and Shaffer, C.
B. Potential health effects from inhalation of low levels of airborne
formaldehyde. Drill, Friess, Hays, Loomis & Shaffer, Inc., Arlington,
Virginia, March, 1982.
Du Vigneaud, V, Verly, W G., and Wilson, J. E. Incorporation ofthe
carbon offormaldehyde and formate into the methyl groups ofcholine.
J. Am. Chem. Soc. 72: 2819-2820 (1950).
Dubreuil, A., Bouley, G., Godin,J., and Boudene, C. L. Inhalation, en
continu, de faibles doses de formaldehyde: etude experimentale chez
le rat. Eur. J. Ibxicol. 9: 245-250 (1976).
Dumas, T. Determination of formaldehyde in air by gas chroma-
tography, J. Chromatog. 247: 289-295 (1982).
Dunn, D. W, Johnson, M. L., Hedley, W H., Pate, J. B., Barrett, G.
J., and McKinnery, W N. Reducing plant pollution exposure: control
practices at formaldehyde production plants. Chem. Eng. Progr.
79(3): 35-38 (1983).
Eberhartinger, C., and Ebner, H. Beitrag zur Kenntnis der Formalin-
Kontakt-Allergie (An addition toformalin contactallergy knowledge).
Berufsdermatosen 12: 301-306 (1976).
Eckmann, A. D., Daily, K. A., Hanrahan, L. P, and Anderson, H. A.
Comparison of the chromotropic acid and modified pararosaniline
methods for the determination of formaldehyde in air. Environ.
Intern. 8: 159-166 (1982).
Eells, J. T., McMartin, K. E., Black, K., Virayotha, V, Tisdell, R. H.,
and Tephly, T. R. Formaldehyde poisoning: rapid metabolism to formic
acid. J. Am. Med. Assoc. 246: 1237-1238 (1981).
Egle, J. L., Jr. Retention ofinhaled formaldehyde, propionaldehyde,
and acrolein in the dog. Arch. Environ. Health 25: 119-124 (1972).
Engle, H. O., and Calnan, C. D. Resin dermatitis in a car factory.
Brit. J. Ind. Med. 23: 62-66 (1966).
Englesberg, E. The mutagenic action offormaldehyde on bacteria. J.
Bacteriol. 63: 1-11 (1952).
Environmental Protection Agency (EPA), Office ofToxic Substances.
Priority review level 1: Formaldehyde (draft). EPA, Washington, DC,
February 19, 1981.
Environmental Protection Agency (EPA), Office ofToxic Substances.
Options paper on formaldehyde (unpublished). EPA, Washington,
DC, September 11, 1981.
Epstein, E., and Maibach, H. I. Formaldehyde allergy: incidence and
patch test problems. Arch. Dermatol. 94: 186-190 (1966).
Epstein, S. S., Arnold, E., Andrea, J., Bass, W, and Bishop, Y.
Detection of chemical mutagens by the dominant lethal assay in the
mouse. Toxicol. Appl. Pharmacol. 23: 288-325 (1972).
Ettinger, I., and Jeremias, M. A study ofthe health hazards involved
in working with flameproofed fabrics. Monthly review, New York
State Department of Labor, Division of Industrial Hygiene, July,
1955, pp. 1-2.
Fall, M., and Pettersson, S. Ureteral complications after intravesical
formalin installation. J. Urol. 122: 160-162 (1979).
Farrelly, J. G., and Steward, M. L. The metabolism of a series of
methylalkylnitrosamines. Carcinogenesis 3: 1299-1302 (1982).
Fassbinder, W, and Koch, K. M. A specific innunohaemolytic anemia
induced by formaldehyde sterilization of dialysers. In: Biocompat-
ability in Hemodialysis (Contributions to Nephrology; Vol. 36).
Workshop on Biocompatability in Hemodialysis, Gernreid, March
18-20, 1982 (C. A. Baldamus, K. M. Koch, and W Schoeppe, Ed.),
Karger, Basel, Switzerland, 1982, pp. 51-67.
Fassbinder, W, Pilar, J., Scheuermann, E., and Koch, M. Formalde-
hyde and the occurrence of anti-N-like cold agglutinins in RDT
patients. In: Proc. Eur. Dialysis Transplant Assoc. 9: 333-338 (1976).
Fassbinder, W, Seidl, S., and Koch, K. M. The role offormaldehyde in
the formation ofhaemodialysis-associated anti-N-like antibodies. Vox
Sang. 35: 41-48 (1978).
Fassett, D. W Formaldehyde. In: Industrial Hygiene and Toxicology,
Vol. II (F A. Patty, Ed.), Interscience, New York, 1958, pp.
1970-1972.
Fassett, D. W Aldehydes and acetals. In: Industrial Hygiene and
Toxicology II., 2nd Ed. (Rev.) (F A. Patty, Ed.), John Wiley & sons,
New York, Chapter 43, 1963, pp. 1959-1989.
Federal Panel on Formaldehyde. Report of the Federal Panel on
Formaldehyde. Environ. Health Perspect. 43: 139-168 (1982).
Feigal, R. J. Potential contraindications forthe use offormaldehyde in
dentistry. Northwest Dentistry 53(5): 13-16 (1982).
Feldman, M. Y Reactions of nucleic acids and nucleoproteins with
formaldehyde. Prog. Nucleic Acid Res. Mol. Biol. 13: 1-48 (1973).
Feldman, M. Y., Balabanova, H., Bachrach, U., and Pyshnov, M.
Effect of hydrolyzed formaldehyde-treated RNA on neoplastic and
normal human cells. Cancer Res. 37: 501-506 (1977).
Feldman, Y G. Biological action ofcertain products from atmospheric
photochemical reactions (abstract), Gig. Sanitar.; Chem. Abstr. 76:
#122530N (1972).
Feldman, Y. G., and Bonashevskaya, T. I. On the effects of low
concentrations offormaldehyde. Hygiene and Sanitation 36: 174-180
(1971).CONSENSUS WORKSHOP ON FORMALDEHYDE 369
Figueroa, W G., Raszkowski, R., and Weiss, W Lung cancer in
chloromethyl methyl etherworkers. New Eng. J. Med. 288:1096-1097
(1973).
Fisher, A. A. Dermatitis due to formaldehyde-releasing agents in
cosmetics and medicaments. Current Contact News 655, 658, 664, 708
(1978).
Fisher, A. A., Kanof, N. B., and Biondi, E. M. Free formaldehyde in
textiles and paper: clinical significance. Arch. Dermatol. 86: 753-756
(1962).
Fleig, I., Petri, N., Stocker, W G., and Thiess, A. M. Cytogenetic
analyses ofblood lymphocytes ofworkers exposed to formaldehyde in
formaldehyde manufacturing and processing. J. Occup. Med. 24:
1009-1012 (1982).
Fontignie-Houbrechts, N. Genetic effects of formaldehyde in the
mouse. Mutat. Res. 88: 109-114 (1981).
Fontignie-Houbrechts, N., Moutschen-Dahmen, J., Moutschen-
Dahmen, M., Degraeve, N., and Gloor, H. Genetic effects in the
mouse of formaldehyde in combination with adenosine and hydrogen
peroxide. Mutat. Res. 104: 371-376 (1982).
Food and Drug Administration (FDA). FDA Talk Paper: Formal-
dehyde, T80-27, May 21, 1980. FDA, Rockville, Maryland.
Food and Drug Administration (FDA). FDA Talk Paper: Formal-
dehyde, T82-40, June 17, 1982. FDA, Rockville, Maryland.
Foodand DrugAdministration. Consensusworkshoponformaldehyde;
Meeting. Fed. Reg. 48: 55034-55035 (1983).
Foodand DrugAdministration. Consensusworkshoponformaldehyde;
Meeting. Fed. Reg. 47: 36201-36203 (1982).
Fornace, A. J., Jr. Detection of DNA single-strand breaks produced
during the repair of damage by DNA-protein cross-linking agents.
Cancer Res. 42: 145-149 (1982).
Fornace, A. J., Jr., Lechner, J. F, Grafstron, R. C., and Harris, C. C.
DNA repair in human brochial eptihelial cells. Carcinogenesis 3:
1373-1377 (1982).
Frankel, L. S., McCallum, K. S., and Collier, L. Formation of
bis(chloromethyl) ether from formaldehyde and hydrogen chloride.
Environ. Sci. Technol. 8: 356-359 (1974).
Frazelle, J. H., Abernethy, D. J., and Boreiko, C. J. Weak promotion
of C3H/1OT1/2 cell transformation by repeated treatments with
formaldehyde. Cancer Res. 43: 3236-3239 (1983).
French, D., and Edsall, J. T. The reactions of formaldehyde with
amino acids and proteins. In: Advances in Protein Chemistry, Vol. II
(M. L. Anson and J. T. Edsall, Eds.), Academic Press, New York,
1945, pp. 277-335.
Frenk, E. Pruriginous eruptions of epidemic character in a foundry
using synthetic resins. Dermatologica 129: 436-439 (1964).
Friedman, G. D., and Ury, H. K. Initial screening for carcinogenicity
of commonly used drugs. J. Natl. Cancer Inst. 65: 723-733 (1980).
Frigas, E., Filley, W V, and Reed, C. E. Asthma induced by dust
from urea-formaldehyde foam insulating material. Chest 79: 706-707
(1981).
Frind, H., and Hensel, R. Bestimmung der personlichen Formal-
dehydbelastung (Determination of the individual load by formal-
dehyde). Fresenius Z. Anal. Chem. 312: 237-240 (1982).
Fujiwara, M., Tomita, S., and Nishimura, T. Micro determination of
formaldehyde in vaccines. Japan. J. Bacteriol. 37: 789-791 (1982).
Fuks, A. B., Bimstein, E., and Bruchim, A. Radiographic and
histologic evaluation ofthe effect oftwo concentrations offormocresol
on pulpotomized primary and young permanent teeth in monkeys.
Pediatric Dent. 5: 9-13 (1983).
Galli, C. L., Ragusa, C., Resmini, P, and Marinovich, M. Ibxicologi-
cal evaluation in rats and mice ofthe ingestion ofa cheese made from
milk with added formaldehyde. Food Chem. Ibxicol. 21: 313-317
(1983).
Gallo, F P Bromuro di metile ossido di etilene formaldeide: problemi
biologici, tossicologici eproblemi correlati al trattamento deimateriali
librari (Methyl bromide, ethylene oxide, formaldehyde: biological,
toxicological problems, and problems related to the treatment of
library materials) (translation available). Nuovi Ann. Microbiol. 29:
131-167 (1978).
Gamble, J. F, McMichael, A. J., Williams, T., and Battigelli, M.
Respiratoryfunctionandsymptoms: anenvironmental-epidemiological
study of rubber workers exposed to a phenol-formaldehyde type
resin. Am. Ind. Hyg. Assoc. J. 37: 499-513 (1976).
Garfield, E. Risk analysis, Part 2. How we evaluated the health risks
of toxic substances in the environment. Cur. Contents 22(35): 5-11
(1982).
Garry, V F, Kreiger, R. A., and Wiencke, J. K. The mutagenic and
cytotoxic effects of formaldehyde in cultured human lymphocytes
(Abstract). Environ. Mutagen. 3: 341 (1981).
Garry, V F, Oatman, L., Pleus, R., and Gray, D. Formaldehyde in the
home: some environmental disease perspectives. Minnesota Med. 63:
107-111 (1980).
Gaylor, D. W The use ofsafety factors for controlling risk. J. Toxicol.
Environ. Health 11: 329-336 (1983).
Gelfand, H. H. Respiratory allergy due to chemical compounds
encountered in the rubber, lacquer, shellac, and beauty culture
industries. J. Allergy 34: 374-381 (1963).
Georghiou, P E., Harlick, L., Winsor, L., and Snow, D. Temperature
dependence ofthe modified pararosaniline method for the determina-
tion of formaldehyde in air. Anal. Chem. 55: 567-570 (1983).
Gibson, J. E. Applied research: a case study with formaldehyde
(Abstract). The First World Congress onToxicology and Environmen-
tal Health, American College of Toxicology, Washington, DC, May
27-30, 1982.
Gibson, J. E. Mechanisms offormaldehyde toxicity and carcinogenic-
ity in laboratory animals. International Particleboard Series, Sympo-
sium No. 16, Washington State University, Pullman, Washington,
march 30, 1982.
Gilli, G., Corrao, G., and Scursatone, E. Dust as carrier of
formaldehyde: low environmental concentrations and allergic phe-
nomena. Tinctoria 78: 101-105 (1981).
Glass, W I. An outbreak of formaldehyde dermatitis. New Zealand
Med. J. 60: 423-427 (1961).
Godish, T. Formaldehyde and building-related illness. J. Environ.
Health 44: 116-121 (1981).
Godish, T. Residential formaldehyde control revisited. Natural Re-
sources Notes, Ball State University, Dept. of Natural Resources,
No. 3, Muncie, Indiana, 1982, pp. 1-6.
Godish, T. Interpretation of formaldehyde sampling results. Natural
Resources Notes, Ball State University, Dept. of Natural Resources,
No. 4, Muncie, Indiana, 1982, pp. 1-4.
Godish, T. Recognition ofbuilding-related illness. Natural Resources
Notes, Ball State University, Dept. of Natural Resources, No. 5,
Muncie, Indiana, 1982, pp. 1-4.
Godish, T. Are residents ofurea-formaldehyde foam insulated houses
uniquely victimized? Natural Resources Notes, Ball State University,
Dept. of Natural Resources, No. 6, Muncie, Indiana, 1982, pp. 1-2.
Gofmekler, V A. Effect on embryonic development of benzene and
formaldehyde in inhalation experiments. Hygiene and Sanitation
(USSR) 33: 327-332 (1968).
Gofmekler, V A., and Bonashevskaya, T. I. Experimental studies of
teratogenic propertis offormaldehyde, based on pathological evalua-
tions. Hygiene and Sanitation (USSR) 34: 266-268 (1969).
Goh, K. O., and Cestero, R. V M. Letters to the Editor: Health
hazards of formaldehyde. J. Am. Med. Assoc. 247: 2778 (1982).
Golberg, L. A code of ethics for scientists reporting and reviewing
information on chemicals. Fundamentals Appl. Toxicol. 2: 289-292
(1982).
Goldmacher, V S., and Thilly, W G. Formaldehyde is mutagenic for
cultured human cells. Mutat. Res. 116: 417-422 (1983).370 CONSENSUS WORKSHOP ON FORMALDEHYDE
Goldman, M., and Stein, A. A. Formaldehyde-health effects, regula-
tion and environmental control. J. Histotechnol. 4: 13-16 (1981).
Goldman, P, Flach H-D., Hey, W, Hochadel, H. Petri, N. Strass-
burger, K. J., and Thiess, A. M. Formaldehyd-morbiditatsstudie
(Formaldehyde morbidity study). Zentralbl. Arbeitsmedizin, Arbeits-
schutz, Prophyl. Ergon. 32: 250-258 (1982).
Goldschmidt, B. M., VanDuuren, B. L., and Frenkel, K. The reaction
of 14C-labelled bis-(chloromethyl)ether with DNA (abstract). Proc.
Am. Assoc. Cancer Res. 16: 66 (1975).
Goodman, D. G., Ward, J. M., Squire, R. A., Chu, K. C., and
Linhart, M. S. Neoplastic and noneoplastic lesions in aging F-344
rats. Toxicol. Appl. Pharmacol. 48: 237-248 (1979).
Goodman, J. I., and Tephly, T. R. Acomparison ofrat and human liver
formaldehyde dehydrogenase. Biochim. Biophys. Acta 252: 489-505
(1971).
Gori, G. B. The regulation of carcinogenic hazards. Science 208:
256-261 (1980).
Gorst, D. W, Riches, R. A., and Renton, P H. Formaldehyde induced
anti-N: a possible cause of renal graft failure. J. Clin. Pathol. 30:
956-959 (1977).
Grafstrom, R. C., Fornace, A. J., Jr., and Harris, C. C. Effect of
formaldehyde on DNA damage and repair in human bronchial
epithelial cells and fibroblasts (abstract). Proc. Am. Assoc. Cancer
Res. 23: 69 (1982).
Graftstrom, R. C., Fornace, A. J., Jr., Autrup, H., Lechner, J. F, and
Harris, C. C. Formaldehyde damage to DNA and inhibition of DNA
repair in human bronchial cells. Science 220: 216-218 (1983).
Gralla, E. J., Heck, H. D'A., Hrubesh, L. W, and Meadows, G. W A
report ofthe review ofthe formaldehyde exposure made by the CIIT
ad hoc analytical chemistry investigative team held at the Battelle
Memorial Columbus (Ohio) Laboratory, 505 King Avenue, Columbus,
Ohio, on January 11, 1980. CIIT Docket #62620, Chemical Industry
Institute ofToxicology, Research Triangle Park, NC, 1980, pp. 1-11.
Grant, W M. Formaldehyde. In: Toxicology ofthe Eye, 2nd ed. (W M.
Grant, Ed.), Charles C Thomas, Springfield, IL, 1974, pp. 502-507.
Green, M. A., and Egle, J. L., Jr. Effects ofintravenous acetaldehyde,
acrolein, formaldehyde andpropionaldehyde onarterial blood pressure
followingacuteguanethidine treatment. Res. Commun. Chem. Pathol.
Pharmacol. 40: 337-340 (1983).
Greenberg, S. R. Formaldehyde: medical ally or adversary. Proc.
Inst. Med. Chicago 34: 105-107 (1981).
Greenberg, S. R. The renal response to formalinization. Urol. Intern.
37: 45-48 (1982).
Greenberg, S. R. Nucleic acid relationshops in formalin-injured renal
tubules. Proc. Inst. Med. Chicago 35: 83-84 (1982).
Grossman, L. I. Paresthesia from N2 or N2 substitute. Oral Surg.,
Oral Med., Oral Pathol. 45: 114-115 (1978).
Grover, S. Effect offoam insulation ban worries formaldehyde firms.
Wall Street Journal, May 21, 1982, p. 33.
Guess, H., Crump, K., and Peto, R. Uncertainty estimates for
low-dose-rate extrapolations of animal carcinogenicity data. Cancer
Res. 37: 3475-3483 (1977).
Gunby, P Fact orfiction aboutformaldehyde? J. Am. Med. Assoc. 243:
1697-1703 (1980).
Gupta, K., and Cohn, M. Health sciences analysis ofcomments on the
proposed ban of UFFI. Memorandum to: Harry Cohen, Program
Manager, Consumer Product Safety Commission, Bethesda, Mary-
land, February 19, 1982.
Guseva, V A. Study ofthe gonadotropic effect in male rats under the
action of formaldehyde during its simultaneous administration from
air and water (translation available). Gigiena I Sanitariya 10: 102-103
(1972).
Hagino, N. Ovulation and mating behavior in female rats under
various environmental stresses or androgen treatment. Japan. J.
Physiol. 18: 350-355 (1968).
Halperin, W E., Goodman, M., Stayner, L., Elliott, L. J., Keenlyside,
R. A., and Landrigan, P J. Nasal cancer in a worker exposed to
formaldehyde. J. Am. Med. Assoc. 249: 510-512 (1983).
Hanselaar, A. G. J. M., Ariens, E. J., Henderson, P Th., and
Simonis, A. M. Vergorgen Formaldehyde (Hidden formaldehyde).
Pharmaceut. Weekblad 117: 505-507 (1982).
Hanst, P L., Wong, N. W, and Bragin, J. A long-path infra-red study
ofLos Angeles Smog. Atmospheric Environment 16: 969-981 (1982).
Harrington, J. M. Health and safety in medical laboratories. Bull.
WHO 60: 9-16 (1982).
Harrington, J. M., and Oakes, D. Mortality study of British
pathologists 1974-80 (submitted for publication).
Harrington, J. M., and Shannon, H. S. Mortality study ofpathologists
and medical laboratory technicians. Brit. Med. J. 4: 329-332 (1975).
Harris, C. C., Grafstrom, R. C., Lechner, J. F, and Autrup, H.
Metabolism ofN-nitrosamines and repair ofDNA damage in cultured
human tissues and cells. In: Banbury Report 12, Nitrosamines and
Human Cancer (P N. Magee, Ed.), Cold Spring Harbor Laboratory,
New York, 1982, pp. 121-139.
Harris, J. C., Rumack, B. H., and Aldrich, F D. Toxicology of urea
formaldehyde and polyurethane foam insulation. J. Am. Med. Assoc.
245: 243-246 (1981).
Harrison, P B., Jansson, K., Kronenberg, H., Mahony, J. F, and
Tiller, D. Cold agglutinin formation in patients undergoing haemo-
dialysis. A possible relationship to dialyser re-use. Austral. New
Zealand J. Med. 5: 195-197 (1975).
Hatch, G. C., Conklin, P M., Christensen, C. C., Casto, B. C., and
Nesnow, S. Synergism in the transformation ofhamster embryo cells
treated with formaldehyde and adenovirus. Environ. Mutagen. 5:
49-57 (1983).
Hatch, T. F, and Gross, P Pulmonary Deposition and Retention of
Inhaled Aerosols. Academic Press, New York, 1964, pp. 45-68.
Hawthorne, A. R., and Gammage, R. B. Formaldehyde release from
simulated wall panels insulated with urea-formaldehyde foam insula-
tion. J. Air Pollution Control Assoc. 32: 1126-1131 (1982).
Hays, S. M. Formaldehyde as a feed additive found to make cattle
grow faster. Arkansas Democrat, September 12, 1982, p. 3J.
Heck, H. D'A. Biochemical toxicology ofinhaled formaldehyde. CIIT
Activities, Chemical Industry Institute ofToxicology 2(3): 3-7 (1982).
Heck, H. D'A., and Casanova-Schmitz, M. Reactions offormaldehyde
in the rat nasal mucosa. In: Formaldehyde-Toxicology-Epidemiology-
Mechanisms (J. J. Clark, J. E. Gibson and R. S. Waritz, Eds.), Marcel
Dekker, New York, 1983, pp. 211-223.
Heck, H. D'A., and Casanova-Schmitz, M. Covalent binding of
formaldehyde with macromolecules in the rat nasal mucosa (abstract).
Toxicologist 3(1): 61 (1983).
Heck, H. D'A., and Casanova-Schmitz, M. Biochemical toxicology of
formaldehyde (in press).
Heck, H. D'A., Chin, T. Y., and Schmitz, M. C. Distribution of 14C
formaldehyde in rats after inhalation exposure. In: Formaldehyde
Toxicity, (J. E. Gibson, Ed.), Hemisphere Publishing, Washington,
DC, 1983, pp. 26-37.
Heck, H. D'A., Schmitz, M. C., and White, E. L. Disposition and
analysis of formaldehyde in F-344 rats after inhalation exposure
(abstract). Toxicologist 2(2): 158 (1982).
Heck, H. D'A., White, E. L., and Casanova-Schmitz, M. Determina-
tion offormaldehyde inbiological tissuesbygaschromatography/mass
spectrometry. Biomed. Mass Spectrometry 9: 347-353 (1982).
Helander, I. Contact urticaria from leather containing formaldehyde.
Arch. Dermatol. 113: 1443 (1977).
Heling, B., Ram, Z., and Heling, I. The root treatment ofteeth with
toxavit. Oral Surg., Oral Med., Oral Pathol. 43: 306-309 (1977).
Helmes, C. T., Atkinson, D. L., Jaffer, J., Sigman, C. C., Thompson,
K. L., Kelsey, M. I., Kraybill, H. F, and Munn, J. I. Evaluation and
classification ofthe potential cacinogenicity of organic air pollutants.
J. Environ. Sci. Health A17: 321-389 (1982).CONSENSUS WORKSHOP ON FORMALDEHYDE 371
Helwig, H. Wie ungefahrlich ist Formaldehyd? (How safe is formal-
dehyde?) Deut. Med. Wochenschr. 102: 1612- 1613 (1977).
Hemminki, K. Reactions of formaldehyde with guanosine. Toxicol.
Letters 9: 161-164 (1981).
Hemminki, K. Urinary sulfur containing metabolites after adminis-
tration of ethanol, acetaldehyde and formaldehyde to rats. Toxicol.
Letters 11: 1-6 (1982).
Hemminki, K. Carcinogen adducts excreted in urine: Experimental
studies withformaldehyde and dimethylnitrosamine. In: Prevention of
Occupational Cancer. International Symposium, Occupational Safety
and Health Series 46, International Labour Office, Geneva, Switzer-
land, 1982, pp. 459-465.
Hemminki, K., Mutanen, P., Saloniemi, I., Niemi, M-L., and Vainio,
H. Spontaneous abortions in hospital staff engaged in sterilising
instruments with chemical agents. Brit. Med. J. 285: 1461-1463
(1982).
Hendrick, D. J., and Lane, D. J. Formalin asthma in hospital staff.
Brit. Med. J. 1: 607-608 (1975).
Hendrick, D. J., and Lane, D. J. Occupational formalin asthma. Brit.
J. Ind. Med. 34: 11-18 (1977).
Hendrick, D. J., Rando, R. J., Lane, D. J., and Morris, M. J.
Formaldehyde asthma: challenge exposure levels and fate after five
years. J. Occup. Med. 24: 893-897 (1982).
Henschler, D. Zur Frage eines Karzinogenen Risikos durch Formal-
dehyd (The carcinogenic risk of formaldehyde) (abstract). Zentralbl.
Arbeitsmed. Arbeitsschutz Prophyl. 30: 53 (1980).
Herskowitz, I. H. Mutation rate in D. melanogaster males treated
with formaldehyde and 2,4-dinitrophenol (abstract). Genetics 36:
554-555 (1951).
Herskowitz, I. H. Formaldehyde-induced mutation in mature sper-
matozoa and early developmental stages ofDrosophila melanogaster
(abstract). Genetics 38: 668-669 (1953).
Hileman, B. Formaldehyde: how did EPA develop its formaldehyde
policy? Environ. Science Technol. 16: 543A-547A (1982).
Hinds, M. D. Product safety agency bans use of formaldehyde foam
insualtion. The New York Times, February 23, 1982, p. 15.
Hodgson, A. T., Geisling, K. L., Remijn, B., and Girman, J. R.
Validation of a passive sampler for determining formaldehyde in
residential indoor air. Lawrence Berkeley Laboratory, University of
California/Berkeley, Report No. LBL-14626, EEB-VENT 82-10,
Berkeley, California, 1982.
Hollowell, C. D., Berk, J. V, Lin, C.-I., and Turiel, I. Indoor air
quality in energy-efficient buidlings. Lawrence Berkeley Laboratory,
University of California! Berkeley, Report No. LBL-8892, EEB-
VENT 79-2; Berkeley, California, 1979.
Hollowell, C. D., Berk, J. V, and Traynor, G. W Impact of reduced
infiltration and ventilation on indoor air quality in residential
buildings. ASHRAE Trans. 85(Part 1): 816-827 (1979).
Hooper, K. The hazard evaluation system and information service: a
physician's resource in toxicology and occupational medicine. Western
J. Med. 137: 560-571 (1982).
Horton, A. W., Tye, R., and Stemmer, K. L. Experimental
carcinogenesis of the lung. Inhalation ofgaseous formaldehyde or an
aerosol of coal tar by C3H mice. J. Natl. Cancer Inst. 30: 31-48
(1963).
Howell, E. D., and Perkins, H. A. Anti-N-like antibodies in the sera
of patients undergoing chronic hemodialysis. Vox Sang. 23: 291-299
(1972).
Hsiao, S.-H., and Villaume, J. E. Occupational health and safety and
environmental aspects of urea-formaldehyde resins: Final Report-
April 1978, Vol. 6, Contract No. DAMD-17-77-C-7020, Science
Information Services Department, The Franklin Institute Research
Laboratories, Philadelphia, Pennsyvania, 1978.
Hsie, A. W, O'Neill, J. P, San Sebastian, J. R. S., Couch, D. B.,
Fuscoe, J. C., Sun, W N. C., Brimer, P A., Machanoff, R., Riddle, J.
C., Forbes, N. L., and Hsie, M. H. Mutagenicity ofcarcinogens: study
of 101 agents in a quantitative mammalian cell mutation system,
CHO/HGPRT (Abstract). Fed. Proc. 37: 1384 (1978).
Hurni, H., and Ohder, H. Reproduction study with formaldehyde and
hexamethylenetetramine in beagle dogs. Food Cosmet. Toxicol. 11:
459-462 (1973).
Infante, P F Documentation of excess nasal cancer among workers
exposed to formaldehyde. U.S. Department ofLabor, Memo, January
1982, to T. G. Auchter, Occupational Safety and Health Administra-
tion, Washington, D.C.
Infante, P F, Ulsamer, A. G., Groth, D., Chu, K. C., and Ward, J.
Correspondence: health hazards of formaldehyde. Lancet ii: 980-981
(1981).
Interagency Regulatory Liaison Group (IRLG). Meeting Report,
IRLF visit to CIIT, January 17-18, 1980, Research Triangle Park,
NC.
Interagency Regulatory Liaison Group (IRLG). Work group on task
assessment scientific bases for identification of potential carcinogens
and estimation of risks. J. Natl. Cancer Inst. 63: 241-268 (1979).
International Agency for Research on Cancer. Background and
purpose ofthe IARC programme on the evaluation ofthe carcinogenic
risk of chemicals to man. IARC Monograph: Some Fumigants, the
Herbicides 2,4-D and 2,4,5-T, Chlorinated Dibenzodioxins and
Miscellaneous Industrial Chemicals, Vol. 15, IARC, Lyon, France,
1977, pp. 11-25.
International Agency for Research on Cancer. Formaldehyde (gas)
(Group 2B). In: IARC Monographs on the Evaluation of the
Carcinogenic Risk of Chemicals to Humans, Supplement 4, IARC,
Lyon, France, 1982, pp. 131-132.
International Agency for Research on Cancer. Formaldehyde. In:
IARC Monographs on the Evaluation of Carcinogenic Risk of
Chemicals to Humans, Some Industrial Chemicals and Dyestuffs, Vol.
29, IARC, Lyon, France, 1982, pp. 345-389.
Irr, J. D. Mouse lumphoma L5178Y cell TK locus assay for
mutagenicity: a study of formaldehyde. Haskell Laboratory Report
No. 581-80, E. I. DuPont de Nemours Co., Haskell Laboratory for
Toxicology and Industrial Medicine, Elkton Road, Newark, Delaware,
1980.
Ishchenko, V N., and Pushkina, I. K. Evaluation of working
conditions in a plant engaged in processing phenol-formaldehyde
resins. Gig. Sanitar. 11: 98-100 (1978).
Jaeger, R. J., and Gearhart, J. M. Respiratory and metabolic
response of rats and mice to formalin vapor. Toxicology 25: 299-309
(1982).
Jensen, D. E., Lotlikar, P D., and Magee, P. N. The in vtiro
methylation of DNA by microsomally-activated dimethynitrosamine
and its correlation with formaldehyde production. Carcinogenesis 2:
349-354 (1981).
Jensen, 0. M. Correspondence: Cancer risk from formaldehyde.
Lancet ii: 480-481 (1980).
Jensen, 0. M., and Andersen, S. K. Correspondence: Lung cancer
risk from formaldehyde. Lancet i: 913 (1982).
Johansen, M., and Bundgaard, H. Kinetics of formaldehyde release
from the cosmetic preservative Germall 115. Arch. Pharmici Chemi,
Sci. Ed. 9: 117-122 (1981).
Johansson, E. B., and Tjalve, H. The distribution of 14C dimethyl-
nitrosamine in mice. Autoradiographic studies in mice with inhibited
and noninhibited dimethylnitrosamine metabolism and a comparison
with the distribution of 14C formaldehyde. Toxicol. Appl. Pharmacol.
45: 565-575 (1978).
Johnson, E. M. Screening for teratogenic potential: are we asking the
proper question? Teratology 21: 259 (1980).
Johnson, E. M., and Gabel, B. E. G. Application of the hydra assay
for rapid detection ofdevelopmental hazards. J. Am. Coll. Toxicol. 1:
57-71 (1982).
Johnson, E. M., Gorman, R. M., Gabel, B. E. G., and George, M. E.
The hydra attenuata system for detection of teratogenic hazards.
Teratog. Carcinog. Mutagen. 2: 263-276 (1982).372 CONSENSUS WORKSHOP ON FORMALDEHYDE
Jordan, W F, Sherman, W T., and King, S. E. Threshold responses in
formaldehyde-sensitive subjects. J. Am. Acad. Dermatol. 1: 44-48
(1979).
Kallos, G. J., and Solomon, R. A. Investigations of the formation of
bis-chloromethyl ether in simulated hydrogen chloride-formaldehyde
atmospheric environments. Am. Ind. Hyg. Assoc. J. 34: 469-473
(1973).
Kamchatnov, V P, and Gayazova, S. S. Temperature asymmetry in
workers exposed to fornaldehyde vapor. Hygiene and Sanitation
(USSR) 36: 286-287 (1971).
Kamei, H., Yamamoto, T., Yoshida, T., Kuroiwa, Y, Kawai, Y,
Kawai, M., Kuroiwa, S., Masahide, K., and Kaneko, Y Toxicological
studies on effects offormaldehyde on bronchial tissue. Eisei Kagaku
27: 356-362 (1981).
Kane, L. E., and Alarie, Y Sensory irritation to formaldehyde and
acrolein during single and repeated exposures in mice. Am. Ind. Hyg.
Assoc. J. 38: 509-522 (1977).
Kaplan, W D. Formaldehyde as a mutagen in Drosophila. Science
108: 43 (1948).
Kaplan, W D., and Pelc, S. R. Autoradiographic studiesofDrosophila
gonads following the feeding ofC'4 labelled formaldehyde (abstract).
Genetics 40: 578 (1955).
Karol, M. H., and Lee, K. Experimental sensitization toformaldehyde
(abstract). Toxicologist 3(1): Abstract 339 (1983).
Kato, N., Miyawaki, N., and Sakazawa, C. Formaldehyde dehydroge-
nase from formaldehyde-resistant Debaryomyces vanriji FT-1 and
Pseudomonas putida F61. Agric. Biol. Chem. 47: 415-416 (1983).
Kayser, R., Sterling, D., and Viviani, D. Intermediaprioritypollutant
guidance documents. Report ofOffice ofToxics Integration and Office
ofPesticides andlbxic Substances, Environmental ProtectionAgency,
Washington, D.C., July, 1982.
Kemp, W M. Formaldehyde report-executive summary. Oklahoma
State Department of Health, P 0. Box 53551, Oklahoma City,
Oklahoma, 1982.
Kennedy, E. R., and Hill, R. H., Jr. Determination offormaldehyde in
air as an oxazolidine derivative by capillary gas chromatography.
Anal. Chem. 54: 1739- 1742 (1982).
Kensler, C. J., and Battista, S. P Components ofcigarette smoke with
ciliary-depressant activity: theirselectiveremovalbyfilters containing
activated charcoal granules. New Engl. J. Med. 269: 1161-1166
(1963).
Kerfoot, E. J., and Mooney, T. F., Jr. Formaldehyde and parafor-
maldehyde study in funeral homes. Am. Ind. Hyg. Assoc. J. 36:
533-537 (1975).
Kerns, W D., Pavkov, K. L., Donofrio, D. J., Gralla, E. J., and
Swenberg, J. A. Carcinogenicity of formaldehyde in rats and mice
after long term inhalation exposure. Cancer Res. 43: 4382-4392
(1983).
Khishin, A. F E. The requirement ofadenylic acid for formaldehyde
mutagenesis. Mutat. Res. 1: 202-205 (1964).
Kilburn, K. H., Warshaw, R., Boylen, C. T., Balmes, J., Johnson, S.,
Seidman, B., and Deflorio, G. Ibxic effects of formaldehyde and
solventsinhistologytechnicians: apreliminaryreport.J. Histotechnol.
6: 73-76 (1983).
Kimmelman, B. B. Letter to the Editor: potential hazards of
formaldehyde. J. Am. Dental Assoc. 104: 288 (1982).
Kimmelman, B. B., and Hillman, E. E. Formaldehyde vapor in the
dentalenvironment: absenceofpotentialhazard.J. DentistryChildren
50: 55-57 (1983).
Kitchens, J. F., Casner, R. E., Edwards, G. S., Harward, W E. III,
and Macri, B. J. Investigation of selected potential environmental
contaminants: Formaldehyde. EPA Draft Report #560/2-76-009,
Washington, DC, 1979.
Kleeberg, U., and Klinger, W Sensitive formaldehyde determination
with Nash's reagent and tryptophan reaction. J. Pharmacol. Methods
8: 19-31 (1982).
Kligerman, A. D., Wilmer, J. L., and Erexson, G. L. Analyses of
cytogenetic damage in rat lymphocytes after inhalation of toxicants
(abstract). Environ. Mutagen. 5: 400 (1983).
Kline, B. S. Formaldehyd poisoning: with report of a fatal case.
Arch. Int. Med. 36: 220-228 (1925).
Knecht, U., and Woitowitz, H. J. Felduntersuchungen zur Belastung
der Raumluft durch Formaldehyd im Kliniken und Instituten (Field
investigations on the burdening of indoor-air by formaldehyde in
hospitals and institutes). Offent. Gesundh.-Wesen 41: 715-723 (1979).
Knight, B. W Healthimplications fromexposuretoureaformaldehyde
foaminsulation. CommunicableDisease Report, AlabamaDepartment
of Public Health, Bureau of Epidemiology and Consultation 14: 1-5
(1982).
Koivusalo, M., Koivula, T., and Uotila, L. Oxidation offormaldehyde
by nicotinamide nucleotide dependent dehydrogenases. In: Enzymol-
ogy ofCarbonyl Metabolism: Aldehyde Dehydrogenase and Aldo/Keto
Reductase (H. Weiner and B. Wermuth, Eds.), Alan R. Liss Inc.,
New York, 1982, pp. 155-168.
Kojima, S., Kaniwa, M.-A., and Nakamura, A. Investigations on the
underlying principles of test methods for formaldehyde release from
plywoods and furnitures (translation available). Eisei Kagaku 28:
205-218 (1982).
Konopinski, V J. Formaldehyde in office and commercial environ-
ments. Am. Ind. Hyg. Assoc. J. 44: 205-208 (1983).
Kopylova, L. S., Gleiberman, S. E., Likhtman, T. V, Semenova, T. F.,
and Alekseeva, M. I. Safety study of a method for disinfecting
artificial pulmonary ventilation apparatus with aerosols containing
formaldehyde (translation available). Anesteziol. Reanimatol. 2: 33-37
(1980).
Kornbrust, D. J., and Bus, J. S. The role of glutathione and
cytochrome P-450 in the metabolism ofmethyl chloride. Toxicol. Appl.
Pharmacol. 67: 246-256 (1983).
Kratochvil, I. Effects offormaldehyde on the health ofworkers in the
crease-resistant clothing industry (translation available). Pracovni
Lekarstvi 23: 374-375 (1971).
Kreiger, N. Letters to the Editor: Formaldehyde and nasal cancer
mortality. Can. Med. Assoc. J. 128: 248-249 (1983).
Kreiger, R. A., and Garry, V F Formaldehyde-induced cytotoxicity
and sister chromatid exchanges in human lymphocyte cultures.
Mutat. Res. 120: 51-55 (1983).
Kring, E. B., Thornley, G. D., Dessenberger, C., Lautenberger, W J.,
and Ansul, G. R. A new passive colorimetric air monitoring badge for
sampling formaldehyde in air. Am. Ind. Hyg. Assoc. J. 43: 786-795
(1982).
Krivanek, N. D., McAlack, J. W, and Chromey, N. C. Mouse skin
painting-initiation-promotion study with formaldehyde solutions,
preliminary results (abstract). Toxicologist 3(1): abstract 573 (1983).
Kuhn, M. Belastung der Raumluft durch Formaldehyd (Room air load
of formaldehyde). Swiss Chem. 4: 63-66 (1982).
Kuhn, M., and Wanner, H. U. Pollution of indoor air by materials.
Sozial. Praventivmed. 27: 260-261 (1982).
Kulle, T. J., and Cooper, G. P Effects offormaldehyde and ozone on
the trigeminal nasal sensory system. Arch. Environ. Health 30:
237-243 (1975).
Kumar, S. Effect of intravesical formalin on the urothelium. Brit. J.
Urology 51: 375-377 (1977).
Kuschner, M., Laskin, S., Drew, R. T., Cappiello, V, and Nelson, N.
Inhalation carcinogenicity of alpha halo ethers: III. Lifetime and
limited period inhalation studies with bis(chloromethyl) ether at 0.1
ppm. Arch. Environ. Health 30: 73-77 (1975).
Kwong, F, Kraske, G., Nelson, A. M., and Klaustermeyer, W B.
Acute symptoms secondary to formaldehyde exposure in a pathology
resident. Ann. Allergy 50: 326-328 (1983).
Labuc, G. E., and Archer, M. C. Esophageal and hepatic microsomal
metabolism ofN-nitroso-methylbenzylamine (NMBZA) and N-nitro-CONSENSUS WORKSHOP ON FORMALDEHYDE 373
sodimethylamine (NDMA) in the rat (abstract). Proc. Am. Assoc.
Cancer Res. 23: 79 (1982).
Lapkina, T. I., Saburova, L. M., Rozvadovskii, V D., and Shcher-
bakova, L. N. Endogenous and exogenous formaldehyde in acute
ischemia of various organs. Bull. Exper. Biol. Med. 93: 182-184
(1982).
Laskin, S., Kuschner, M., Drew, R. T., Cappiello, V R, and Nelson,
N. Tumors of the respiratory tract induced by inhalation of
bis(chloromethyl) ether. Arch. Environ. Health 23: 135-136 (1971).
Lawler, P G. Inhalation offormaldehyde vapour: a potential hazard of
a method ofsterilisation ofbacterial filters. Anaesthesia 37: 1102-1103
(1982).
Lazar, P Reactions to nail hardeners. Arch. Dermatol. 94: 446-448
(1966).
Le Botlan, D. J., Mechin, B. G., and Martin, G. J. Proton and
carbon-13 nuclear magnetic resonance spectrometry offormaldehyde
in water. Anal. Chem. 55: 587-591 (1983).
Leach, C. L., Sharma, R. R, and Oberg, S. G. Immunotoxic and
pathologic effects of inhalation of various levels of formaldehyde
vapour in F-344 rats (abstract). Toxicologist 3(1): 73 (1983).
Lebowitz, M. D. Health effects ofindoor pollutants. Ann. Rev. Publ.
Health 4: 203-221 (1983).
Lee, C. W, Fung, Y S., and Fung, K. W Determination of
formaldehyde vapour in the atmospheres ofclinical laboratories using
chromotropic acid. Analyst 107: 30-34 (1982).
Leong, B. K. J., MacFarland, H. N., and Reese, W H., Jr. Induction
of lung adenomas by chronic inhalation of bis(chloromethyl) ether.
Arch. Environ. Health 22: 663-666 (1971).
Leung, K. H., Fischer, D. G., and Koren, H. S. Erythromyeloid
tumor cells (K562) induce PgE synthesis in human peripheral blood
monocytes. J. Immunol. 131: 445-449 (1983).
Levin, D. E., Hollstein, M., Christman, M. F., Schwiers, E. A., and
Ames, B. N. A new Salmonella tester strain (TA102) with A-T base
pairs at the site of mutation detects oxidative mutagens. Proc. Natl.
Acad. Sci. (U.S.) 79: 7445-7449 (1982).
Levine, R. J. Mortality of Ontario undertakers. CIIT Activities,
Chemical Industry Institute of Toxicology 2(12): 3-5 (1982).
Levine, R. J., Corso, R. D. D., Blunden, P B., and Battigelli, M. C.
The effects ofoccupational exposure on the respiratory health ofWest
Virginia morticians. In: Formaldehyde Toxicity (J. E. Gibson, Ed.),
Hemisphere Publishing Corp., Washington, DC, 1983, pp. 212-226.
Levy, S., Nocentini, S., and Billardon, C. Induction of cytogenetic
effects in human fibroblast cultures after exposure toformaldehyde or
x-rays. Mutat. Res. 119: 309-317 (1983).
Lewin, T. Formaldehyde issue stirred by U.S. ban. The New York
Times, May 25, 1982, pp. Dl and D9.
Lewis B. B., and Chestner, S. B. Formaldehyde in dentistry: a review
of mutagnic and carinogenic potential. J. Am. Dental Assoc. 103:
429-434.
Lewis, K. J., Ward, M. K., and Kerr, D. N. S. Residual formaldehyde
in dialyzers: quantity, location, and the effect ofdifferent methods of
rinsing. Artificial Organs 5: 269-277 (1981).
Leysen, J., and Laduron, P Characterization of an enzyme yielding
formaldehyde from 5-methyltetrahydrofolic acid. FEBS Letters 47:
299-303 (1974).
Liebling, T., Roserman, K., Pastides, H., and Lemeshow, S. Cancer
mortality at a western Massachusetts chemical plant (abstract). Am.
J. Epidemiol. 116: 570 (1982).
Linkskov, R. Contact urticaria to formaldehyde. Contact Dermatitis
8: 333-334 (1982).
Lipari, F, and Swarin, S. J. Determination offormaldehyde and other
aldehydes in automobile exhaust with an improved 2,4-dinitrophenyl-
hydrazine method. J. Chromatog. 247: 298-306 (1982).
Logan, W S., and Perry, H. 0. Contact dermatitis to resin-containing
casts. Clin. Orthoped. Related Res. 90: 150-152 (1973).
Loomis, T. A. Formaldehyde toxicity Arch. Pathol. Lab. Med. 103:
321-324 (1979).
Ludwig, H. Acute formaldehyde bronchiolitis in a synthetic resin
worker. Samml. Vergiftungsfaellen 6: 277-330 (1935).
Lundberg, J. M., and Saria, A. Capsaicin-induced desensitization of
airway mucosa to cigarette smoke, mechanical and chemical irritants.
Nature 302: 251-253 (1983).
Lundqvist, K. Formaldehyd Auspaltas ej Fran Fiberskivor (Formal-
dehyde is not emitted from fiberboard). Byggmastaren 9: 18-20
(1979).
Luo, J. E., Nielsen, G. D., and Alarie, Y Formaldehyde: an exception
in the series of saturated aldehydes, aliphatic alcohols and alkyl-
benzenes (abstract). Toxicologist 3(1): 74 (1983).
Luster, M. I., and Dean, J. H. Symposium summary: immunological
hypersensitivity resulting from environmental or occupational ex-
posure to chemicals: a state-of-the-art workshop summary. Funda-
mentals Appl. Toxicol. 2: 327-330 (1982).
Lynde, C. W, andMitchell, J. C. Patchtestsresults in66hairdressers,
1973-1981. Contact Dermatitis 8: 302-307 (1982).
Lynen, R., Rothe, M., and Gallasch, E. Characterization of formal-
dehyde-related antibodies encountered in hemodialysis patients at
different stages of immunization. Vox Sang. 44: 81-89 (1983).
Ma, T. Micronuclei induced by x-rays and chemical mutagens in
meiotic pollen mother cells of Tradescantia. Mutat. Res. 64: 307-313
(1979).
Ma, T. Thradescantia micronucleus bioassay and pollen tube chromatid
aberration test for in situ monitoring and mutagen screening.
Environ. Health Perspect. 37: 85-90 (1981).
Ma, T.-H. Project summary: T'radescantia mcn-in-tetrad mutagen
test foron-site monitoring and further validation. EPA-600/Sl-81-019,
Environmental Protection Agency, Washington, DC, April 1981.
Ma, T. 7'radescantia cytogenetic tests (root-tip mitosis, pollen mitosis,
pollen mother-cell meiosis). Mutat. Res. 99: 293-302 (1982).
Ma, T. 'radescantia micronuclei (trad-mcn) test for environmental
clastogens. In: In Vitro Toxicity Testing of Environmental Agents,
Part 1 (A. Kolber, et al., Eds.), Plenum Press, New York, 1983, pp.
191-214.
Ma, T., Anderson, V A., and Ahmed, I. Environmental clastogens
detected bymeiotic pollenmothercells ofTradescantia. In: Genotoxic
Effects of Airborne Agents (R. R. Tice, D. L. Costa and K. M.
Schaich, Eds.), Plenum Press, New York, 1982, pp. 141-157.
Ma, T., Anderson, V A., and Sandhu, S. S. A preliminary study ofthe
clastogenic effects of diesel exhaust fumes using the Tradescantia
micronucleus bioassay. In: Short-Term Bioassays in the Analysis of
Complex Environmental Mixtures. II (M. Waters, S. Sandhu, J.
Huisingh, D. Claxton and S. Nesnow, Eds.), Plenum Press, New
York, 1982, pp. 351-358.
Ma, T., Kontos, G. J., Jr., and Anderson, V A. Stage sensitivity and
dose response of meiotic chromosomes of pollen mother cells of
Tradescantia to x-rays. Environ. Exptl. Bot. 20: 169-174 (1980).
Ma, T., Sparrow, A. H., Schairer, L. A., and Nauman, A. E Effect of
1,2-dibromoethane (DBE) on meiotic chromosomes of 7Tradescantia.
Mutat. Res. 58: 251-258 (1978).
Magana-Schwencke, N., and Ekert, B. Biochemical analysis of
damage induced in yeast by formaldehyde: II. Induction ofcross-links
between DNA and protein. Mutat. Res. 51: 11-19 (1978).
Magana-Schwencke, N., Ekert, B., and Moustacchi, E. Biochemical
analysis ofdamage induced in yeast by formaldehyde: I. Induction of
single-strand breaks in DNA and theirrepair. Mutat. Res. 50: 181-193
(1978).
Malorny, G., Rietbrock, N., and Schneider, M. The oxidation of
formaldehyde to formic acid in the blood. A contribution on the
metabolism of formaldehyde (translation available). Exptl. Pathol.
Pharmakol. 250: 419-436 (1963).
Malter, K. E. The man on socks: hypersensitivity for materials in374 CONSENSUS WORKSHOP ON FORMALDEHYDE
shoes and clothing. Nederl. Tijdschr. Geneeskunde 125: 649-654
(1981).
Mann, G. K., and Parida, B. B. Formalin induced sex chromosome
breakage in spermatocyte cells ofthegrasshopper, Tirstriapulvinata.
Uvarov (abstract). Indian Sci. Congr. Assoc. Proc. 53: 321 (1966).
Mantel, N., and Schneiderman, M. A. Estimating safe levels, a
hazardous undertaking. Cancer Res. 35: 1379-1386 (1975).
Marison, I. W, and Attwood, M. M. A possible alternative mechanism
for the oxidation offormaldehyde to formate. J. Gen. Microbiol. 128:
1441-1446 (1982).
Marks, T. A., Worthy, W C., and Staples, R. E. Influence of
formaldehyde and Sonacide (potentiated acid glutaraldehyde) on
embryo and fetal development in mice. Teratology 22: 51-58 (1980).
Markuson, K. E., Mancuso, T. F, and Soet, J. S. Dermatitis due to
the formaldehye resins: prevention and methods ofcontrol. Ind. Med.
12: 383-386 (1943).
Marsh, G. M. Proportional mortality patterns among chemical plant
workers exposed to formaldehyde. Brit. J. Ind. Med. 39: 313-322
(1982).
Marshall, E. EPAs high-risk carcinogen policy: the government is
changing the way it identifies dangerous chemicals, with potentially
tragic consequences, critics say. Science 218: 975-978 (1982).
Marshall, E. Revisions in cancer policy: Rita Lavelle had something to
say about cancer risk assessment, House inquiry learns. Science 220:
36-37 (1983).
Marshall, T. C., Hahn, F F., Henderson, R. F, Silbaugh, S. A., and
Wolff, R. K. Subchronic inhalation exposure of guinea pigs to
formaldehyde (CH20) (abstract). Toxicologist3(1): abstract 244 (1983).
Martin, C. N., McDermid, A. C., and Garner, R. C. Testing ofknown
carcinogens and noncarcinogens fortheirabilitytoinduceunscheduled
DNA synthesis in Hela cells. Cancer Res. 38: 2621-2627 (1978).
Martin-Amat, G., McMartin, K. E., Hayreh, S. S., Hayreh, M. S.,
and Tephly, T. R. Methanol poisoning: ocular toxicity produced by
formate. Toxicol. Appl. Pharmacol. 45: 201-208 (1978).
Marutzky, R., Mehlhorn, L., and Menzel, W Reducing the formal-
dehyde emission from furniture. Holz als Roh- und Werkstoff39: 7-10
(1981).
Marzulli, F N., and Maibach, H. I. Contact allery: predictive testing
in humans. In: Advances in Modern Toxicology, Vol. 4, Dermato-
toxicology and Pharmacology (F N. Marzulli and H. I. Maibach,
Eds.), Hemisphere Publishing, Washington, DC, 1977, pp. 353-372.
Marzulli, F N., and Maibach, H. I. Antimicrobials: experimental
contact sensitization in man. J. Soc. Cosmet. Chem. 24: 399-421
(1973).
Marzulli, F N., and Maibach, H. I. The use ofgraded concentrations
in studying skin sensitizers: experimental contact sensitization in
man. Food Cosmet. Toxicol. 12: 219-227 (1974).
Mashford, P M., and Jones, A. R. Formaldehyde metabolism by the
rat: a re-appraisal. Xenobiotica. 12: 119-124 (1982).
Masilungan, A. O., Gerry, R. T., Kamatari, O., and Bakker, J. CEH
Report Abstract Formaldehyde. Chemical Industry Division News-
letter, SRI International, Menlo Park, California, January-February,
1983, pp. 6-7.
Mathis, J. F An industrial scientist's perspective on scientific peer
review. Fundamentals Appl. Toxicol. 2: 280-282 (1982).
Matthews, T. G. Evaluation of a modified CEA Instruments, Inc.
Model 555 analyzer for the monitoring of formaldehyde vapor in
domestic environments. Am. Ind. Hyg. Assoc. J. 43: 547-552 (1982).
Matthews, T. G., Hawthorne, A. R., Howell, T. C., Metcalfe, C. E.,
and Gammage, R. B. Evaluation of selected monitoring methods for
formaldehyde in domestic environments. Environ. International (in
press).
Matthews, T. G., Hawthorne, A. R., Schrimsher, J. M., Corey, M. D.,
and Daffron, C. R. Formaldehyde surface emission monitor. Pro-
ceedings, Environmental Protection Agency National Symposium on
Recent Advances in Pollutant Monitoring of Ambient Air and
Stationary Sources, Raleigh, NC, May 4-7, 1982 (in press).
Matthews, T. G., and Howell, T. C. Visual colorimetric formaldehyde
screening analysis for indoor air. J. Air Pollution Control Assoc. 31:
1181-1184 (1981).
Matthews, T. G., and Howell, T. C. Solid sorbent for formaldehyde
monitoring. Anal. Chem. 54: 1495-1498 (1982).
Mattia, M. A. Hazards in the hospital environment. The sterilants:
ethylene oxide and formaldehyde. Am. J. Nurs. 83: 240-243 (1983).
McCann, J., Choi, E., Yamasaki, E., and Ames, B. N. Detection of
carcinogens as mutagens in the Salmonella/microsome test: assay of
300 chemicals. Proc. Natl. Acad. Sci. (U.S.) 72: 5135-5139 (1975).
McNulty, M. J., Casanova-Schmitz, M., and Heck, H. D'A. Metabo-
lism of dimethylamine to formaldehyde in the rat nasal mucosa
(abstract). Toxicologist 2(2): abstract 275 (1982).
Meadows, G., and Rusch, G. M. The measuring and monitoring of
formaldehyde in inhalation test atmospheres. Am. Ind. Hyg. Assoc.
J. 44: 71-77 (1983).
Mecke, P, Keller, R., Schumacher, G., and Beckert, J. ZurBedeutung
von Gasruckstanden bei der Formaldehyd-sterilization (Significance
of gas traces in formaldehyde sterilization). Forum Staedte-Hygiene
33: 120-123 (1982).
Medford, R. L. Decision briefing package on urea-formaldehyde foam
insulation. Office ofProgram Management, Consumer Product Safety
Commission, Washington, DC, February, 1982.
Melekos, M., and Lalos, J. Letters to the Editor: Intravesical
instillation of formalin and its complications. Urology 21: 331-332
(1983).
Merimsky, E., Blum, M., and Aviram, A. Tubular necrosis compli-
cating intravesical formaldehyde treatment. Intern. Surg. 67: 504-505
(1982).
Merkur'eva, R. V, and Tsapkova, N. N. Hygienic significance of a
system of biochemical criteria for the evaluation of hepatotoxic and
neurotoxic effects of some chemical factors in the environment. J.
Hyg. Epidem. Microbiol. Immunol. 26: 336-341 (1982).
Meyer, B., and Carlson, N. L. Formaldehyde emission from particle
board post-cured by radio frequency heating. Holzforschung 37:
41-45 (1983).
Meyer, B., Koshlp, K., Geisling, K. L., and Micksch, R. R.
Comparison ofwet and dry desiccator test methods for formaldehyde
emission from UF-bonded wood products. Forest Prod. J. 33: 35-37
(1983).
Miksch, R. R., Anthon, D. W, Fanning, L. Z., Hollowell, C. D.,
Revzan, K., and Glanville, J. Modified pararosaniline method for the
determination of formaldehyde in air. Anal. Chem. 53: 2118-2123
(1981).
Miller, S. Risks: how to get more science in assessments. Environ.
Sci. Technol. 17: 199A-200A (1983).
Miller, W H. Dynamical effects of symmetry along a reaction path:
mode specificity in the unimolecular dissociation of formaldehyde. J.
Am. Chem. Soc. 105: 216-220 (1983).
Miretskaya, L. V, and Shvartsman, P Y Study of chromosomal
aberrations in human lymphocytes under the influence of formal-
dehyde. I. Formaldehyde treatment of lymphocytes in vitro. Tsitolo-
giya 24: 1056-1060 (1982).
Moerman, D. G., and Baillie, D. L. Formaldehyde mutagenesis in the
nematode: Caenorhabditis elegans. Mutat. Res. 80: 273-279 (1981).
Molhave, L. Therelation betweenthefreeformaldehyde concentration
in stored (urea-formaldehyde) chipboard, and the formaldehyde
concentration in the air. Holzforsch. Holzverwert. 29: 73-74 (1977).
Montgomery, S. Paresthesia following endodontic treatment. J.
Endodontics 2: 345-347 (1976).
Morgan, K. T., Patterson, D. L., and Gross, E. A. Formaldehyde and
the nasal mucociliary apparatus. In: Formaldehyde: Toxicology,
Epidermiology, Mechanisms (J. J. Clary, J. E. Gibson and R. S.
Waritz, Eds.), Marcel Dekker Inc., New York, 1983, pp. 193-209.CONSENSUS WORKSHOP ON FORMALDEHYDE 375
Morgan, K. T., Patterson, D. L., and Gross, E. A. Frog palate
mucociliary apparatus: Structure, function, and response to formal-
dehyde gas. Fundamentals Appl. Toxicol. 4: 58-68 (1984).
Morin, N. C., and Kubinski, H. Potential toxicity ofmaterials used for
home insulation. Ecotoxicol. Environ. Safety 2: 133-141 (1978).
Morrill, E. E., Jr. Formaldehyde exposure from paper process solved
by air sampling and current studies. Air Cond., Heat. Vent. 58: 94-95
(1961).
Moss, E., and Lee, W R. Occurrence oforal and pharyngeal cancers
in textile workers. Brit. J. Ind. Med. 31: 224-232 (1974).
Mudakavi, J. R., and Ravindram, M. Spectrophotometric determina-
tion oftraces offormaldehyde with ,3-naphtol. Current Sci. 51: 39-41
(1982).
Muller, R, Raabe, G., and Schumann, D. Leukoplakia induced by
repeated deposition of formalin in rabbit oral mucosa; long term
experiments with a new oral tank. Exptl. Pathol. 16: 36-42 (1978).
Muller, R. E., and Schurath, U. Generation of formaldehyde in test
atmospheres with low concentrations of hydrogen and carbon
monoxide. Anal. Chem. 55: 1440-1442 (1983).
Musher, D. M., and Griffith, D. P Generation of formaldehyde from
methenamine: effect of pH and concentration, and antibacterial
effect. Antimicro. Agents Chemother. 6: 708-711 (1974).
Myers, D. R., Pashley, D. H., Whitford, G. M., and McKinney, R. V
Tissue changes induced by the absorption of formocresol from
pulpotomy sites in dogs. Pediatric Dent. 5: 6-8 (1983).
Myers, G. E., and Nagaoka, M. Formaldehyde emission: methods of
measurement and effect of several particleboard varibles. Wood Sci.
13: 140-150 (1981).
Nagao, T., Ozawa, A., and Sasaki, S. Maintenance of germ-free
environment and its clinicalutility. Japan. J. Clin. Oncol. 13(Suppl. 1):
103-110 (1983).
Nagornyi, P Hygenic evaluation of working conditions and health
status ofworkers inthe production ofphenol-formaldehyde polymers.
Gig. Truda, Respubl. Mezhvedom. Sborn. 13: 48-52 (1977).
Nagornyi, P A., Sudakova, Zh. A., and Shchablenko, S. M. General
toxic and allergic effects offormaldehyde. Gig. Truda Profess. Zabol.
1: 27-30 (1979).
Nahata, M. C., Cummins, B. A., McLeod, D. C., and Butler, R.
Predictability of methenamine efficacy based on type of urinary
pathogen and pH. J. Am. Geriat. Soc. 29: 236-239 (1981).
Nantel, A. J., Tolszczuk, M., Weber, J. P, Guillot, J. G., and Landry,
B. The health problem related to urea-formaldehyde foam insulation
of public schools in the province of Quebec (Abstract). Vet. Human
Toxicol. 24: 19 (1982).
Nantel, A. J., Tolszczuk, M., Weber, J. P Guillot, J. G., and Tat-Ha,
C. Health problems related to houses insulated with urea-formal-
dehyde foam insulation in the province of Quebec (Abstract). Vet.
Human Tbxicol. 24: 19 (1982).
National Cancer Advisory Board. General criteria for assessing the
evidence for carcinogenicity of chemical substances: Report of the
Subcommittee on Environmental Carcinogenesis. National Cancer
Advisory Board. J. Natl. Cancer Inst. 58: 461-465 (1977).
NIOSH. Health Hazard Evaluation Report, HHE 80-181-909, Ralston
Purina Co., Cincinnati, OH. NTIS PB82-25828 6, 1981, pp. 1-9.
NIOSH. Health Hazard Evaluation Report, HETA 81-141-892,
McKeesport Hospital, McKeesport, PA, June 1981. NTIS PB82-25845
0, pp. 1-10.
NIOSH. Health Hazard Evaluation Report, HETA 81-084-917,
Kutztown State College, Kutztown, PA, July 1981. NTIS PB83-10280
6.
NIOSH. Health Hazard Evaluation Report, HETA 81-002-875,
Atlanta Jewish Federation, Atlanta, GA. NTIS PB83-10444, May
1981.
NIOSH. Health Hazard Evaluation Report, HETA 81-098-941,
Lab-Crest Scientific Glass Co., Subsidiary of Fischer & Porter Co.,
Warminster, PA, August 1981. NTIS PB83-12645 8, pp. 1-7.
NIOSH. Health Hazard Evaluation Report, TQ 80-118-928, Dept. of
Transportation, Augusta, ME, July 1980. NTIS PB83-102855.
NIOSH. Report: Formaldehyde: evidence of carcinogenicity. NIOSH
Current Intelligence Bulletin 34, Cincinnati, Ohio, April 1981.
NIOSH. Report: Formaldehyde exposures in dialysis units. Dialysis
and Transplantation 12: 43-44 (1983).
NIOSH Center for Disease Control (CDC). Formaldehyde exposures
in a gross anatomy laboratory. Colorado Morbidity and Mortality
Weekly Report 31: 698-700 (1983).
NIOSH. Formaldehyde: evidence of carcinogenicity. NIOSH/OSHA
Current Intelligence Bulletin 34, Cincinnati, Ohio, December, 1980.
National Research Council, Committee on Tbxicology. Formaldehyde-
an assessment of its health effects/prepared for the Consumer
Product Safety Commission bythe Committee onToxicology. National
Academy of Sciences, Washington, DC, March, 1980.
Natvig, H., Andersen, J., and Rasmussen, E. W A contribution to
thetoxicologicalevaluation ofhexamethylenetetramine. FoodCosmet.
Toxicol. 9: 491-500 (1971).
Neely, W B. Themetabolicfateofformaldehyde-14C intraperitoneally
administered to the rat. Biochem. Pharmacol. 13: 1137-1142 (1964).
Nestler, F H. M. Theformaldehyde probleminwood-basedproducts
an annotated bibliography. U.S. Department of Agriculture, Forest
Service, USDA Forest Service General Technical Report FPL-8,
Forest Products Laboratory, Madison, Wisconsin, 1977.
Nethercott, J. R., Albers, J., Guirguis, S., Ching, G., Hofstader, S.
and From, L. Erythema multiforme exudativum linked to the
manufacture ofprinted circuit boards. Contact Dermatitis 8: 314-322
(1982).
Newhouse, M. T. Letter to the Editor: UFFI dust: nonspecific
irritant only? Chest 82: 511 (1982).
Newmann, J. Reuse of dialyzers. NAPHT News, National Assoc. of
Patients on Hemodialysis and Transplantation, Inc., 156 William St.,
New York, New York, May 1982, pp. 1-4.
Niemela, R., and Vainio, H. Formaldehyde exposure in work and the
general environment. Scand. J. Work, Environ. Health 7: 95-100
(1981).
Nikiforov, B., Balabaeve, L., and Kazakova, B. Effect offormaldehyde
on liver function of albino rats with chronic toxic hepatitis. Gig.
Sanitar. 9: 73-74 (1980).
Nioshioka, H. Lethal andmutagenic actionofformaldehyde in HCR +
and HCR- strains ofEscherichia coli. Mutat. Res. 17: 261-265 (1973).
North American Contact Dermatitis Group. Epidemiology ofcontact
dermatitis in North America: 1972. Archiv. Dermatol. 108: 537-540
(1973).
North Carolina Dept. of Human Resources, Environmental Health
Section. The North Carolina Tbxic Substances Management Guide.
Formaldehyde, Environmental Health Section, Raleigh, NC, 1981.
Nova, M. M. H., andTouraine, R. G. Asthmaauformol (Asthma from
formaldehyde). Soc. Med. Trav. 17: 293-294 (1956).
Obe, G., and Beek, B. Mutagenic activity ofaldehydes. Drug Alcohol
Dependence 4: 91-94 (1979).
Odom, R. G., and Maibach, H. I. contact urticaria: a different contact
dermatitis. In: Advances in Modern Tbxicology, Vol. 4, Dermato-
toxicology and Pharmacology (F N. Marzulli and H. I. Maibach,
Eds.), Hemisphere Publishing, Washington, DC, 1977, pp. 441-452.
Ogden, D. A., Myers, L. E., Eskelson, C. D., and Ziegler, E. J.
latrogenic administration of formaldehyde to hemodialysis patients.
Trans. Dialysis Transplant Forum, 141-146 (1973).
Oldham, J. D., Hart, I. C., and Bines, J. A. Formaldehyde-treated
proteins for dairy cows-effects on blood hormone concentrations.
Brit. J. Nutr. 48: 543-547 (1982).
Ols0n, J. H., and D0ssing, M. Formaldehyde induced symptoms in
day care centers. Am. Ind. Hyg. Assoc. J. 43: 366-370 (1982).
O'Quinn, S. E., and Kennedy, C. B. Contact dermatitis due to
formaldehyde in clothing textiles. J. Am. Med. Assoc. 194: 123-126
(1965).376 CONSENSUS WORKSHOP ON FORMALDEHYDE
Orringer, E. P, and Mattern, W D. Formaldehyde-induced hemolysis
during chronic hemodialysis. New Engl. J. Med. 294: 1416-1420
(1976).
OSHA. General Industry. OSHA Safety and Health Standards (29
CFR Part 1910). Occupational Safety and Health Administration, US
Government Printing Office, RevisedJanuary 1976, pp. 504-505, 509.
Osterloh, J., Kaysen, G., and Becker, C. E. Handling formalin in
dialysis units. Dialysis Transplantation 12: 353-361 (1983).
Palese, M., and Tephly, T. R. Metabolism of formate in the rat. J.
Toxicol. Environ. Health 1: 13-24 (1975).
Paliard, F., Roche, L., Exbrayat, P, and Sprunck, H. Chronic asthma
due toformaldehyde. Bull. Offic. Soc. Travail Lyon 10: 528-530 (1949).
Parkinson, D. K. Scientific objectivity: a labor perspective. Food
Appl. Toxicol. 2: 278-279 (1982).
Partanen, T., Kauppinen, T., Nurminen, M., Jickels, J., Hernberg,
S., and Thiel, K. Formaldehyde exposure and risk of respiratory
cancer: an epidemiologic study plotocol. Institute of Occupational
Health, Helsinki, Finland, November 1982.
Pattison, E. M. Is there a formaldehyde-disulfiram reaction? J.
Studies Alcohol 43: 1257-1259 (1982).
Pereira, M. A., Chang, L. WV, McMillan, L., Ward, J. B., and
Legator, M. S. Battery of short-term tests in laboratory animals to
corroborate the detection ofhuman population exposures to genotoxic
chemicals (abstract). Environ. Mutagen. 4: 317 (1982).
Perera, F., and Petito, C. Formaldehyde: a question of cancer policy
Science 216: 1285-1291 (1982).
Pertosovskii, A. L., Charnikova, G. A., Kremko, L. M., and Sidenko,
A. T. Chromatographic determination ofdicyandiamide formaldehyde
resin aerosol in the air ofthe workplace on the skin ofworkers and on
work clothing (translation available). Gig. Truda Profess. Zabol. 12:
57-58 (1982).
Petersen, N. J., Carson, L. A., Doto, I. L., Aguero, S. M., and
Favero, M. S. Microbiologic evaluation ofa new glutaraldehyde-based
disinfectant for hemodialysis systems. Trans. Am. Soc. Artificial
Internal Organs 28: 287-290 (1982).
Peto, R. Carcinogenic effects ofchronic exposure to very low levels of
toxic substances. Environ. Health Perspect. 22: 155-159 (1978).
Pirila, V, and Kilpio, 0. On dermatitis caused by formaldehyde and
its compounds. Ann. Med. Intern. Fenn. 38: 38-51 (1949).
Pisati, G., Brini, D., and Cirla, A. H. Alergia alla formaleide in una
fabbrica di resine sinthetiche (Formaldehyde allergy in a synthetic
resin factory). Med. Lavoro 1: 88-91 (1980).
Place, A. R., Benyajati, C., and Sofer, W Themolecularconsequences
of formaldehyde and ethyl methanesulfonate mutagenesis in Droso-
phila: analysis of mutants in the alcohol dehydrogenase gene. In:
Methods in Protein Sequence Analysis (M. Elzinga, Ed.), Humana
Press, Clifton, NJ, 1982, pp. 373-379.
Plesner, B. H., and Hansen, K. Formaldehyde and hexamethylene-
tetramine in Styles' cell transformation assay. Carcinogenesis 4:
457-459 (1983).
Plunkett, E. R., andBarbela, T. SummaryReport... Areembalmer's
at risk. Am. Ind. hyg. Assoc. J. 38: 61-62 (1977).
Polakoff, P L. Odor pollution: don't deny what the nose knows (odors
in the workplace can irritate, envigorate, and even warn us of
impending danger). Occupational Health Safety 52: 26-28 (1983).
Popa, V, Teculescu, D., Stanescu, D., and Gavrilescu, N. Bronchial
asthma and asthmatic bronchitis determined by simple chemicals.
Dis. Chest 56: 395-404 (1969).
Porter, J. A. H. Correspondence: acute respiratory distress following
formalin inhalation. Lancet i: 603-604 (1975).
Poverenny, A. M., Siomin, Y A., Saenko, A. S., and Sinzinis, B. I.
Possible mechanisms oflethal and mutagenic action offormaldehyde.
Mutat. Res. 27: 123-126 (1975).
Prasad, T. R., Ram, B. S., and Rao, T. N. Potentiometric study ofthe
kinetics of oxidation of formaldehyde, acetaldehyde propionaldehyde
and n-butyraldehyde by ammonical silver nitrate. Current Sci. 52:
749-751 (1982).
Prokopenko, Yu. I., Il'in, V P, and Zhurkov, V S. Effect oflong-wave
ultraviolet irradiation on mutagenic and embryotoxic effects of
chemical substances in an experiment. Gig. Sanitar. 7: 12-15 (1981).
Protasova, I. A., Semin, Y. A., Alder, V V, and Poverennyi, A. M.
Influence offormaldehyde and products ofits interaction with amines
on processes ofDNA transcription in vitro. Biochemistry (USSR) 47:
1509-1515 (1982).
Pruett, J. J. Scheuenstuhl, H., Michaeli, D., and Nevo, Z. The
incorporation and localization of aldehydes (highly reactive cigarette
smoke components) into cellular fractions of cultured human lung
cells. Arch. Environ. Health 35: 15-20 (1980).
Pushkina, N., Gofmekler, V A., and Klevtsova, G. N. Changes in
content of ascorbic acid and nucleic acids produced by benzene and
formaldehyde. Bull. Exptl. Biol. Med. 66: 868-869 (1968).
Ragan, D. L., and Boreiko, C. J. Initiation of C3H/1OT1/2 cell
transformation by formaldehyde. Cancer Lett. 13: 325-331 (1981).
Ranly, D. M., and Fulton, R. An autoradiographic study of the
response of rat molar pulp to formocresol using 3H-thymidine.
Pediactric Dent. 5: 20-24 (1983).
Rapoport, I. A. Mutations under the influence of unsaturated
aldehydes. Doklady Akad. Nauk SSSR 61: 713-715 (1948); Chem.
Abstr. 43: 1115-1116 (1949).
Re, M. R., and Crovato, E. Esposizione a formaldeide: valore e
significato della progettazione statistica I-II guidizio di rispetto dello
standard (Exposure to formaldehyde: value and significance of
statistical projections. I-The evaluation under consideration of the
standard. Ann. Inst. Super. Sanita 17: 511-514 (1981).
Rea, W J., Peters, D. W, Smiley, R. E., Edgar, R., Greenberg, M.,
and Fenyves, E., Recurrent environmentally triggered thrombo-
phlebitis: a five year follow up. Ann. Allergy 47: 338-344 (1981).
Richter, G. Testing formaldehyde and mercury (II) chloride in
petrolatum. Dermatol. Monatsschr. 168: 49-50 (1982).
Roffael, E., Miertzsch, H., and Menzel, W Nachtragliche Behandlung
von Spanplatten zur Verminderung ihers Formaldehydabgabepoten-
tials (Supplemental treatment of particleboards for the reduction of
their potential for emitting formaldehyde). Adhasion 3: 18-23 (1982).
Rooke, J. A., Brookes, I. M., and Armstrong, D. G. The digestion of
untreated and formaldehyde-treated soya-bean and rapeseed mealsby
cattle fed a basal silage diet. J. Agr. Sci. (Cambridge) 100:329-342
(1983).
Rosenkranz, H. S. Formaldehyde as a possible carcinogen. Bull.
Environ. Contam. Toxicol. 8: 242-244 (1972).
Ross, W E., and Shipley, N. Relationship between DNA damage and
survival informaldehyde-treated mouse cells. Mutat. Res. 79: 277-283
(1980).
Ross, W E., McMillan, D. R., and Ross, C. F. Comparison of DNA
damage bymethylmelamines and formaldehyde. J. Natl. Cancer Inst.
67: 217-221 (1981).
Rostenberg, A., Bairstow, B., and Luther, T. W Astudyofeczematous
sensitivity to formaldehyde. J. Invest. Dermatol. 19: 459-462 (1952).
Rudzki, E., and Schubert, H. Contact eczema incidence in the
German Democratic Republic and the People's Republic ofPoland-a
comparison. II. Skin diseases from rubber and other occupational
contactants. Dermatol. Monatsschr. 167: 665-671 (1981).
Ruempling, D. R., Morton, T. H., Jr., and Anderson, M. W
Electrosurgical pulpotomy in primates-a comparison with formo-
cresol pulpotomy. Pediatric Dent. 5: 14-18 (1983).
Rumack, B. H. Position paper: urea-formaldehyde foam. Rocky
Mountain Poison Center, Denver, Colorado, November, 1978.
Rusch, G. M., Clary, J. J., Rinehart, W E., and Bolte, H. F. a
26-week inhalation toxicity study with formaldehyde in the monkey,
rat, and hamster. Toxicol. Appl. Pharmacol. 68: 329-343 (1983).
Rusch, G. M., Clary, J. J., Rinehart, W E., and Bolte, H. F. ACONSENSUS WORKSHOP ON FORMALDEHYDE 377
26-week inhalation toxicity study with formaldehyde in the monkey,
rat and hamster (Abstract). The Toxicologist 3(1), abstract #291
(1983).
Rycroft, R. J. G. Contact sensitization to 2-monomethylolyphenol in
phenol formaldehyde resin as an example of the recognition and
prevention of industrial dermatoses. Clin. Exper. Dermatol. 7:
285-290 (1982).
Sakula, A. Correspondence: formalin asthma in hospital laboratory
staff. Lancet ii: 816 (1975).
Saladino, A. J., Willey, J. C., Lechner, J. F, and Harris, C. C.
Altered human respiratory epithelial cell growth patterns induced by
aldehydes and peroxides in vitro (abstract). Fed. Proc. 42: 513 (1983).
Salem, H., and Cullumbine, H. Inhalation toxicities of some
aldehydes. Tbxicol. Appl. Pharmacol. 2: 183-187 (1960).
Sandler, S. G., Sharon, R., Bush, M., Stroup, M., and Sabo, B.
Formaldehyde-related antibodiesinhemodialysispatients. Iransfusion
19: 682-687 (1979).
Sankaranarayanan, K. Determination and evaluation ofgenetic risks
to humans from exposure to chemicals. Progr. Mutat. Res. 3: 289-321
(1982).
Sanotskii, I. V, Fomenko, V N., Sheveleva, G. A., Sal'nikova, L. S.,
Nakoryakova, M. V, and Pavlova, T. Y Study of the effect of
pregnancy onthe sensitivity ofanimals tochemicalagents. Gig. TIruda
Profess. Zabol. 1: 25-28 (1976).
Sardinas, A. V, Most, R. S., Guilietti, M. A., and Honchar, P Health
effects associated with urea-formaldehyde foam insulation in Connec-
ticut. J. Environ. Health 41: 270-272 (1979).
Sargenti, A. Letter to the Editor: Potential hazards offormaldehyde.
J. Am. Dent. Assoc. 104: 288 (1982).
Savolainen, H. Neurotoxicityofindustrialchemicalsandcontaminants:
aspects of biochemical mechanisms and effects. New toxicology for
old. Arch. Tbxicol. 5: 71-83 (1982).
Savolainen, H. Dose-dependent effects ofperoral dimethylformamide
administration on rat brain. Acta Neuropathol. 53: 249-252 (1981).
Savolainen, H., and Zitting, A. Glial cell effects of subacute formic
acid vapour exposure. Acta Pharmacol. Toxicol. 47: 239-240 (1980).
Schoenberg, J. B., and Mitchell, C. A. airway disease caused by
phenolic (phenol-formaldehyde) resin exposure. Arch. Environ.
Health 30: 574-577 (1975).
Schorr, W F Allergic skin reactions from cosmetic preservatives.
American Perfumer Cosmetics 85: 39-47 (1970).
Schreiber, H., Bibbo, M., Weid, G. L., Saccomanno, G., and
Nettesheim, P Bronchial metaplasia as a benign or premalignant
lesion. Acta Cytol. 23: 496-503 (1979).
Schubert, H., and Agatha, G. Zur Allergennatur der para-tert.
Butyl-phenolformaldehydharze (The allergenic nature of para-tert-
butylphenolformaldehyde resins). Dermatosen 27: 49-52 (1979).
Schuck, E. A., Stephens, E. R., and Middleton, J. T. Eye irritation
response at low concentrations ofirritants. Arch. Environ. Health 13:
570-575 (1966).
Schutte, W C., Cole, R. S., Long, K. R., and Frank, C. W
Formaldehyde levels in homes insulated with urea-formaldehyde
foam. Environ. Monitoring Assessment 1: 257-261 (1982).
Sejersted, 0. M., Jacobsen, D., Ovrebo, S., andJansen, H. Formate
concentrations in plasma from patients poisoned with methanol. Acta
Med. Scand. 213: 105-110 (1983).
Sellakumar, A. R., Albert, R. E., Rusch, G. M., Katz, G. V, Nelson,
N. and Kuschner, M. Inhalation carcinogenicity offormaldehyde and
hydrogen chloride in rats (abstract). Proc. Am. Assoc. Cancer Res.
21: 106 (1980).
Sellakumar, A. R., Laskin, S., Kuschner, M., Rusch, G., Katz, G. V,
Snyder, C. A., and Albert, R. E. Inhalation carcinogenesis by
dimethylcarbamoyl chloride in Syrian golden hamsters. J. Environ.
Pathol. Toxicol. 4: 107-115 (1980).
Sentein, P Action of glutaraldehyde and formaldehyde on segmen-
tation mitoses. Exptl. Cell Res. 95: 233-246 (1975).
Septon, J. C., and Ku,J. C. Workplace airsamplingandpolarographic
determination offormaldehyde. Am. Ind. Hyg. Assoc. J. 43: 845-852
(1982).
Shafaiziev, U. Yu., and Shipovskikh, G. P Working conditions of
health of workers employed in processing of plastic resins in
Uzbekistan (abstract). Referat. Zhur. Khim. Abstract 181420 (1972).
Shaldon, S., Chevallet, M., Maraoui, M., and Mion, C. Dialysis
associated auto-antibodies. Proc. Dialysis Transplant Assoc. 13:
339-346 (1976).
Shapiro, J. L. Letters: Carcinogen policy at EPA. Science 219: 798
(1983).
Sheldrick,J. E., andSteadman, T. R. Finalreportonproduct/industry
profile and related analysis for formaldehyde and formaldehyde-
containing consumer products: Parts I, II, III. Consumer Product
Safety Commission, CPSC-C-78-0091 Task 9, Subtask 9.01, revised
February 5, 1979, Washington, D. C.
Shelley, W B. Immediate sunburn-like reaction in a patient with
formaldehyde photosensitivity. Arch. Dermatol. 118: 117-118 (1982).
Shellow, H., and Altman, A. T. Dermatitis from formaldehyde resin
textiles. Arch. Dermatol. 94: 799-801 (1966).
Sheveleva, G. A. Investigation of the specific effect of formaldehyde
on the embryogenesis and progeny of white rats. Tbksikol. Novykh
Prom. Kim. Veshch. 12: 78-86 (1971).
Shiba, M., Marchok, A. C., and Klein-Szanto, A. J. P An open-ended
rat tracheal implant model: toxic effects of formaldehyde on the
respiratory epithelium. Toxicol. Letters 16: 241-248 (1983).
Shumilina, A. V Menstrual and reproductive functions in workers
with occupational exposure to formaldehyde. Gig. Truda Profess.
Zabol. 12: 18-21 (1975).
Siegel, D. M., Frankos, V H., Schneiderman, M. A. Formaldehyde
risk assessment for occupationally exposed workers. 3rd Annual
Meeting of the American College of Toxicology, December 10, 1982,
abstract #117, Washington, D. C.
Sim, V M., and Pattle, R. E. Effect of possible smog irritants on
human subjects. J. Am. Med. Assoc. 165: 1908-1913 (1957).
Singh, H. B., Salas, L. J., and Stiles, R. E. Distribution of selected
gaseous organic mutagens and suspect carcinogens in ambient air.
Environ. Sci. Technol. 16: 872-880 (1982).
Skiest, E. N. Technical efforts of the formaldehyde institute-an
overview-14th Symposium on Particleboard, Washington State
University, Pullman, Washington, 1980, pp. 137-144.
Skog, E. A toxicological investigation oflower aliphatic aldehydes. I.
Toxicity offormaldehyde, acetaldehyde, propionaldehyde and butyral-
dehyde; as well as ofacrolein and crotonaldehyde. Acta Pharmacol. 6:
299-318 (1950).
Skvortsova, R. I., Poznyakoevskii, V M., and Rudakov, S. A. State of
some metabolic functions in workers manufacturing phenol-formal-
dehyde resins. Gig. Sanitar. 8: 69-71 (1980).
Slizynska, H. Cytological analysis of formaldehyde induced chromo-
somal changes in Drosophila melanogaster. Proc. Royal Soc.
Edinburgh B66: 288-304 (1957).
Smith, D. L., Bolyard, M., and Kennedy, E. R. Instability of
formaldehyde air samples collected on a solid sorbent. Am. Ind. Hyg.
Assoc. J. 44: 97-99 (1983).
Smith, R. G., Bryan, R. J., Feldstein, M., Levadie, B., Miller, F A.,
Stephens, E. R., and White, N. G. Tentative method of analysis for
formaldehyde content of the atmosphere (colorimetric method).
Health Lab. Sci. 7 (Suppl.): 87-91 (1970).
Smyth, H. F., Seaton, J., and Fischer, L. The single dose toxicity of
someglycols andderivatives. J. Ind. Hyg. Toxicol. 23: 259-268 (1941).
Sneddon, I. B. Letters to the Editor: dermatitis in an intermittent
haemodialysis unit. Brit. Med. J. 1: 183-184 (1968).378 CONSENSUS WORKSHOP ON FORMALDEHYDE
Snyder, R. D., and Smith, P D. Mutagen sensitivity of Drosophila
melanogaster V Identification of second chromosomal mutagen
sensitive strains. Molecular Gen. Genet. 188: 249-255 (1982).
Sobels, F. H. Organic peroxides and mutagenic effects in Drosophila.
Nature 177: 979-980 (1956).
Spassowski, M. Estimation offormaldehyde in the urine ofworkers as
an indication of the hygiene of their working conditions (abstract).
Bull. Hyg. (London) 40: 807-808 (1965).
Spellman, G. G. Formaldehyde poisoning successfully treated with
hemodialysis. J. Iowa Med. Soc. 73: 175-176 (1983).
Spengler, J. D., and Sexton, K. Indoor air pollution: a public health
perspective. Science 221: 9-17 (1983).
Starr, T. B. Mechanisms offormaldehyde toxicity and risk evaluation.
In: Formaldehyde: Ibxicology, Epidemiology, Mechanisms (J. J. Clary,
J. E. Gibson and R. S. Waritz, Eds.), Marcel Dekker Inc., New York,
1983, pp. 237-258.
Storrs, E J., and Bell, D. E. allergic contact dermatitis to 2-bromo-
2-nitropropane-1,3-diol in a hydrophilic ointment. J. Am. Acad.
Dermatol. 8: 157-170 (1983).
Strittmatter, R, and Ball, E. G. Formaldehyde dehydrogenase, a
glutathione-dependent enzyme system. J. Biol. Chem. 213: 455-461
(1955).
Stupfel, M. Recent advances in investigation oftoxicity ofautomotive
exhaust. Environ. Health Perspect. 17: 253-285 (1976).
Sulaiman, S. T., and Amin, D. Indirect amplification method for
determining formaldehyde and chloralhydrate by differential pulse
polarography. Microchem. J. 28: 168-173 (1983).
Sun, M. Study shows formaldehyde is carcinogenic. Science 213: 1232
(1981).
Sun, M. OSHAs newthoughts on cancerpolicy. Science 217: 35 (1982).
Sun, M. A firing over formaldehyde. Science 213: 630-631 (1981).
Sun, M. Formaldehyde ban is overturned. Science 220: 699 (1983).
Sundin, B. Formaldehyde emission from particleboard and other
buildingmaterials: astudyfromthe Scandinavian countries. Washing-
ton State University, 12th Symposium on Particleboard, 12: 251-273
(1978).
Suskov, I. I., and Sazonova, L. A. Mutagenic effects of synthetic
resins in man (abstract). Mutat. Res. 97: 224 (1982).
Swarin, S. J., and Lipari, F Determination offormaldehyde and other
aldehydes by high performance liquid chromatography with fluores-
cence detection. J. Liquid Chromat. 6: 425-444 (1983).
Swenberg, J. A. Formaldehyde induced carcinogenesis of the nasal
cavity. Thirty-second AnnualMeeting, AmericanCollegeofVeterinary
Pathologists, PulmonaryPathology, November 10-13, 1981, Monterey,
California.
Swenberg, J. A., Barrow, C. S., Boreiko, C. J., Heck, H. D'A.,
Levine, R. J., Morgan, K. T., and Starr, T. B. Nonlinear biological
responses to formaldehyde and theirimplications forcarcinogenic risk
assessment. Carcinogenesis 4: 945-952 (1983).
Swenberg, J. A., Gross, E. A., Morgan, K. T., Chang, J. C. F., and
Barrow, C. S. Effects of formaldehyde concentrations on deposition
and cell proliferation (abstract). Proc. Am. Assoc. Cancer Res. 23: 55
(1982).
Swenberg, J. A., Kerns, W D., Mitchell, R. I., Gralla, E. J., and
Pavkov, K. L. Induction of squamous cell carcinomas ofthe rat nasal
cavity by inhalation exposure to formaldehyde vapor. Cancer Res. 40:
3398-3402 (1980).
Swenberg, J. A., Kerns, W, Pavkov, K., Mitchell, R., and Gralla, E.
J. Carcinogenicity of formaldehyde vapor: interim findings in a
long-term bioassay of rats and mice. In: Mechanisms of Toxicity and
Hazard Evaluation (B. Holmstedt, R. Lauwerys, M. Mercier and M.
Roberfroid, Eds.) Elsevier/North Holland, 1980, pp. 283-286.
Szabad,J., Soos, I., Polgar, G., andHejja, G. Testingthemutagenicity
ofmalondialydehyde and formaldehyde by the Drosophila mosaic and
the sex-linked recessive lethal tests. Mutat. Res. 113: 117-133 (1983).
Temeharoen, P, and Thilly, W G. Toxic and mutagenic effects of
formaldehyde in Salmonella typhimurium. Mutat. Res. 119: 89-93
(1983).
Tephly, T. R., Watkins, W D., and Goodman, J. I. The biochemical
toxicology ofmethanol. In: Essays in Toxicology, Vol. 5. (W J. Hayes,
Jr., Ed.), Academic Press, New York, 1974, pp. 149-177.
Thun, M. J., Lakat, M. F., and Altman, R. Symptom survey of
residents ofhomes insulated with urea-formaldehyde foam. Environ.
Res. 29: 320-334 (1982).
Todhunter, J. A. Letters to the Editor: Carcinogen policy at EPA.
Science 219: 794 (1983).
Todhunter, J. A. Memorandum: review of data available to the
administratorconcerningformaldehydeanddi(2-ethylhexyl)phthalate
(DEHP). Memorandum to Anne M. Gorsuch, February, 1982, Office
ofPesticides andToxic Substances, EnvironmentalProtectionAgency,
Washington, DC.
Tou, J. C., and Kallos, G. J. Study ofaqueous HCl and formaldehyde
mixtures for formation of bis(chloromethyl) ether. Am. Ind. Hyg.
Assoc. J. 35: 419-422 (1974).
Thain, R. (EPA). Health risk and Economic impact assessments of
suspected carcinogens: interim procedures and guidelines FRL 546-2.
Fed. Reg. 41: 21402-21406 (1976).
Traynor, G. W, Allen, J. R., Apte, M. G., Dillworth, J. E, Girman, J.
R., Hollowell, C. D., and Koonce, J. R., Jr. Indoor air pollution from
portable kerosene-fired space heaters, wood-burning stoves, and
wood-burningfurnaces, LBL-14027, Lawrence Livermore Laboratory,
Berkeley, California, NTIS DE82 013014, March, 1982.
Irezl, L., Rusznak, I., Tihak, E., Szarvas, T., and Szende, B.
Spontaneous N(E)-methylation and N(E) -formylation reactions
between L-lysine and formaldehyde inhibited by L-ascorbic acid.
Biochem. J. 214: 289-292 (1983).
Triebig, V G., Trautner, P, and Lutjen-Drecoll, E. Untersuchung zur
Abschatzung einer Formaldehydeinwirkung im anatomischen Pra-
pariersaal. Arbeitsmed. Sozialmed. Praventivmed. 15:264-266(1980).
Tsuchiya, K., Hayashi, Y, Onodera, M., and Hasegawa, T. Toxicity of
formadehyde in experimental animals -concentrations of the
chemical in the elution from dishes of formadehyde resin in some
vegetables. Keio Journal Med. 24: 19-37 (1975).
Tuazon, E. C., Winer, A. M., Graham, R. A., and Pitts, J. N., Jr.
Atmospheric measurements of trace pollutants by kilometer-path-
length FT-IR spectroscopy. In: Advances in Envrionmental Science
and Toxicology, Vol. 10 (J. N. Pitts, Jr., R. L. Metcalf, and D.
Grosjean, Eds.), John Wiley & Sons, New York, 1980, pp. 259-300.
Turiel, I., Hollowell, C. D., Miksch, R. R., Rudy, J. V, and Young, R.
A. The effects ofreduced ventilation on indoor air quality in an office
building. Atmos. Environ. 17: 51-64 (1983).
Tuss, H., Neitzert, V, Seiler, W, and Neeb, R. Method for
determination of formaldehyde in air in the PPTV-range by HPLC
after extraction as 2,4-dinitrophenyl-hydrazone. Fresenius Z. Anal.
Chem. 312: 613-617 (1982).
Uehara, M. Follicular contact dermatitis due to formaldehyde.
Dermatologica 156: 48-54 (1978).
Uehleke, H. Wo liegen Sicherheit und Gefahren von Formaldehyd?
Umweltmedizin 3: 48-51 (1981).
United States of America Standards Institute. USA standard
acceptable concentrations offormaldehyde. United States ofAmerica
Standards Institute, New York, New York, USAS Z37.16 (1967).
United States Court of Appeals. Gulf South Insulation v. United
States Consumer Product Safety Commission, C. P Chemical
Company, Inc. v. Consumer Product Safety Commission, Public
Citizen v. Consumer Product Safety Commission, The Formaldehyde
Institute, Inc. v. United States Consumer Product Safety Commis-
sion. Nos. 82-4218, 82-4136, 82-4311, 82-4135. United States Court
of Appeals, Fifth Circuit, Apr: 3632-3645 (1983).
Uotila, L., and Koivusalo, M. Formaldehyde dehydrogenase from
human liver. J. Biol. Chem. 249: 7653-7663 (1974).CONSENSUS WORKSHOP ON FORMALDEHYDE 379
Usdin, V R., and Arnold, G. B. Final Report: Transfer of formal-
dehyde to guinea pig skin. Gillette Research Institute (Contract No.
78-391), Rockville, Maryland (1979).
Vainio, H. Inhalation anesthetics, anticancer drugs and sterilants as
chemical hazards in hospitals. Scand. Work, Environ. Health 8:
94-107 (1982).
Van Der Wal, J. F Formaldehyde measurements in Dutch houses,
schools and offices in the years 1977-1980. Atmos. Environ. 16:
2471-2478 (1982).
Van Duuren, B. L., Sivak, A., Goldschmidt, B. M., Katz, C., and
Melchionne, S. Carcinogenicity of halo-ethers. J. Natl. Cancer Inst.
43: 481-486 (1969).
Van Netten, C. Analysis of sources contributing to elevated formal-
dehyde concentrations in the air in a new elementary school. Can. J.
Publ. Health 74: 55-59 (1983).
Vicini, J. L., Clark, J. H., and Crooker, B. A. Effectiveness ofacetic
acid and formaldehyde for preventing protein degradation in the
rumen. J. Dairy Sci. 66: 350-354 (1983).
Volkova, Z. A., and Sidorova, E. A. Formaldehyde content in the
blood ofworkers incontactwithurea-formaldehyde resins(translation
available). Gig. Truda Profess. Zabol. 15: 44-46 (1971).
Von Einbrodt, H. J., Prajsnar, D., and Erpenbeck, J. Der Formal-
dehyd- und Ameisensaurespiegel im Blut und Urin beim Menschen
nach Formaldehyde Exposition (The formaldehyde and formic acid
levels in the blood and urine ofman upon exposure to formaldehyde).
Zentralbl. Arbeitsmed. Arbeitsschutz und Prophyl. 26: 154-158
(1976).
Walker, J. F. Formaldehyde. Kirk-Othmer Encyclopedia of Chemical
Technology, 2nd ed., Vol. 10, John Wiley & Sons, New York, 1966, pp.
77-99.
Walrath, J., and Fraumeni, J. F, Jr. Mortality patterns among
embalmers. Intern. J. Cancer 31: 407-411 (1983).
Watanabe, F., and Sugimoto, S. Studies on the carcinogenicity of
aldehydes (Part II). Seven cases of transplantable sarcomas of rats
developed inthe area ofrepeated subcutaneous injections ofurotropin
(Hexamethylene tetramine). Gann 46: 365-367 (1955).
Watanabe, F, and Sugimoto, S. Study on the carcinogenicity of
aldehyde (Report 3). Fourcases ofsarcomas in rats appearing in areas
ofrepeated subcutaneous injection ofacetaldehyde. Gann 47: 599-601
(1956).
Watanabe, F, Matsunaga, T., Soejima, T., and Iwata, Y Study on
aldehyde carcinogenicity. Communication I. Experimentally induced
rat sarcomas by repeated injection of formalin. Gann 45: 451-452
(1954).
Waydhas, C., Weigl, K., and Sies, M. The disposition offormaldehyde
and formate arising from drug N-demethylations dependent on
cytochrome P-450 in hepatocytes and in perfused rat liver. Eur. J.
Biochem. 89: 143-150 (1978).
Weber-Tschopp, A., Fischer, T., and Grandjean, E. Irritating effects
of formaldehyde on men (Summary only translated). Intern. Arch.
Occup. Environ. Health 39: 207-218 (1977).
Weber-Tschopp, A., Jermini, C., and Grandjean, E. Luftverunreini-
gung und Belastigung durch Zigaretten Rauch (Air pollution and
irritation due to cigarette smoke) (abstract). Sozial- Praeventivmed.
21: 101-106 (1976).
Weinstein, I. B. Letters: Carcinogen policy at EPA. Science 219:
794-795 (1983).
Weiss, W, Moser, R. L., and Auerbach, C. Lung cancer in
chloromethyl ether workers. Am. Rev. Respir. Dis. 120: 1031-1037
(1979).
Werner, J. Experiences in formaldehyde reduction from health
aspects. Inst. Vatten-och Luftvardsforskning, Stockholm, Sweden,
1979.
Wessel, M. R. The state ofthe science conference: a new approach to
scientific decision making. Fundamentals Appl. Toxicol. 2: 283-288
(1982).
Whittinghill, M., and Lewis, B. M. Clustered crossovers from male
Drosophila raised on formaldehyde media. Genetics 46: 459-462
(1961).
Wiberg, G. S., and Baranowski, E. Health implications of urea-
formaldehyde foam insulation. Can. J. Publ. Health 72: 335-338
(1981).
Willdns, R. J., and MacLeod, H. D. Formaldehyde induced DNA-
protein crosslinks in Escherichia coli. Mutat. Res. 36: 11-16 (1976).
Williams, R. T. The metabolism of some aliphatic aldehydes, ketones
and acids: Aliphatic aldehydes. In: Detoxification Mechanisms: The
Metabolism and Detoxication of Drugs, Toxic Substances and Other
Organic Compounds, 2nd ed. (R. T. Williams, Ed.), John Wiley &
Sons, New York, 1959, pp. 88-90.
Williford, B. Letters tothe Editor: Potentialhazards offormaldehyde.
J. Am. Dental Assoc. 104-288 (1982).
Willingmyre, G. T. Reuse of single-use hemodialyzers: technical,
legal, medical and economic implications. Health Industry Manu-
facturers Association Report, Washington, D. C., March 1979.
Wills, J. H. Nasal carcinoma in woodworkers: a review. J. Occup.
Med. 24: 526-530 (1982).
Wong, 0. Epidemiologic studies of occupational cancers: approaches
and data sources (abstract). Abstracts of Papers of the American
Chemical Society, 182: abstract 24 (1981).
Wood, R. W Determinants of irritant termination behavior. Toxicol.
Appl. Pharmacol. 61: 260-268 (1981).
Yager, J. W, Cohn, K., Spear, R., Fisher, J. M., and Morse, L.
Exposure to formaldehyde in a gross anatomy laboratory. Internal
Project Report, Northern California Occupational Health Center,
School ofPublic Health, University ofCalifornia, Berkeley, California,
December, 1982.
Yefremov, G. G. State ofthe upper respiratory tract in formaldehyde
production workers (by the data ofthe a special investigation). Zhur.
Ushnykh. Nos. Forl. Bolez. 30: 11-15 (1970).
Yodaiken, R. E. The uncertain consequences offormaldehyde toxicity.
J. Am. Med. Assoc. 246: 1677-1678 (1981).
York, M., Lawrence, R. S., and Gibson, G. B. An in vitro test for the
assessment of eye irritancy in consumer products-preliminary
findings. Intern. J. Cosmet. Sci. 4: 223-234 (1982).
Young, E. Overgevoeligheid voor formaldehyde (Hypersensitivity to
formaldehyde). Nederlands Tijdschr. Geneeskunde 126: 985-989
(1982).
Zapp, J. A., Jr. HMPA: apossible carcinogen. Science 190: 422 (1975).
Zarubin, G. R, Dmitriev, M. T., and Mishchikhin, V A. Hygienic
prediction ofindoor air pollution by harmful substances released from
polymeric materials. Gig. Sanitar. 4: 51-54 (1981).
Zitting, A., and Savolainen, H. Biochemical effects ofsubacute formic
acid vapor exposure. Res. Commun. Chem. Pathol. Pharmacol. 27:
157-162 (1980).
Zitting, A., Savolainen, H., and Nickels, J. Biochemical and
toxicological effects of single and repeated exposures to polyacetal
thermodegradation products. Environ. Res. 29: 287-296 (1982).
Appendix II. List of Panelists
E. A. Acheson
MRC Environmental Health Unit
Southhampton General Hospital
Southhampton, S09 4XT, England
Yves Alaire
Graduate School of Public Health
University of Pittsburgh
Pittsburgh, PA 15261CONSENSUS WORKSHOP ON FORMALDEHYDE
Roy Albert
New York University Medical Center
Institute of Environmental Medicine
550 First Avenue
New York, NY 10015
Joseph Arcos
Existing Chemical Assessment Division
Office of Ibxic Substances
United State Environmental Protection Agency
401 M St., S. W
Washington, DC 20460
Jean L. Balmat
E. I. du Pont de Nemours
Chemicals and Pigments Department
Experimental Station 336/243
Wilmington, DE 19898
James R. Beall
United States Department of Energy
ER-72, E-201 GTN
Washington, DC 20545
Ruth E. Billings
University of Texas Health Science Center
Department of Pharmacology
P 0. Box 20708
Houston, TX 77225
Aaron Blair
National Cancer Institute
Landow Building, Rm. 4C16
Bethesda, MD 20205
Craig Boreiko
Chemical Industry Institute of Toxicology
P 0. Box 12137
Research Triangle Park, NC 27709
Sarah H. Broman
Mental Retardation and Learning Disorders Section
Developmental Neurology Branch
NINCDS, CDNCP, NIH
7550 Wisconsin Ave., Rm. 8C-06
Bethesda, MD 20205
Charles C. Brown
National Cancer Institute
Landow Building, Rm. 5C03
Bethesda, MD 20205
Frank W Carlborg
400 South Ninth Street
Saint Charles, IL 60174
Jean Chen Shih
Institute for Tbxicology
University of Southern California
John Stauffer Pharmaceutical Sciences Center
1985 Zonal Ave.
Los Angeles, CA 90033
Murray S. Cohn
Consumer Product Safety Commission
5401 Westbard Avenue
Bethesda, MD 20207
Michael J. Colligan
National Institute for Occupational Safety and Health
4676 Columbia Parkway
Cincinnati, OH 45226
Thomas F. Coflins
Bureau of Foods
Food and Drug Administration
FB8, 200 C St., S. W
Washington, DC 20204
Jack H. Dean
Department of Cell Biology
Chemical Industry Institute of Toxicology
P 0. Box 12137
Research Triangle Park, NC 27709
Frederick J. de Serres
National Institute of Environmental Health Sciences
A2-02, P 0. Box 12233
Research Triangle Park, NC 27709
John M. Fajen
National Institute for Occupational Safety and Health
Industry-Wide Studies Branch
4676 Columbia Parkway
Cincinnati, OH 45226
Victor J. Feron
Institute CIVO-Toxicology and Nutrition TNO
P. 0. Box 360
3700 AJZEIST, The Netherlands
John F. Gamble
NIOSH/DRDS Epidemiology Investigation Branch
944 Chestnut Ridge Road
Morgantown, WV 26505
Richard Gammage
Rm. S-256, Bldg. 45005
Oak Ridge National Laboratory
P 0. Box X
Oak Ridge, TN 37830
David Gaylor
Division of Biometry
National Center for Toxicological Research
Jefferson, AR 72079
James E. Gibson
Chemical Industry Institute of Tbxicology
P 0. Box 12137
Research Triangle Park, NC 27709
Leon Golberg
Division of Occupational Medicine
Box 2914
Duke University Medical Center
Durham, NC 27710
Richard Griesemer
Biology Division
P 0. Box 4, Bldg. 9207
Oak Ridge National Laboratory
Oak Ridge, TN 37830
K. C. Gupta
Consumer Products Safety Commission
5401 Westbard Avenue
Bethesda, MD 20207
Henry d'A. Heck
Chemical Industry Institute of Tbxicology
P 0. Box 12137
Research Tiangle Park, NC 27709
Peter F. Infante
United States Department of Labor/OSHA
Health Standards Program-Rm. N3718
200 Constitution Avenue, N. W
Washington, DC 20210
Eugene R. Kennedy
National Institute for Occupational Safety and Health
4676 Columbia Parkway
Cincinnati, OH 45226
Carole A. Kimmel
Perinatal and Postnatal Evaluation Branch
Division of Teratogenesis Research
National Center for Tbxicological Research
Jefferson, AR 72079
380CONSENSUS WORKSHOP ON FORMALDEHYDE
Michael D. Lebowitz
Department of Internal Medicine
University of Arizona Health Sciences Center
Division of Respiratory Sciences, Rm. 2332
Tucson, AZ 85724
Keith R. Long
Institute of Agricultural Medicine and Environmental Health
University of Iowa
Oakdale, IA 52319
Mary F Lyon
MRC Radiobiology Unit
Harwell Didcot
Oxon OR1l ORD, England
Howard Maibach
University of California Medical School
San Francisco, CA 94143
Thomas A. Marks
Teratology and Reproduction
Upjohn Co.
301 Henrietta St.
Kalamazoo, MI 49001
J. Justin McCormick
Michigan State University
Carcinogenesis Lab, Fee Hall
East Lansing, MI 48824
Edward A. Mortimer, Jr.
Dept. of Epidemiology and Community Health
Case Western Reserve University School of Medicine
Cleveland, OH 44106
Paul Nettesheim
Laboratory of Pulmonary Function and Toxicology
National Institute of Environmental Health Sciences
P 0. Box 12233
Research Triangle Park, NC 27709
Ian Nisbet
Clement Associates, Inc.
1515 Wilson Blvd., Suite 700
Arlington, VA 22209
Godfrey P Oakley, Jr.
Birth Defects Branch
Chronic Disease Division
Centers for Disease Control
1600 Clifton Rd., N. E.
Atlanta, GA 30333
Roy Patterson
Department of Medicine
Northwestern University Medical School
303 E. Chicago Ave.
Chicago, IL 60611
Jack Pepys
34 Ferncroft Ave.
Hampstead
London NW3 7PE, England
Kenneth J. Rothman
Epidemiology Department
Harvard School of Public Health
677 Huntington Avenue
Boston, MA 02115
Marc Schenker
Occupational and Environmental Health Unit
Department of Medicine, TB 136
University of California Davis
Davis, CA 95616
Marvin A. Schneiderman
6503 Halbert Road
Bethesda, MD 20817
Bernd Seifert
Institute for Water, Soil and Air Hygiene
Federal Health Office
Corrensplatz 1, D-1000 BERLIN 33
Federal Republic of Germany
Anna Seppalainen
Institute of Occupational Health
Haartmaninkatu 1, SF-00290
Helsinki 29, Finland
Robert Sielken, Jr.
Institute of Statistics
Texas A&M University
College Station, TX 77843
Michael Silverstein
Occupational Health Physician
United Auto Workers
8000 East Jefferson
Detroit, MI 48214
James A. Swenberg
Chemical Industry Institute of Toxicology
P 0. Box 12137
Research Tiangle Park, NC 27709
Thomas R. Tephly
The Toxicology Center
Department of Pharmacology
University of Iowa
Iowa City, IA 52242
Benjamin F Trump
Department of Pathology
University of Maryland School of Medicine
Baltimore, MD 21201
Andrew G. Ulsamer
Consumer Product Safety Commission
5401 Westbard Ave.
Bethesda, MD 20207
Arthur C. Upton
Department of Environmental Medicine
New York University Medical Center
550 First Ave.
New York, NY 10016
Jerrold M. Ward
National Cancer Institute
Frederick Cancer Research Facility
Building 538
Frederick, MD 21701
Phillip G. Watanabe
Director of Toxicology Research Laboratory
Dow Chemical U.S.A., 1803 Bldg.
Midland, MI 48640
Sidney Weinhouse
Fels Research Institute
Temple University School of Medicine
3420 N. Broad St.
Philadelphia, PA 19140
Rochelle Wolkowski-Tyl
Center for Environmental Health
Bushy Run Research Center
RD 4 Mellon Rd.
Export, PA 15632
Mike Wright
United Steelworkers of America
Safety and Health Department, Rm. 901
Five Gateway Center
Pittsburgh, PA 15222
381